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1 SECTION I: Overview 
1.1 Abstract  
Background: The Hospital Eye Service (HES) was receiving an 
unsustainable level of new referrals for suspected glaucoma, which was 
resulting in delays in clinic appointments. In an attempt to reduce the burden 
on the HES the concept of refining a referral from the high street optometrist 
was introduced. Glaucoma Referral Refinement schemes (GRRS) have 
proliferated across the country over the past decade, often demonstrating 
marked variation in pathway design, referral criteria as well as the level of 
specialist optometrist competency and training. Standardisation of GRRS 
through national policy is required. 
Plan of Research: The investigations are focused around 6 parts. The first 
three parts address referral criteria of GRRS and the agreement between eye 
health professionals through a multi-site review of schemes in England. The 
next two parts look at the experience of care and the access to eye health in a 
GRRS. The last section builds upon the findings from the first three parts and 
focuses on safety and in particular the role of virtual review in these schemes. 
Results: Specialist optometrists working within GRRS can reduce the 
proportion of patients discharged at the first visit in the HES. However 
overemphasis on intra-ocular pressure as a criterion for referral is having an 
adverse effect on detection of glaucomatous optic nerve features. Low-risk 
referrals are suitable for specialist optometrist review, with virtual review an 
effective extra safety measure. High-risk referrals should be reviewed directly 
in the HES.  
Clinical Significance: GRRS is a safe and cost effective method of reviewing 
low-risk glaucoma referrals. This research can contribute evidence to help 
establish a national policy for both the referral criteria and the organisational 
set-up of GRRS in the UK. 
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2 SECTION II: Introduction 
2.1 Glaucoma 
2.1.1 Definition 
 
Glaucoma is the name given to a group of disorders that are characterised by 
both optic nerve head damage and visual field loss (Hitchings, 1996). The 
characteristic enlargement of the optic nerve cup and visual field loss are a 
result of retinal ganglion cell death. The traditional triad of raised intra-ocular 
pressure (IOP), enlargement of the optic nerve cup and visual field loss are 
perceived to be the hallmark features of glaucoma. 
 
Although raised IOP does not form part of the definition for glaucoma, a raised 
IOP is recognised as one of the strongest risk factors for glaucoma (Wilson 
and Martone, 1996). Large, population-based epidemiological studies have 
demonstrated the mean IOP to be 15.5mmHg with a standard deviation of 
2.6mmHg (Leydhecker, 1976). Subsequently a “normal” IOP range was 
defined as 2 standard deviations above and below the mean, approximately 
10-21mmHg. The Baltimore Eye Survey showed increased risk of 
glaucomatous optic nerve damage with increased IOP, particularly above 
22mmHg (Sommer et al., 1991b). Despite this trend there is no IOP that can 
effectively be labelled as “safe” with damage occurring in some individuals 
with IOP as low as 12mmHg (Infeld and O'Shea, 1998). 
 
2.1.2 Classification 
 
Glaucoma is classified as open angle or closed angle as well as primary or 
secondary. Open angle glaucoma is classified as primary when no 
anatomically identifiable underlying cause to outflow obstruction and IOP 
elevation can be found. Glaucoma can be classified as secondary when there 
is a known abnormality and pathogenesis. It is argued that all glaucomas are 
in fact secondary to some abnormality, whether currently identified or not 
(Cioffi et al., 2010). 
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2.1.2.1 Primary Open Angle Glaucoma (POAG) 
 
POAG can be further sub-divided on the basis of the untreated IOP into High 
Tension Glaucoma (HTG) and Normal Tension Glaucoma (NTG), with HTG 
being the commonest cause of glaucoma worldwide. 
 
Prevalence varies depending on age and ethnicity. It is estimated the 
worldwide prevalence for POAG in those aged over 40 is 2.1% (2.1% among 
white Europeans, 4.2% among black Africans and 1.4% among Asians) 
(Rudnicka et al., 2006). The UK prevalence of POAG in those aged over 40 
has been estimated at 1.2% (Tuck and Crick, 1998). 
 
POAG is usually insidious in onset, slowly progressive and demonstrates 
some bilaterality. The disease is often asymptomatic until significant visual 
field loss has occurred as central vision is relatively unaffected until late in the 
disease. For a diagnosis of HTG to be given the anterior chamber angle must 
be open on gonioscopic examination, the IOP have exceeded 21mmHg at 
some point in the disease and the optic nerve have evidence of glaucomatous 
damage. Visual field loss does not necessarily have to be present to reach the 
diagnosis as evidence has demonstrated anatomical changes can occur 
before detectable functional changes; so called pre-perimetric glaucoma 
(Quigley et al., 1982, Quigley et al., 1992, Sommer et al., 1991a, Sommer et 
al., 1979a). 
 
NTG is diagnosed when the untreated IOP is always below 22mmHg in the 
presence of an open anterior chamber angle on gonioscopic examination and 
evidence of glaucomatous damage to the optic nerve. Whether NTG 
represents a distinct disease entity from HTG is the source of considerable 
debate as IOP is a continuous variable with no clear division of normality from 
abnormality (Caprioli and Spaeth, 1984, Chumbley and Brubaker, 1976, 
Drance et al., 1973a, Drance et al., 1973b, Lewis et al., 1983). Most of the 
evidence suggests that IOP is an important risk factor for NTG (Araie et al., 
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1994, Jonas et al., 1998), though evidence for the opposite argument is also 
present (Noureddin et al., 1991). The prevalence of NTG for those aged over 
40 years is 0.2% - 0.6% (Klein et al., 1992, Bonomi et al., 1998). 
2.1.2.2 Ocular Hypertension 
 
Primary ocular hypertension (OHT) is diagnosed in the presence of an 
elevated IOP (normally greater than 21mmHg) but in the absence of structural 
and functional damage and an open angle on gonioscopy. If there is an 
attributable cause, either ocular or systemic, for the elevated IOP this is 
termed secondary OHT. The prevalence of OHT varies widely depending on 
ethnicity and age. Prevalence amongst Japanese over the age of 40 years is 
0.9% (Iwase et al., 2004), for a predominately white Australian population 
over the age of 49 years it is 3.7% (Mitchell et al., 1996), whilst in an African 
Caribbean population over 40 years the prevalence is 12.6% (Nemesure et 
al., 2003). The Framingham Eye Study showed 6.2% of Caucasians under 65 
years of age had an IOP greater than 21mmHg, while this increased to 8.7% 
for those over 75 (Leibowitz et al., 1980). OHT is a risk factor for the 
development of POAG, with a 10% conversion risk over ten years if untreated 
(Kass et al., 2002). 
 
2.1.2.3 Angle Closure Glaucoma 
 
Angle closure is defined by the apposition of the peripheral iris to the 
trabecular meshwork and the resulting reduced drainage of aqueous humour. 
A person with 180 degrees or more of iridotrabecular contact in primary gaze 
on gonioscopy is at risk of angle closure glaucoma or an acute attack of angle 
closure. A person with this amount of iridotrabecular contact, no peripheral 
anterior synechaie, and a normal IOP is considered a primary angle closure 
suspect (Weinreb and Friedman, 2006). It accounts for half the total 
prevalence of glaucoma worldwide. Primary angle closure glaucoma (PACG), 
which can be acute or chronic, is the commonest cause of bilateral blindness 
(Cioffi et al., 2010). Incidence figures are more appropriate than prevalence 
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for acute PACG as it often manifests with acute and transient symptoms. 
Prevalence is more appropriate for chronic PACG. The prevalence of PACG 
varies widely depending on ethnicity with an age and gender standardised 
values of 4.7/100 000 in Finland (Teikari et al., 1987) to 15.5/100 000 among 
Chinese Singaporeans (Seah et al., 1997, Wong et al., 2000). 
 
 
Some of the content from 2.1.3, 2.1.4 and 2.1.5 has been adapted from 
Shield’s Textbook of Glaucoma and its references. 
 
2.1.3 Epidemiology of POAG 
 
Glaucoma affects more than 67 million people worldwide, of whom 10% are 
estimated to be blind (Quigley, 1996). Glaucoma is the leading cause of 
irreversible blindness worldwide, and only cataracts are a more common 
cause of blindness. In excess of £300 million was spent on glaucoma in the 
UK in 2002 (Rouland et al., 2005). Not only are more patients being started on 
topical treatment at an earlier stage, but also the cost of treatment is rising. 
Furthermore, only 45% of the costs associated with glaucoma are direct 
medical costs, with 20% direct nonmedical costs and 35% indirect costs 
(Rouland et al., 2005). 
 
The two most important measures of all epidemiological studies are incidence 
and prevalence. Incidence is the number of new cases in a given population 
over a specified period of time, and is derived from cohort studies, trials and 
disease registers. Prevalence is the number of all cases in a given population 
at one point in time, and this can be determined from cross-sectional studies 
and disease registers.  
 
The prevalence of open-angle glaucoma varies greatly among ethnic groups 
(table 2-1). Prevalence amongst black populations is generally higher than 
whites or Hispanics (4.7% vs 1.3% and 2.0%) (Tielsch et al., 1991, Quigley et 
al., 2001). The reported prevalence of POAG in Asian populations varies 
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considerably with several studies reporting incidences comparable to white 
populations (1.7% in India to 2.6% in Japan) (Ramakrishnan et al., 2003, 
Shiose et al., 1991), whilst others have reported lower incidences (Mongolian 
0.5% and Alaskan Inuit 0.1%) (Arkell et al., 1987, Foster et al., 1996). 
 
Age has an even more powerful influence (figure 2-1) and can be a useful 
clinical adjunct when assessing an individual’s probability of POAG, especially 
when combined with their ethnic group; though some caution does need to be 
applied as the definition of glaucoma in these studies has varied considerably 
(Foster et al., 2002). 
 
  
Table 2-1. Prevalence of open angle glaucoma in selected population-based 
studies 
(Adapted from Shield’s Textbook of Glaucoma) 
 
Ethnic Group, Location and 
Year  
Age Group 
(years) 
Number of 
Participants 
Prevalence 
of POAG 
 
WHITE 
 
Baltimore, USA, 1991  
 
>40 2913 1.3% 
 
Beaver Dam, USA, 1992  43-84 4926 2.1% 
 
Bedford, UK, 1968  >30 5941 0.7% 
 
Blue Mountains, Australia, 1996  >49 3654 3.0% 
 
Egna-Neumarkt, Italy, 1998  >40 5816 1.4% 
 
Framingham, USA, 1977  52-85 2477 1.2% 
 
Melbourne, Australia, 1998  40-98 3271 1.7% 
 
Rhonda Valley, UK, 1966  40-74 4231 0.3% 
 
Roscommon, Ireland, 1993  >50 2186 1.9 
 
Rotterdam, Netherlands, 1994  >55 3062 3.1% 
 
Reykjavik, Iceland, 2003  >50 1045 4.0% 
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BLACK 
 
Baltimore, USA, 1991  
 
 >40  2396  4.7% 
Barbados, 1994  
 
40-84  4709  6.6% 
Kongwa, Tanzania, 2000  
 
>40  3268  3.1% 
St. Lucia, 1989  
 
30-86  1679  8.8% 
Temba, South Africa, 2003  >40 839 2.9% 
 
HISPANIC 
 
Arizona, USA, 2001  
 
>40  4774  2.0% 
 
ASIAN 
 
Andhra Pradesh, India, 2000  
 
>40  1399  2.6% 
Japan, 1991  
 
>40  8126  2.6% 
Hovsgol, Mongolia, 1996  
 
>40  1000  2.2% 
Singapore, 2000  
 
40-79  1717  2.4% 
Tamil Nadu, India, 2003  >40 5150 1.7% 
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Figure 2-1. Age-specific prevalence of open angle glaucoma from selected 
surveys 
(Adapted from Shield’s Textbook of Glaucoma) 
 
 
 
2.1.4 Risks factors for POAG and NTG 
 
Understanding the risk factors for glaucoma is important when clinically 
assessing a patient and formulating risk assessment. Risk factors help identify 
patients at greatest risk of progressing to symptomatic glaucoma. Many of the 
risk factors for HTG also apply to NTG though there are certain risk factors 
that are more specific to NTG and therefore these will be described 
separately.  
 
 
 
 17 
2.1.4.1 Risk factors for HTG 
 
Optic Nerve Head 
It can be argued that the appearance of the optic nerve head is both one of 
the strongest risk factors for POAG as well as a diagnostic sign. Evidence 
suggests a large cup:disc ratio in itself is a risk factor (Epstein et al., 1989, 
Schulzer et al., 1991), though some argue this merely represents undetected 
existing glaucomatous damage. 
 
IOP 
IOP is one of the strongest risk factors for glaucoma progression and much 
emphasis is placed on this measurement in the clinical assessment of 
patients (Gordon et al., 2002, Kass et al., 2002, Kass et al., 1989, Quigley et 
al., 1994). It is known that as the IOP increases the risk of POAG diagnosis 
also increases (Gordon et al., 2002). The Ocular Hypertension Treatment 
Study (OHTS) demonstrated that a reduction in IOP resulted in reduced 
incidence of glaucoma (Kass et al., 2002). The Early Manifest Glaucoma Trial 
(EMGT), the Collaborative Normal Tension Glaucoma Study Group (CNTGS) 
and the United Kingdom Glaucoma Treatment Study (UKGTS) highlighted 
that a reduction in IOP also resulted in reduced progression of glaucoma 
compared to no treatment (CNTGS, 1998, Heijl et al., 2002, Garway-Heath et 
al., 2015). 
The diurnal variation, as well as the range over several days is also a risk 
factor (Asrani et al., 2000, Bengtsson et al., 2007, Wilensky et al., 1993). 
 
Age 
Age is known to be one of the most important risk factors for the presence 
and progression of POAG. The Baltimore Eye Survey found the prevalence of 
glaucoma increased dramatically with age, and this was more pronounced in 
black populations where prevalence in those aged over 80 was 11% (Tielsch 
et al., 1991). The Collaborative Initial Glaucoma Treatment Study (CIGTS) 
showed that visual field defects were 7 times more likely to develop in those 
aged over 60 compared to younger than 40 (Gillespie et al., 2003). The 
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EMGT identified the relative risk of progression of early glaucoma was 1.5 for 
those 68 years or older compared to those younger than 68 (Leske et al., 
2003). 
 
 
 
Race  
POAG is four to six times more prevalent and develops at an earlier age in 
African Americans compared to Caucasians (Tielsch et al., 1991, Friedman et 
al., 2006, Lichter et al., 2001, Sommer et al., 1991c). A meta-analysis has 
confirmed the above findings, whilst also reporting Caucasians showed the 
steepest increase in POAG prevalence with age (Rudnicka et al., 2006). 
Chinese individuals have a reduced risk of progression compared to 
Caucasians as demonstrated in the CNTGS (Drance et al., 2001).  
 
Family History 
A family history is a known risk factor for POAG, although the exact 
inheritance pattern is unknown. The Glaucoma Inheritance Study in Tasmania 
found patients with genealogically confirmed familial POAG were significantly 
younger at diagnosis and had more severe disease than those with sporadic 
POAG (Wu et al., 2006). The Rotterdam Study found a 10-fold increase in the 
lifetime absolute risk of POAG at the age of 80 years in those with a positive 
family history of glaucoma (Wolfs et al., 1998). Likewise, the Barbados Family 
Study of Open-Angle Glaucoma found family history to be a major risk for 
POAG among black individuals (Leske et al., 2001).  
 
 
Genetics 
The genetics of glaucoma is complex with environmental interactions believed 
to play a crucial role in both its development and age of onset. However 
Mendelian inheritance is also observed in patients with MYOC mutations 
(Resch and Fautsch, 2009, Sheffield et al., 1993). 
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In order to develop a better understanding of the pathogenesis of all the 
glaucoma phenotypes a major emphasis has been placed in identifying the 
causative genes of inherited glaucoma. So far 15 glaucoma loci have been 
discovered, and can be grouped into three categories: GLC1, GLC2, and 
GLC3, referring to POAG, PACG, and congenital glaucoma (CG), 
respectively.  
 
The causative gene at the GLC3A locus is CYP1B1, encoding a cytochrome 
P450 enzyme, involved in the metabolism of steroids, retinol/retinal, 
arachidonate, and melatonin (Stoilov et al., 1997, Vasiliou and Gonzalez, 
2008). Mutations in the lysyl oxidase-like 1 (LOXL1) gene at 
chromosome15q22 cause exfoliative glaucoma (Thorleifsson et al., 2007). 
The gene underlying GLC1A is the trabecular meshwork-inducible 
glucocorticoid response factor (TIGR), also known as myocilin (MYOC) 
(Kubota et al., 1998, Stone et al., 1997). The gene underlying NTG on 
chromosome 10 is optineurin (OPTN) (Rezaie et al., 2002). GLC1 glaucoma 
results from WDR36 mutations (Monemi et al., 2005). Mutations of NTF4 
(Pasutto et al., 2009) and LTBP2 (Ali et al., 2009, Moren et al., 1994, Narooie-
Nejad et al., 2009) cause POAG and CG, respectively. Mutations of the PITX2 
(Alward et al., 1998, Kulak et al., 1998, Semina et al., 1996) and FOXC1 
(Mears et al., 1998) genes cause Axenfeld-Rieger syndrome. 
 
 
 
Diabetes 
The effect of diabetes on the development of POAG is controversial with 
several studies demonstrating a relationship between diabetes and POAG 
diagnosis and progression (Klein et al., 1994, Mitchell et al., 1997, Leske et 
al., 2003, 2002), although the Baltimore Eye Survey found this association 
weak (age-race adjusted odds ratio 1.03; 95% CI, 0.85-1.25). The OHTS 
suggested diabetes might actually be protective against progression from 
OHT to POAG (hazard ratio of 0.37 in the multivariate analysis with p < 0.05) 
(Kass et al., 1989). 
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Hypertension 
Like diabetes the literature is divided with respect to the effect of hypertension 
on the development of POAG. The Blue Mountains Eye Study showed 
participants with POAG were more likely to have systemic hypertension 
compared to those without POAG (65.7%; 95% CI, 56.6-74.8 vs 45.4%; 95% 
CI, 43.8-47.1) (Lee et al., 2006). This association however was not observed 
in larger population based studies such as the Framingham Eye Study (Kahn 
et al., 1977). There is also epidemiological and trial evidence that the 
treatment for hypertension may be an important risk factor (Coleman and 
Miglior, 2008, De Moraes et al., 2012). 
Lower perfusion pressure (blood pressure – IOP) was strongly associated 
with an increased prevalence of POAG, with a six fold increase for those in 
the lowest perfusion pressure category (Tielsch et al., 1995).  
 
Myopia 
Myopia is associated with an increased frequency of POAG and OHT, as well 
as an increased progression of OHT to POAG (Perkins and Phelps, 1982). 
POAG is found more commonly in those with a myopic refraction exceeding -
6 dioptres compared to low myopia of -3 dioptres or less (Xu et al., 2007). 
 
Pseudoexfoliation and migraine have also been reported as risk factors for 
glaucoma progression (Leske et al., 2003, Drance et al., 2001). 
 
 
 
 
2.1.4.2 Risk factors for NTG 
 
The clinical appearance of patients with HTG and NTG can be 
indistinguishable, however there is evidence to suggest that optic disc 
phenotypes and visual field characteristics differ (Ahrlich et al., 2010, 
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Broadway et al., 1999). Despite its name, a reduction of IOP reduces the risk 
of progression of NTG by two-thirds and implies IOP is involved in the 
pathogenesis. NTG and HTG are both multifactorial diseases where both IOP 
and non-IOP factors play a role. For NTG it seems the non-IOP factors play a 
relatively larger role, including some specific associations (Sommer and 
Tielsch, 1997). 
 
Sleep Apnoea Syndrome 
Repetitive closure of the upper airway in sleep apnoea results in hypoxia, 
hypercapnia and fragmented sleep. It has been postulated that this may lead 
to abnormal autoregulation of blood flow to the optic nerve as a result of blood 
gas abnormalities (Mojon et al., 1999). It has been reported the prevalence of 
NTG in patients with sleep apnoea is higher than controls (Mojon et al., 1999, 
Sergi et al., 2007), although others have found no association (Geyer et al., 
2003, Girkin et al., 2006). 
 
Blood Pressure 
In the Low-pressure Glaucoma Treatment Study (LoGTS), 44.2% of the 
subjects were on hypertensive treatment (Krupin et al., 2005), a similar figure 
that was reported in other studies (Goldberg et al., 1981, Levene, 1980, Leske 
et al., 2007). NTG patients are reported to have lower systolic blood pressure 
than POAG patients (Drance et al., 1973b). In LoGTS, 17% of patients not on 
hypertensive treatment had a systolic pressure lower than 110mmHg and 
21.7% had a diastolic pressure lower than 70mmHg (Krupin et al., 2005, De 
Moraes et al., 2012). This is likely to be linked to other studies associating 
postural and nocturnal hypotension with NTG (Hayreh et al., 1994, Meyer et 
al., 1996).  
 
Migraine and Vasospasm 
The reported occurrence of migraine in patients with NTG varies considerably 
from 37% to 4.4% (Klein et al., 1993, Krupin et al., 2005, Lewis et al., 1989, 
Phelps and Corbett, 1985). The association between migraine and Raynaud’s 
disease to NTG is linked to abnormalities in blood flow caused by vasospasm 
or abnormal autoregulation. Endothelin-1 (ET-1) is a vascular endothelium 
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derived vasoconstricting peptide, which after exposure to the cold, has been 
reported to be raised in patients with glaucoma compared to healthy controls 
(Goldberg et al., 1981). 
 
Autoimmunity 
Autoantibodies to various antigens are present in higher concentrations in the 
sera of glaucoma patients compared to healthy controls. Antibodies to α-
fodrin, heat shock proteins, phosphatidylserine and other antigens have been 
found in NTG (Grus et al., 2006, Kremmer et al., 2001, Wax et al., 1998). It is 
not known whether these autoantibodies represent a marker of injury to the 
optic nerve in glaucoma rather than being causative. If α-fodrin were a marker 
of optic nerve injury then it would be expected to be equally raised in all types 
of glaucoma; however it has been shown to be significantly more raised in 
NTG than POAG (Grus et al., 2006, Kremmer et al., 2001, Wax et al., 1998). 
 
Optic Disc Haemorrhage 
Optic disc haemorrhages are more common in NTG than other types of 
glaucoma, and optic disc haemorrhage is established as a risk factor (Drance 
et al., 2001). 
 
2.1.5 Pathophysiology and anatomy relevant to POAG 
2.1.5.1 Pathophysiology relevant to POAG 
 
The pathogenesis of POAG is related to a disturbance of the structural or 
functional integrity of the eye leading to elevated IOP accompanied by 
progressive damage to the optic nerve and visual field loss. The main cause 
of elevated IOP in POAG is due to increased resistance to outflow through the 
trabecular meshwork (Becker, 1961, Larsson et al., 1995). Much less is 
known about uveoscleral outflow, though it has been demonstrated that eyes 
with severe glaucoma had an 80% increase of uveoscleral outflow compared 
to an 37% increase in contralateral eyes with less severe glaucoma. This 
suggests as POAG progresses there is a shift from trabecular meshwork 
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outflow to uveoscleral when the resistance for the former reaches a critical 
value (Toris et al., 2002, Yablonski et al., 1985). 
 
Within the trabecular meshwork of glaucomatous specimens, endothelial 
numbers are decreased though the basement membrane is thickened, 
suggesting increased cellular activity (Alvarado et al., 1984). Plaques 
consisting of clusters of material appear in the corneoscleral beams and 
juxtacanalicular meshwork leading to reduced inter-trabecular spaces and 
narrowing of the flow pathways to the inner wall endothelium. This is age 
related, though also increased in eyes with POAG (Lutjen-Drecoll et al., 
1986). 
 
Alterations of the extracellular matrix components such as collagen 
fragmentation, altered orientation and abnormal spacing are present in 
specimens with POAG. Fibronectin is deposited in the sub-endothelial region 
of Schlemm’s canal (Babizhayev and Brodskaya, 1989). In addition there is 
an increased expression of myocilin and αB-crystalline in the trabecular 
meshwork in some POAG specimens (Lutjen-Drecoll et al., 1998). In addition 
to the complex alterations to the trabecular meshwork described above, non-
aqueous humour related factors such as diurnal variation in IOP (Liu et al., 
1998, Liu et al., 1999a, Liu et al., 1999b, Liu et al., 2003) and blood pressure 
(Hayreh et al., 1994) are also known to be involved in the development of 
POAG. 
 
2.1.5.2 Anatomy relevant to POAG 
 
1.2 million axons of retinal ganglion cells converge at the optic disc to form the 
optic nerve. The distribution of these axons is important when interpreting 
glaucomatous visual field loss. Within the retina, fibres arising from the fovea 
follow a straight course to the optic nerve head, called the papillomacular 
bundle. Nasal retinal fibres also follow a relatively straight course to the nasal 
optic nerve, whereas temporal fibres follow an arcuate path around the 
papillomacular bundle and are the most vulnerable to glaucomatous damage. 
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Within the optic nerve head, fibres from the peripheral fundus lie deep within 
the retinal nerve fibre layer but occupy the peripheral portion of the optic 
nerve. In contrast fibres originating from near the optic nerve lie within the 
superficial portion of the nerve fibre layer but then occupy the central portion 
of the optic nerve (Kanski, 2003). However, Garway-Heath et al, 
demonstrated when the visual field is mapped to the optic disc in normal 
tension glaucoma this anatomical relationship is rather more complex 
(Garway-Heath et al., 2000).   
 
As the retinal ganglion fibres bend sharply posteriorly at the optic disc they 
are unmyelinated and supported by astrocytes. At the periphery of the disc 
these fibres are covered by the internal limiting membrane of the retina but 
the retinal pigment epithelial cells and the choroid are absent. These fibres 
pass though the orifices of the lamina cribrosa and become myelinated and 
synapse at the lateral geniculate ganglion (Snell and Lemp, 1998).   
 
2.1.5.3 Optic Disc Evaluation  
 
Optic disc evaluation in glaucoma is complex. Certain characteristics are often found 
in glaucomatous optic disc such as progressive narrowing of the neuroretinal rim 
which may be a diffuse narrowing, localised notching, or both in combination (Jonas 
et al., 1988, Sommer et al., 1979b, Tuulonen and Airaksinen, 1991).  
 
The cup to disc ratio alone is of limited value in glaucoma diagnosis without 
knowledge of the size of the disc. A cut-off CDR of 0.6 to identify discs as 
glaucomatous has been reported to have a sensitivity of 92% and specificity of 65% 
(Sommer et al., 1979b) and sensitivity of 85% and specificity of 91% (Garway-Heath 
et al., 1997). 
 
As the cup enlarges in glaucoma, nasal displacement of the main disc vessels may 
occur. However, nasal exit is a feature of physiologically cupped discs (Armaly, 1969, 
Tomlinson and Phillips, 1971) and should not be regarded as acquired unless 
change is observed. A more specific, and early, sign of acquired cup enlargement is 
the bared circumlinear vessel (Herschler and Osher, 1980). Bayonetting refers to the 
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course of disc vessels up a steep cup slope, or undermined rim.  The frequency of 
peripapillary atrophy increases in glaucoma compared to normal eyes (Jonas et al., 
1989). 
 
Hoyt (Hoyt et al., 1973, Hoyt and Newman, 1972) reported slit-like defects, wedge-
shaped defects, and diffuse loss of the nerve fibre layer in glaucoma. Sommer 
(Sommer et al., 1991a) described nerve fibre layer defects up to 6 years before the 
onset of visual field loss in ocular hypertensive patients. The prevalence of nerve 
fibre layer defects in the normal population is very low, at less than 3% (Jonas and 
Schiro, 1994, Quigley et al., 1980). As with rim loss, the initial abnormality in 
glaucoma may be either diffuse thinning or localised defects (Quigley et al., 1980, 
Tuulonen and Airaksinen, 1991). Glaucoma suspects are more likely to have 
localised defects (Airaksinen et al., 1984, Quigley et al., 1980) and patients with field 
defects are more likely to have diffuse loss, with or without localised loss (Airaksinen 
et al., 1984, Tuulonen and Airaksinen, 1991). 
 
The above features may or may not be present in a glaucomatous optic disc, and 
therefore the variation in the literature for inter-professional agreement between 
ophthalmologists, as well as between ophthalmologists and optometrists,  is not 
surprising (Andersson et al., 2011, Kong et al., 2011, van der Schoot et al., 2013, 
Hadwin et al., 2013). It is also reported that quantitative imaging devices out perform 
clinicians at optic disc assessment (Reus et al., 2010). Agreement in optic disc 
assessment will be explored further in chapter 3.4. 
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2.2 Glaucoma Referral Pathway 
 
2.2.1 The introduction of the NHS 
 
During World War II the Conservative party produced the first White Paper in 
which it was proposed that health services would be run by local authorities 
(Health and Department of Health, 1944). However, after Labour’s election 
victory in 1945, Bevan presented a radically different proposal to the Cabinet; 
a nationalised health service where free health care would be provided to all. 
After some concessions the plan was passed. The health service was almost 
entirely funded through central taxation with the wealthier contributing more. 
All persons, including temporary residents and visitors to the country were 
entitled to this free service. This organisation of healthcare had not been seen 
outside the Soviet block, with most ‘western’ countries favouring insurance 
based schemes. 
 
Following the passing of the National Health Service Act of 1946, the National 
Health Service (NHS) was born on 5th July 1948. Society at this time was 
weary and accustomed to austerity following the efforts of World War II. 
Therefore the concept of free health care, including spectacles and dental 
treatment, was seen as a luxury and there was a concerted effort by the rich 
and poor alike to co-operate to help make the NHS a success.  
 
2.2.1.1 The National Health Service Act, 1946 
 
The National Health Service Act, 1946, is divided into 6 parts: 
 
 Part I:  Central Administration. 
 Part II: Hospital and Specialist Services. 
 Part III: Health Services Provided by Local Health Authorities. 
 Part IV: General Medical and Dental Services, Pharmaceutical  
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Services and Supplementary Ophthalmic Services. 
 Part V:  Special Provisions as to Mental Health Services. 
 Part VI: General  
 
Parts I, II and IV are of most interest to the ophthalmic profession, although 
they are only specifically mentioned in Part IV (Scott, 1947). Further detailed 
guidance was given in a White Paper that was published simultaneously with 
the Bill (Health and Department of Health, 1946). The following extract from 
the White Paper describes the intention of the Minister with regard to 
Ophthalmic Services: 
 
 “Eye Services 
 65. The Object is to secure that the care of the eyes, with sight-testing 
and the supply of spectacles is carried out – as rapidly as resources allow – 
in special ophthalmic departments and clinics forming part of the Hospital and 
Specialist Services. These clinics will be in the charge of the specialist 
medical ophthalmologists, and in them the qualified sight-testing opticians will 
also play their proper professional part. Spectacles will be obtainable at the 
clinics themselves or at the premises of dispensing opticians taking part in the 
service. 
 66. While the full eye clinic system is developing, however, a 
supplementary eye service is to be arranged by the Executive Councils in 
each area. Their arrangements are to be made with suitably qualified general 
medical practitioners, sight-testing opticians and dispensing opticians…. 
 68. People will be entitled both to sight-testing and to the supply of 
spectacles, free of charge, either at the specialist ophthalmic clinics or 
through the supplementary scheme just described. The Bill provides, 
however, that as soon as the Minister is satisfied that adequate ophthalmic 
services are being provided in any area through the specialist service he may 
wind up the supplementary service in that area.” 
 
It is evident from the extract above it was the Minister’s intention to provide all 
ophthalmic services under the NHS and this was to be carried out only in 
hospitals with eye departments and clinics. The supplementary ophthalmic 
services were seen only as a temporary measure during this transition. 
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Hospital clinics were to be run by specialist medical ophthalmologists, with 
ophthalmic opticians playing their “proper professional part” (Giles, 1953). 
 
Minutes from the first Annual General Meeting of the Faculty of 
Ophthalmologists on the 1st June 1946 (figure 2-2) revealed a mixed reaction 
to the NHS Bill of 30th April 1946 (Council of Ophthalmologists, 1946). The 
Faculty in general welcomed the idea of opticians working under the 
supervision of ophthalmologists in the hospital setting and laid down three 
principles for which the National Eye Service should be based, 
 
“ (a) the ultimate responsibility of the care of the eyes must rest with an 
ophthalmologist of full specialist status. 
 
  (b) that the Government accept the principle that qualified sight-testing opticians 
have a proper and full professional part to play, in association with ophthalmologists, 
in the work of these clinics. 
 
  (c) that no one can receive ophthalmic attention from the specialist service unless 
he comes in through the recommendation of the general practitioner.” 
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Figure 2-2. Photograph of Faculty of Ophthalmology Books kept at the Royal 
College of Ophthalmologists. 
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2.2.2 The National Health Service Act, 1951 
 
The availability of free sight tests and spectacles for the first time resulted in 
extremely high usage of this service, particularly among older persons who 
often required two pairs of glasses. This is reflected in Ministry of Health 
Annual Reports (figure 2.3), where 7,000,000 lenses were supplied in 
England and Wales in 1949 after a total of approximately 5,500,000 sight 
tests. In 1950 over 8,000,000 lenses were supplied after approximately 
4,500,000 sight tests. This together with the relatively expensive fees for sight 
testing was reflected in the high expenditure in the first 2 years of the NHS, 
£25.9 million in 1949 and £24.7 million in 1950 (figure 2.4). Other areas of 
NHS expenditure were also rising rapidly such as dentistry. Part of the 
rationale behind the National Health Services Act of 1951 was to try and keep 
total expenditure on health below £400 million. This brought significant 
changes to the organisation of ophthalmic services as detailed below: 
 
 
 “New Arrangements for the Supply of Glasses 
2. CHARGES – As from 21st May 1951 a person of 16 years of age and over, 
and a child in certain circumstances, using the supplementary ophthalmic 
services will be required to pay towards the cost of glasses –  
 (i) a sum of £1 per pair (or 10s. if one lens only is supplied) and 
 (ii) the whole cost of the National Health Service frames he selects for  
    his glasses.  
3. PAYMENTS BY EXECUTIVE COUNCIL AND BY PERSONS SUPPLIED. 
- For the supply of glasses following a sight test on or after 21st May – 
(i) The Executive Council’s payment to the optician will cover only the 
dispensing fee and the cost of lenses less £1 per pair, or 10s. where 
only one lens is supplied. 
(ii) The person supplied will pay the optician the corresponding £1 per 
pair, on 10s. as the case may be, and the cost of the National Health 
Service frames he chooses for his glasses.” 
 
The effect of this Act was immediate and pronounced with the cost of the 
General Ophthalmic Services (GOS) in the United Kingdom reducing from 
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£24.7 million in 1950 to £11.1 million in 1952, of which only approximately £6 
million was from public funding with the remaining £5 million from patient 
payments (figure 2.4). This represented a decrease in percentage of NHS 
funds devoted to the ophthalmic service from 5% to less than 1.5% (figure 2-
5). This was largely due to the change in prescription patterns by opticians 
following the 1951 Act, with a dramatic reduction in the number of lenses 
supplied despite a relatively stable number of sight tests being carried out. In 
1950 over 8,000,000 lenses were supplied after approximately 4,500,000 
sight tests, whereas in 1952 approximately 3,300,000 lenses were supplied 
after approximately 3,700,000 sight tests (The Ophthalmic Service, 1970). 
 
It would therefore seem that it was the cost of fully integrating the 
supplementary eye services into the NHS that led to its dissolution in the 1951 
Act, a similar fate to that of dental services.  Dentists are competent to provide 
virtually all medical services connected with teeth and therefore in theory are 
equally able to treat patients in a hospital or community based setting 
provided adequate instrumentation is available. However, ophthalmic 
opticians are primarily concerned with correcting refractive errors in vision and 
the provision of appliances to correct these errors. The diagnosis and 
treatment of eye disease is the role of medically qualified practitioners, either 
in general practice or in the hospital.  
 
The NHS Act of 1951 contradicted two of the three principles stipulated by the 
Faculty of Ophthalmologists after the National Health Service Bill, and raised 
significant concern among ophthalmologists.  
 
Minutes from the Faculty of Ophthalmologists meeting of the 29th February 
1952 highlighted the divided opinion even within the Council (Council of 
Ophthalmologists, 1952). Three options were considered, 
 
“ (a) To approve the continuation of the Supplementary Ophthalmic Service; 
 
   (b) To implement the Final Hospital Eye Service;  
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   (c) To concentrate on the improvement of ophthalmological standards in this  
country, leaving the screening of the public to a higher grade of ophthalmic 
optician.” 
 
After a great deal of discussion, Sir Stewart Duke-Elder proposed and Dr 
Scott seconded the third option. Despite their approval, the Faculty expressed 
concerns whether ophthalmic opticians were fully competent to practice 
independent of medical control and therefore suggested this practice be 
reserved for low-risk individuals aged between school leaving age and the 
arbitrary age of 50. Every child was to have an exclusively ophthalmological 
service, and from age 50 onwards, all fundi, optic discs and lenses should be 
seen by ophthalmologists with ophthalmic opticians not to prescribe glasses 
for these persons. 
 
 
In the majority of other medical specialities, technical and medical aspects of 
diagnosis and treatment are overseen by senior medical personnel, who takes 
ultimate responsibility for the care of the patient. Though ophthalmic opticians 
were not sufficiently qualified to diagnose and treat ocular disease, they 
played a crucial role in the opportunistic case finding of eye disease, which 
would have otherwise not been alerted to the attention of a medical 
practitioner. 
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Figure 2-3. Number of sight tests and number of lenses ( in 1000’s) supplied 
in England and Wales. (Adapted from The Ophthalmic Service). 
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Figure 2-4. Cost of the General Ophthalmic Service in the United Kingdom.  
(Adapted from The Ophthalmic Service). 
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Figure 2-5. Percentage of NHS funds devoted to the ophthalmic service.  
(Adapted from The Ophthalmic Service). 
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2.2.3 Traditional Referral Pathways 
 
After the National Health Service Act of 1951 ophthalmic opticians, or 
optometrists as they are now termed, would work in community practices 
rather than in the hospital as initially envisaged in the National Health Service 
Act of 1946. Optometrists perform an internal examination of the eye during 
all routine sight tests. If an abnormality is suspected this would be 
documented on a general optical services 18 form and relayed to the patients’ 
General Practitioner (GP). The GP would then either examine the patient and 
offer appropriate treatment or alternatively refer the patient to an 
Ophthalmologist. GP’s often examine for, and instigate treatment of, external 
eye and ocular surface pathology, however for intra-ocular pathology most 
GP’s would refer to ophthalmologists due to the lack of appropriate 
instrumentation such as a slit lamp. The three largest causes for 
Ophthalmology referral; suspected glaucoma (20%), cataract and posterior 
capsule opacification (27%) and diabetic retinopathy (10%), can only be 
accurately diagnosed after an intra-ocular examination (Davey et al., 2011). 
This along with the increased sensitivity of investigations available at 
optometry practices such as visual field tests and optical coherence 
tomography have resulted in a larger proportion of referrals to the hospital eye 
services (HES) being instigated by optometrists (Davey et al., 2011). In 1999, 
direct referral by the optometrist to the HES was introduced (National Eye 
Care Services Steering Group, 1999), although the GP would be informed 
and be required to provide a medical summary for the patient. With the GP no 
longer necessarily acting as the “gate-keeper” for ophthalmology referrals 
closer communication between community optometrists and hospital-based 
Ophthalmologists should have been possible, a vision shared in the original 
National Health Service Act of 1946 and re-emphasised in the Joint 
Declaration by the Faculty of Ophthalmologists and the General Optical 
Council which was passed shortly after the Opticians Act of 1958. 
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2.2.4 The National Institute for Health and Clinical Excellence (NICE) 
guidelines and the Association of Optometrists (AOP) 
 
The NICE guidelines for the diagnosis and management of chronic open 
glaucoma (COAG) and OHT were published in April 2009 (NICE, 2009a). 
Here it was recommended that people with COAG, suspected to have COAG 
or who have OHT should be offered tests and measurements including IOP, 
central corneal thickness (CCT), gonioscopy, visual field testing and 
assessment and imaging of the appearance of the optic nerve. It went on to 
say people at risk of developing glaucoma (irrespective of whether they are on 
treatment or not), should be monitored regularly using tests similar to those 
used to diagnose glaucoma. The frequency of these tests is determined by 
the risk of developing glaucoma and NICE recommends earlier consideration 
of alternative treatments for worsening glaucoma, such as surgery or laser 
treatment to avoid further disease progression. 
 
These guidelines however did not include in their remit guidance on the 
detection and referral of suspected glaucoma by community optometrists. The 
professional representative organisation for optometry practice, the AOP, 
response to these guidelines was as follows: 
 
“English and Welsh PCTs and Health Boards may not have the resources to 
cope with the numbers of referrals – many of which, because they will have had their 
pressures taken using NCT, will be false positives. Nevertheless, in the absence of 
funding to repeat pressures using Goldmann, the AOP believes strongly that 
optometrists have no choice other than to refer a patient who has a sign of ocular 
hypertension – e.g. pressures measured at over 21 mmHg, using whatever 
tonometer they choose. To identify a sign of OHT and then not to act on it could be 
considered to be unprofessional, especially when the correct course of action has 
been well researched, by a panel of experts in the field, using evidence-based 
methods, and has been officially published by NICE” (Association of Optometrists, 
2010). 
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Prior to this, an optometrist would use their clinical judgement as to whether a 
patient with normal ocular examination and a borderline IOP warranted 
referral based on other risk factors such as age and family history. However 
after the AOP’s recommendation, all of these patients were now being 
referred with a resultant surge in numbers of referrals for suspected glaucoma 
in conjunction with an increase in patients discharged after the first visit. 
(Ratnarajan et al., 2012, Ratnarajan et al., 2013a, Ratnarajan et al., 2013b, 
Shah and Murdoch, 2011, Edgar et al., 2010 ).  
Optometrists would argue these referrals are not “unnecessary” as their 
professional bodies recommend referral to the HES, and failure to comply with 
guidelines could result in professional misconduct charges. The literature to 
date often denotes these referrals as false positive, however the term “first-
visit discharge proportion” is preferred in this work as it describes the 
outcomes of the referral in an absolute term, free from judgement. 
 
2.2.4.1 Joint College Guidance 
 
In December 2009, an attempt by the Royal College of Ophthalmologists and 
College of Optometrists to reduce the total number of referrals discharged at 
the first visit was made by issuing Joint College Group guidance (JCG) in 
relation to ocular hypertensive patients with low-risk of significant visual field 
loss in their lifetime. It was recommended that optometrists consider not 
referring patients aged over 80 years with an IOP of less than 26mmHg with 
an otherwise normal ocular examination. For patients aged between 65 and 
80 this IOP recommendation was 25mmHg, as this subset of patients does 
not qualify for treatment under the current NICE guidance. For the latter 
group, it was recommended that these individuals be reviewed annually by a 
community optometrist (Royal College of Ophthalmologists and College of 
Optometrists, 2009).   
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The dissemination of referral guidelines to optometrists without specialist 
interest in glaucoma failed to translate into an improvement in the diagnostic 
yield or referral quality in a report of performance in the period before 
publication of the NICE guidelines (Vernon and Ghosh, 2001). This, in 
conjunction with large increases in the number of referrals to ophthalmology 
clinics after the AOP’s recommendation, led to the concept of refining the 
quality and accuracy of the initial referral by involving an intermediary 
optometrist with specialist interest in glaucoma (OSI). This has the potential to 
improve the detection of sight-threatening glaucoma as well as lower the 
number of first visit discharges, with the associated reduction in costs and 
patient anxiety.  
 
The most recent version of the JCG was published in March 2013 (Royal 
College of Ophthalmologists and College of Optometrists, 2013a) where it  
was recommended that repeat measurement schemes involving community 
optometrists should be established as a priority as it was shown they can 
significantly reduce false-positive referrals into the hospital eye service and 
are relatively easy to introduce. The JCG does however acknowledge that a 
referral refinement scheme can further reduce the false-positive proportion 
compared to a repeat measurement scheme alone. To improve the quality of 
referral refinement services, the College of Optometrists recommends that 
optometrists involved undertake a Professional Higher Certificate in 
Glaucoma from one of its accredited providers.  
 
The 2013 JCG also suggests sharing the care of patients at relatively low-risk 
of progression between the hospital eye service and suitably trained 
community providers has the potential to reduce costs but acknowledges the 
need for shared clinical information and the appropriate information 
technology infrastructure.  
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2.2.5 Glaucoma referral refinement pathways 
 
 
From April 2009, the HES were receiving unsustainable levels of new referrals 
for suspected glaucoma as a result of the AOP’s response to the NICE 
glaucoma guidelines. This resulted in delays in clinic appointments for both 
new referrals as well as follow-up for those with established glaucoma. 
National Patient Safety Agency figures from June 2009 revealed that 44 
patients lost part of their sight as a result of delayed follow-up appointments 
and a further 13 were rendered blind (National Patient Safety Agency, 2009). 
These cases of avoidable sight-loss, for which undoubtedly there are 
numerous more unreported examples, are a result both of the huge increase 
in referrals for suspected glaucoma as well as the inability of the hospital 
appointment allocation system to triage effectively the patients waiting for 
follow-up appointments. This situation has also lead to the Royal National 
Institute of Blind People (RNIB) to release a Policy Position Statement asking 
that NHS England, NICE, clinical commissioning groups and hospital 
managers to increase their respective efforts to prevent further avoidable 
sight-loss through delays in reviewing glaucoma patients (Royal National 
Institute of Blind People, 2014). 
 
Concurrently the “Transforming Services for Acute Care Closer to Home” 
initiative was being implemented nationally to address the following issues 
(Department of Health, 2010): 
 
• great variation in service quality and health outcomes  
• activity and achievement going unmeasured  
• lack of usable data, tariffs and currencies  
• disparity in quality, productivity and costs  
• outdated infrastructure  
• access can be uncertain and confusing.  
 
Ophthalmology, and glaucoma in particular, was highlighted as a service that 
has scope for more community-based assessments due to the demographics 
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of those mostly affected as well as the longevity of follow-up and care. 
 
  
In an attempt to both reduce the burden on the HES as well as comply with 
“Transforming Services for Acute Care Closer to Home” initiative, the concept 
of refining a referral from the high street optometrist was introduced. These 
Glaucoma Referral Refinement schemes (GRRS) have proliferated across the 
country over the past decade, often demonstrating marked variation in 
pathway design, referral criteria as well as the level of OSI competency and 
training (table 2-2) (Ang et al., 2009, Bourne et al., 2010, Devarajan et al., 
2011, Henson et al., 2003, Parkins and Edgar, 2011, Syam et al., 2010, Local 
Optical Committee Support Unit, 2012, Ratnarajan et al., 2012, Ratnarajan et 
al., 2013a, Ratnarajan et al., 2013b). The variation in national practice as well 
as the lack of national guidance results in differing levels of care provided 
which may impact on patient safety. This is partly addressed in the latest 
version of JCG (see above). However, there is a lack of good quality evidence 
to develop a safe and efficient model of glaucoma referral refinement that can 
be adopted on a national level. The work from this thesis is hoped to help 
inform professional bodies as well as commissioners of eye care how to 
optimise GRRS nationally. 
 
Below is a summary of the leading GRRS currently in operation in the UK: 
 
Huntingdon 
The Community and Hospital Allied Network Glaucoma Evaluation Scheme 
(CHANGES) was established in 2006 and involves an initial triage of the 
community optometrist’s referral letter by a hospital based optometrist into 
either low or high-risk according to a protocol. A referral is deemed low-risk if 
only one/none of the following risk factors was noted for either eye: abnormal 
optic disc, abnormal visual field, abnormal IOP (22-28mmHg or IOP 
asymmetry). All other referrals are deemed high-risk (including any reference 
to a shallow anterior chamber). Low-risk patients are seen by one of 8 
community based OSIs and high-risk patients are seen directly in the 
hospital’s specialist glaucoma clinic. Only those low-risk patients with a 
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normal ocular examination (IOP less than 22mmHg, normal optic disc and 
visual fields) are discharged by the OSI (Bourne et al., 2010). 
 
Manchester 
The Manchester glaucoma referral refinement scheme was established in 
2000. All referrals to Manchester Royal Eye Hospital (MREH) for patients who 
are registered with a GP in central Manchester Primary Care Trust are 
reviewed by one of 12 OSIs. The current IOP criterion necessitating referral to 
MREH is a modification of the original criterion to reflect the JCG. Other single 
referral criteria include unequivocal pathological cupping of the optic disc 
noted after pupil dilation or visual field loss consistent with a diagnosis of 
glaucoma confirmed at a second visit. Combined referral criteria include IOP 
≥22 mmHg plus a suspicious optic disc appearance or optic disc asymmetry. 
An abnormal optic disc and corresponding visual field defect irrespective of 
the IOP necessitates a referral. Additional referral criteria include anterior 
segment signs of secondary glaucoma with IOP >22 mmHg on two occasions, 
or suspected angle closure (symptoms of sub-acute attacks or occludable 
angle and IOP >22 mmHg) (Henson et al., 2003). 
 
Gloucestershire 
The Gloucestershire glaucoma referral refinement scheme was established in 
2008. All community optometrists are offered the opportunity to participate 
and become accredited to the scheme. Patients who are registered with a 
Gloucestershire GP practice are seen by one of 103 (85% of the total number 
of optometrists in this area) accredited community optometrists and have their 
referral refined by the same accredited optometrist. The optometrist is only 
reimbursed for referral of those patients who meet the following NICE 
compliant referral criteria: patients younger than 65 years with IOP in either 
eye of ≥ 22mmHg, patients aged 65 years or older with an IOP ≥ 25mmHg, 
measured twice on each of 2 separate patient visits. If initial measurement is 
≥ 30mm Hg and/or angle closure is suspected, repeated IOP measurements 
on one occasion are sufficient for referral. Regardless of IOP, patients are 
referred if the optic disc appearance is glaucomatous and/or a reproducible 
visual field defect (evident on two separate occasions) is noted with 
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automated perimetry. When a patient attends a non-accredited optometrist, a 
referral is made in the usual way, without refinement, via the patient’s GP to 
the hospital. 
 
Nottingham 
The glaucoma referral refinement scheme based at The Queens Medical 
Centre was established in 2009. All new referrals for suspected glaucoma are 
assessed by one of 3 hospital-based optometrists. Patients found to have a 
normal ocular examination by these optometrists are discharged. Those 
patients who are found to have unequivocal glaucoma and who require urgent 
treatment or who are identified as having occludable anterior chamber angles 
are discussed with a consultant on the same day with a treatment plan 
established and an appropriate prescription issued if necessary. Those with 
advanced glaucoma (Mean deviation of >12dB on visual field testing or a 
visual field defect within 10 degrees of fixation) are directed to a specialist 
glaucoma clinic. Patients diagnosed as ocular hypertensive, with less severe 
glaucoma or in whom glaucoma is suspected are given a review appointment 
in a general clinic, which may or may not be run by a glaucoma specialist.  
 
Carmarthen 
The Carmarthen glaucoma referral refinement scheme was established in 
2003, and is run by 19 accredited OSIs. Single referral criteria are IOP ≥ 
26mmHg on two occasions, visual-field defect on two occasions, or 
pathological disc cupping or asymmetry of > 0.2. Combined referral criteria 
are IOP > 22mmHg and visual-field defect, suspected optic disc defect and 
visual-field defect, IOP > 22 and suspect optic discs. Additional referral criteria 
are optic disc change or haemorrhage, signs of secondary glaucoma, pigment 
dispersion, pseudoexfoliation and uveitis, rubeosis and finally history 
suggesting angle closure (Devarajan et al., 2011). 
 
The Carmarthen glaucoma referral refinement also includes a further OSI 
review at 12 months for those patients found to be normal at initial OSI 
review. This has been included to further increase the safety of the scheme 
(Devarajan et al., 2011).  
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Grampian 
In 2004 a new optometric glaucoma service, including referral refinement, was 
established in Grampian. The schemes described above relate solely to 
refining a referral for suspected glaucoma, whereas the Grampian scheme 
also encompasses a follow-up service for suspects, in addition to permitting 
the three accredited glaucoma optometrists to initiate anti-glaucoma treatment 
by instructing the GP to provide a topical prostaglandin prescription.  
Patients who are found by the accredited glaucoma optometrist to be normal 
are discharged. Low-risk glaucoma suspects or OHT patients are given a 
further review appointment by the same optometrist. High-risk glaucoma 
suspects or OHT patients as well as those with definite glaucoma are referred 
to an ophthalmologist (Azuara-Blanco et al., 2007).  
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Table 2-2. Summary of some glaucoma referral refinement schemes in the 
UK 
 
 
 
Huntingdon Manchester Gloucestershire Nottingham Carmarthen Grampian 
All glaucoma 
referrals seen in 
GRRS 
No Yes No Yes Yes Yes 
Setting of GRRS Community Community Community Hospital  Community Community 
Contact 
(Goldmann/Perkins) 
tonometry required 
Yes Yes Yes Yes Yes Yes 
Dilated disc 
assessment 
required 
Yes Yes At discretion of 
refining 
optometrist 
Yes At discretion of 
refining 
optometrist 
Yes 
Visual Field 
machine 
requirement 
 
Humphrey Any 
Suprathreshold 
Any 
Suprathreshold 
Humphrey Any 
Suprathreshold 
Humphrey 
Year of introduction 2006 2000 2008 2009 2003 2004 
Number of GRR 
optometrists 
involved 
8 12 103 3 19 3 
Cost of GRR 
appointment (£) 
50.00 46.50 50.00  
(only if referred) 
118.08 38.00 50.00  
(based on 
session fee of 
£400 for 8 
patients) 
Hospital 
accreditation of 
optometrist 
Yes Yes Yes Yes Yes Yes 
Specialist 
qualification in 
glaucoma 
Preferred, 
not 
essential 
Preferred, not 
essential 
Preferred, not 
essential 
Preferred, 
not 
essential 
Preferred, not 
essential 
Preferred, 
not 
essential 
 
 
 
 46 
Figure 2-6. Schematic flow chart of the organizational structure of each of the 
6 glaucoma referral refinement schemes 
(HES = Hospital Eye Service) 
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Each of these schemes requires participating optometrists to gain local 
accreditation of core optometric competencies (such as Goldmann 
applanation tonometry, slit-lamp binocular indirect ophthalmoscopy and visual 
field interpretation) through a hospital approved training scheme.  
 
The relatively few reports published on referral refinement schemes have 
demonstrated that they can serve as an effective method of reducing the first 
visit discharge proportion to the hospital, but opinion is divided on the optimal 
pathway design, triaging and referral criteria, to ensure efficiency but also 
patient safety. The results from this research will attempt to address this with 
the objective of helping to establish a national framework for glaucoma 
referral refinement. 
 
NICE acknowledged the value that refining referrals for suspect glaucoma has 
had on reducing referrals to the HES in its guideline published in March 2011, 
entitled ‘’Glaucoma Quality Standard” (NICE, 2011). This guidance detailed 
the differences between referral refinement and repeat measurement 
schemes as follows: 
 “Definitions of referral refinement and repeat measures 
 
Referral refinement 
A two-tier assessment in which initial evidence of abnormality during case-
finding assessment or screening is validated by a subsequent enhanced 
assessment which adds value beyond that achieved through a simple 
'repeat measures' scheme. A referral refinement service involves the 
undertaking of tests sufficient for diagnosis of ocular hypertension and 
suspected chronic open angle glaucoma and the interpretation of these 
clinical findings, with specialist practitioners who are delivering this service 
independently, being qualified and experienced in accordance with NICE 
guidance. 
 
Repeat measures 
Primarily describes the repeated measurements of eye pressures, but may 
also include repeated measurements of visual fields and other relevant ocular 
parameters when clinically necessary.” 
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In March 2012, NICE published commissioning guidelines titled “Services for 
people at risk of developing glaucoma” (NICE, 2012b). In this guidance risk 
stratification was also addressed, with a recommendation that patients with an 
IOP of greater than 30mmHg be referred to secondary care without delay 
suggesting that these patients are not suitable for a community-based 
refinement of the referral.  
 
2.2.6 The role of Central Corneal thickness (CCT) in GRSS 
At the time of this work, none of the schemes described above in 2.2.5 were 
calibrating IOP measurements based on CCT using pachmetry, whereas in 
the first-visit to the HES this was routine practice. The use of pachymetry to 
further improve the quality of OSI referrals is still largely unexplored. Sandhu 
et el, demonstrated significant reductions in referrals of suspected ocular 
hypertensive patients through retrospective modelling (Sandhu et al., 2011). 
The use of pachmetry by OSIs does raise many questions. The remit of an 
OSI is to refine the quality of the referrals and to safely discharge normal 
patients. It can be argued that the use of pachymetry to discharge a patient 
that would otherwise have been referred to the HES actually substantiates to 
a diagnosis of low-risk ocular hypertension, and is out of the remit of GRR. 
The cost effectiveness of GRRS could be reduced if additional instrument 
costs are required, and OSI would not want to shoulder the cost of purchasing 
the pachymeter as their profit margins are minimal at present, and certainly 
less profitable than dispensing spectacles (Ratnarajan et al., 2013a, Parkins 
and Edgar, 2011). From my discussions with commissioners of eye care 
services and optometrists alike, the cost of purchasing the pachymeter is the 
main limitation to its current widespread use in GRRS. This will be discussed 
further in section 3.2.  
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2.2.7 Local Optical Committee Support Unit (LOCSU) 
 
The Local Optical Committee Support Unit (LOCSU) describe themselves as, 
“a key link between national professional optical bodies such as the 
Association of British Dispensing Opticians, the Association of Optometrists or 
the Federation of Ophthalmic and Dispensing Opticians and the local optician 
or optometrist working to improve eye services in their region.”  
 
The LOCSU have developed enhanced service pathways for glaucoma and 
cataract. The glaucoma pathway was set up in May 2009, one month after the 
NICE glaucoma guidelines were published, and was revised in June 2012 
(Local Optical Committee Support Unit, 2012). They are broadly divided into 
two levels, with level one further subdivided. Level 1(a) is an IOP repeat 
measuring scheme using Goldmann or Perkins tonometry and use onward 
referral criteria similar to those recommended by the JCG. Except for a 
suspicious IOP then the rest of the eye examination must be deemed normal. 
Level 1(b) is a visual field (VF) repeat scheme for patients where this was the 
only suspicious finding on initial examination. Level 1(c) was established to 
allow referral refinement for patients seen initially by a non-LOCSU accredited 
optometrist. This patient will be referred to a LOCSU optometrist, who will 
carry out a more comprehensive eye examination including anterior chamber 
and optic disc assessment. The more detailed examination is warranted as 
this optometrist is now assuming clinical responsibility for the patient, and 
must base the reason to refer or discharge based on clinical findings they 
have elicited and not on the findings of the original optometrist. The Level 2 
scheme is an OHT or COAG monitoring scheme for patients with a confirmed 
diagnosis. The clinical examination involves Goldmann tonometry, 
suprathreshold perimetry, Van Herick’s test, and dilated slit lamp 
biomicroscopic examination of the optic nerve head. After each review the 
patient is either followed-up or referred to the HES or equivalent (Local 
Optical Committee Support Unit, 2012). The LOCSU schemes run 
independently of secondary care providers. A report of audit data from 
LOCSU claims a ‘deflection rate’ of 72% for repeat IOP measurement 
schemes and 38.6% for repeat visual fields schemes. ‘Deflection rate’ was 
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used to describe a patient that was not then referred to the HES after review 
in the LOCSU scheme (Local Optical Committee Support Unit, 2014). These 
data are audit data from Webstar patient records and have not been validated 
against another health professional, such as the Ophthalmologist, to 
determine what proportion of these deflections are appropriate  
 
2.2.8 The new General Ophthalmic Services contract in Scotland 
 
In April 2006, a new GOS contract for NHS community optometrists was 
implemented in Scotland as part of the Smoking, Health and Social Care 
(Scotland) Act. All those attending routine sight tests were now to have a 
comprehensive eye examination by the community optometrist, which 
includes the use of supplementary examinations, such as contact applanation 
tonometry, dilated indirect fundoscopy, and threshold automated perimetry. 
The main aim was to reduce inappropriate referrals to the HES (Ang et al., 
2009). 
 
All community optometrists in Scotland wishing to be involved in the new GOS 
contract attended mandatory workshops. Here the basic competencies of 
applanation tonometry, slit lamp biomicroscopy, threshold VF, and indirect 
ophthalmoscopy were assessed before accreditation was gained. 
  
The old GOS contract in Scotland, much like the current GOS contract in 
England, states a mandatory refraction is carried out on all patients attending 
a community optometrist. There was no provision for supplemental 
examinations unless paid for privately by the patient. The new GOS contract 
does not state refraction is mandatory and allows the optometrist to decide 
which tests need to be performed based on the patient’s specific presenting 
complaint. It has been shown that this patient specific approach to examining 
patients in community optometry practices has resulted in both a reduction in 
the first visit discharge proportion (36.6% pre GOS contract to 21.7% post 
GOS contract) as well as an improvement in the quality of the referral to HES 
(Ang et al., 2009).  
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2.3 Preventable sight loss: a Public Health Indicator 
 
The Public Health Outcomes Framework ‘ Healthy lives, healthy people: 
Improving outcomes and supporting transparency’ (Department of Health, 
2012) sets out a strategy for public health, desired outcomes and the 
indicators that will help us understand how well public health is being 
improved and protected. 
The framework concentrates on two high-level outcomes to be achieved 
across the public health system, and groups further indicators into four 
‘domains’ that cover the full spectrum of public health. The outcomes reflect a 
focus not only on how long people live, but on how well they live at all stages 
of life.  
 
In January 2012, preventable sight loss was included as a public health 
indicator, thereby establishing eye health as a public health priority by the 
government. Eye health was chosen as a public health indicator because half 
of sight loss is estimated to be avoidable. In 2011 alone 22,500 were certified 
as sight impaired (partially sighted) or severely sight impaired (blind).  
The data used will be based on certificate of visual impairment (CVI) 
registrations and will be measured annually based on rate of sight loss 
through chronic glaucoma, age related macular degeneration and diabetic 
retinopathy per 100,000 of the population. 
The indicator will enable the eye health and sight loss sector to work with the 
new NHS and Public Health England to improve eye health as well as 
address inequality across England. Furthermore a VISION 2020 UK 
Ophthalmic Public Health Group has been created to inform eye health 
professionals about public health issues. I am a member of this group, and 
the data from this work have been included in discussions during meetings. 
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2.4 Index of Multiple Deprivation  
 
The Communities and Local Government Department have calculated local 
measures of deprivation in England the latest of which were constructed in 
2010 and form the English Indices of Multiple Deprivation (IMD) 2010 
(Communities and Local Government, 2011). The IMD is a measure of 
deprivation, not affluence, and within even the least deprived areas there will 
be some deprived individuals. Deprivation covers a broad range of issues and 
refers to unmet needs caused by a lack of resources of all kinds, not just 
financial. The IMD scores are a continuous measure of relative deprivation 
therefore there is no definitive point on the scale below which areas are 
considered to be deprived and above which they are not.  
 
2.5 Equity Profile 
 
Equity profiles are an established public health tool for embedding evidence 
on health inequalities into planning, commissioning, and service delivery. 
They quantify how fairly services or other resources are distributed in relation 
to the health needs of different groups and areas. It is an important tool when 
planning new models of care such as community based eye-health care, the 
majority of which are provided by optometrists, who operate outside the 
umbrella of the NHS. Whilst offering NHS services such as free sight-testing 
to those entitled, they are essentially private providers of eye care, either 
working independently or as part of a chain or franchise. The location of 
community optometrist practices has been shown to be poorly correlated with 
service demands with fewer optometrists in areas of higher social deprivation 
(Day et al., 2010). Individuals from these deprived areas were also shown to 
present with more advanced disease (Fraser et al., 2001, Day et al., 2010). 
These studies focused on deprived and urban populations, and may not be a 
reflection of the problem nationally. 
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2.6 The Health Innovation and Education Cluster (HIEC) 
 
2.6.1 Organisational set-up 
 
The HIEC is a national collaborative organisation of NHS bodies, universities, 
third sector and commercial organisations that together aim to improve the 
health of the immediate population. The HIEC for North East London, North 
Central London and Essex has 3 founding partners; Barts and The London 
School of Medicine and Dentistry Queen Mary University London, UCL 
Partners and the Post Graduate Medical Institute Anglia Ruskin University. 
 
 
2.6.2 HIEC Glaucoma Pathways Project 
 
The Glaucoma Pathways project was one work stream for the HIEC. This 
project involved both the acquisition of data from GRRS across England to 
create an evidence base for future national guidance, but also the direct 
engagement with commissioners of eye care services, Ophthalmologists, 
Optometrists and LOCs in areas of north London and Essex. This work 
entailed numerous meetings with all stakeholders to update and develop new 
GRRS within this area. The work described in this thesis was an invaluable 
evidence source to all stakeholders, and the HIEC’s impartial position helped 
overcome organisational, sector and professional boundaries in order to drive 
change.  
 
There was a relative paucity of GRRS in operation in north London and 
Essex when the HIEC Glaucoma Pathways project began in April 2011. 
Multiple meetings with relevant stakeholders has resulted in a general 
increase in the awareness GRRS, and how implementation of these 
schemes can successfully result in many more patients being reviewed in a 
community setting in keeping with the Care Closer to Home initiative, as 
well as reducing the considerable burden new glaucoma out-patients 
appointments are placing on Ophthalmology departments nationwide. It is 
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anticipated that these meetings will serve as a platform for continued 
communication between all stakeholders.  
 
In the 12 months from April 2011 – April 2012 a new glaucoma referral 
refinement scheme has been agreed upon in Islington. The majority of 
glaucoma referrals to Moorfields Eye Hospital are generated by 
optometrists working within Islington and this scheme should successfully 
reduce the number of referrals for suspected glaucoma to Moorfields Eye 
Hospital by 25% in keeping with the recent NICE commissioning guidance 
on glaucoma. 
 
Through close collaboration with the HIEC, the GRRS in Barnet has been 
successfully updated to reflect national and College guidance. Education 
and training has been provided to both participating specialist optometrists 
as well as non-participating optometrists in an endeavour to raise the 
awareness and skills of optometrists in this region. 
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3 SECTION III: Investigations 
 
3.1 Aims of Research 
 
1. The impact of glaucoma referral refinement criteria on referral 
proportions and first-visit discharge proportions – the aim of this 
study was to evaluate the low and high-risk criteria of the CHANGES 
scheme in order to maximise efficiency of this glaucoma referral 
refinement pathway (Ratnarajan et al., 2013a). 
2. Multi-site review of glaucoma referral refinement schemes - the 
aim of this study was to conduct a multi-site review of established 
organisationally distinct GRRS across the UK, with the objective of 
helping to establish a national framework for glaucoma referral 
refinement (Ratnarajan et al., 2013b). 
3. Agreement between eye health professionals - the aim of this study 
was to assess the effect on agreement in clinical findings between 
clinicians in the referral pathway since the publication of the NICE 
guidelines and AOP/ABDO/FODO response (Ratnarajan et al., 2012). 
4. The experience of care and awareness of sight testing 
entitlements in patients referred for suspected glaucoma - the aim 
of this study was to explore the reported experience of care of new 
patients attending a glaucoma clinic appointment as well as their 
awareness of sight testing entitlements. Factors associated with 
experience of care in glaucoma have not previously been reported for 
new patients to a glaucoma clinic (Ratnarajan et al., 2014). 
5. The Equity profile of an Enhanced Optometry scheme - the aim of 
this study was to perform an equity profile for an enhanced optometry 
scheme to establish if effective eye health care was being provided to 
its catchment population (Ratnarajan, 2015).  
6. The false negative proportion and the role for virtual review in a 
nationally evaluated glaucoma referral refinement scheme – the 
primary aim of this study was to establish the numbers of patients who 
may be falsely discharged by community-based specialist optometrists 
 56 
involved in this GRRS. The secondary aim of this work was to compare 
decision-making between a specialist optometrist and a consultant 
ophthalmologist when evaluating optic disc images for the presence of 
glaucomatous optic neuropathy (Ratnarajan et al., 2015). 
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3.2 The impact of glaucoma referral refinement criteria on   
            referral proportions and first-visit discharge  
   proportions. 
 
3.2.1 Background 
 
As stated in 2.2.4 the number of referrals for suspected glaucoma, particularly 
those discharged at the first visit to the HES, had increased after the 
publication of the NICE guidelines ‘Glaucoma: Diagnosis and management of 
chronic open angle glaucoma and ocular hypertension’ in April 2009 and the 
response of the Association of Optometrists (AOP), Association of British 
Dispensing Opticians (ABDO) and the Federation of Ophthalmic and 
Dispensing Opticians (FODO) (Association of Optometrists, 2010, Edgar et 
al., 2010 , Henson et al., 2003, Khan et al., 2012, NICE, 2009a, Shah and 
Murdoch, 2011, Vernon, 1998, Lawrenson, 2013). Therefore the concept of 
refining a referral for suspected glaucoma in the community, to reduce the 
referral rate to the HES, seemed appropriate as this is where most referrals 
are generated (Bowling et al., 1997, Burr et al., 2007, Davey et al., 2011).  
 
As stated in 2.2.5 numerous glaucoma referral refinement schemes are 
currently in operation in the UK, with marked variation in pathway design and 
criteria for onward referral (Ang et al., 2009, Bourne et al., 2010, Devarajan et 
al., 2011, Henson et al., 2003, Local Optical Committee Support Unit, 2012, 
Parkins and Edgar, 2011, Ratnarajan et al., 2012, Ratnarajan et al., 2013a, 
Ratnarajan et al., 2013b, Syam et al., 2010, Warburton, 2010 ). 
 
The Community and Hospital Allied Network Glaucoma Evaluation Scheme 
(CHANGES) involves risk stratification of patients based on the referral letter 
from the community optometrist. Bourne et al demonstrated a reduction in the 
number of referrals discharged at the first hospital visit between 2006-2007 
(Bourne et al., 2010). Since this time a number of new guidelines have been 
published. The first of these was the NICE ‘Guidelines For The Diagnosis And 
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Management Of Chronic Open Glaucoma’ in April 2009 (NICE, 2009a). The 
response from the AOP, ABDO and FODO to recommend optometrists to 
refer all patients with an intraocular pressure (IOP) greater than 21mmHg, led 
to an increase in the number of referrals for suspected glaucoma (Association 
of Optometrists, 2010).  
 
Subsequently in December 2009, the College of Optometrists and Royal 
College of Ophthalmologists released Joint College Group (JCG) referral 
guidance recommending additional criteria: that a practitioner may consider 
not referring a patient aged 80 years and over with an IOP of less than 
26mmHg, or patients aged 65 years and older with IOP less than 25mmHg, if 
the remainder of the ocular examination is normal, as these patients are not 
recommended for treatment under the current NICE guidance (College of 
Optometrists, 2010). 
 
A more recent guideline published by NICE in March 2012, entitled ‘Services 
for people at risk of developing glaucoma’, was aimed at the commissioning of 
glaucoma services. It recommends that patients with an IOP of greater than 
30mmHg be referred to secondary care without delay suggesting that these 
patients are not suitable for a community-based refinement of the referral 
(Royal College of Ophthalmologists and College of Optometrists, 2013a).  
 
In the light of this additional guidance on glaucoma referrals, there was a 
need to re-evaluate to maximise efficiency.  
 
3.2.2 Purpose 
 
The aim of this study was to evaluate the low and high-risk criteria of the 
CHANGES scheme in order to maximise efficiency of the glaucoma referral 
refinement pathway. 
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3.2.3 Methods 
 
Outcomes of all patients referred under the CHANGES scheme from its 
introduction in August 2006 until June 2011 were analyzed. This constituted a 
local audit/service review and was approved by the Trust Caldicott Guardian 
and audit department. This work did not require research and ethics approval 
as no patient identifiable information was used. 
 
CHANGES scheme 
Eight optometrists with specialist interest in glaucoma (OSI) working in the 
CHANGES scheme review all low-risk referrals for the catchment area of 
Hinchingbrooke Hospital, Cambridgeshire. The equipment used by each OSI 
is standardised to that used in the hospital glaucoma service, namely a 
slitlamp, a Humphrey visual field analyser (www.meditec.zeiss.com), 
applanation tonometer (www.haag-streit-usa.com) and digital fundus camera 
for imaging of the optic disc (www.topconmedical.com). Each optometrist 
received training by the hospital glaucoma team in the form of four half-day 
sessions including practical sessions on examination of the optic disc and the 
correct use of the Goldmann tonometer. In addition, they had all achieved a 
nationally recognised postgraduate certificate in glaucoma shared care (City 
University London). 
 
Present study organisation 
All referral letters for suspected glaucoma are categorized by an experienced 
hospital-based optometrist as either low- or high-risk according to a protocol 
based on the examination findings listed in the letter (see figure 3-1.). A 
referral is deemed low-risk if only one of the following risk factors was noted: 
abnormal optic disc (cup to disc ratio of greater than or equal to 0.7, or cup to 
disc ratio asymmetry of greater than or equal to 0.2, or the presence of a 
notch in the disc rim), abnormal visual field, raised IOP (22-28mmHg) or IOP 
asymmetry (>5mmHg). A referral is categorised as high-risk if more than one 
low-risk factor was present, or alternatively if a shallow anterior chamber, IOP 
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>28mmHg, optic disc haemorrhage, pigment dispersion or pseudoexfoliation 
were detected.  
 
Low-risk patients are reviewed by an OSI of their choice within their 
community practice and high-risk patients are seen directly in the hospital 
glaucoma clinic. IOP, optic disc and VF findings are recorded by all OSIs. A 
patient is discharged by the OSI if they are found to have all the following 
features in both eyes: a Goldmann IOP below 22mmHg, a normal optic disc 
after dilated optic disc examination, normal visual fields and van Herick’s 
temporal limbal chamber depth deeper than 15% of corneal thickness. 
 
 
Figure 3-1. Schematic diagram of the CHANGES scheme 
 
 
 
 
The outcomes following assessment by the OSI for low-risk referrals and at 
the hospital appointment for high-risk referrals were reviewed to establish the 
first-visit discharge proportion (FVDP) based on reason for referral.  
 
Data management and statistical analysis 
Patient information from the referral forms of the community optometrist and 
the OSI, as well as the hospital patient records, was collated on a database in 
Microsoft Excel; statistical analysis was performed in R (version 2.15.1, R 
foundation for statistical computing). The application of referral criteria based 
on the guidance from the JCG and the NICE commissioners guide ‘services 
for people at risk of developing glaucoma’ on the composition of referrals was 
also modelled.  
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3.2.4 Results 
 
The analysis included 2912 patients (average age 61.4 years; 45% male) of 
these 2154 (74%) were categorised as high-risk (average age 63.6 years; 
44% male) and 758 (26%) were deemed low-risk (average age 59.5 years; 
46% male).  
 
 
Outcomes and temporal trends of low-risk referrals from community 
optometrists 
 
Raised IOP or IOP asymmetry 
429 referrals from community optometrists were due to moderately raised IOP 
(22-28mmHg), of which 34% were discharged by the OSI. Of those referred 
on by the OSI to the hospital, 45% were discharged by the consultant, giving 
a total discharge proportion of 64%.  
38 referrals were for IOP asymmetry > 5mmHg of which 45% were 
discharged by the OSI. Of those referred on by the OSI, 53% were discharged 
by the consultant, giving a total discharge proportion of 74%. 
 
The percentage of low-risk referrals made for a moderately raised IOP alone 
were 33%, 33%, 21%, 72%, 73% and 75% for each year from 2006 to 2011, 
respectively. For IOP asymmetry, the respective percentages were 19%, 7%, 
13%, 3%, 1% and 0% (see figure 3-2). 
 
Abnormal optic disc. 
207 referrals from community optometrists were for an abnormal optic disc 
alone, of which 37.7% were discharged by the OSI. Of those referred on by 
the OSI, 19% were discharged by the consultant, giving a total discharge 
proportion of 50%. 
The percentage of low-risk referrals made for an abnormal optic disc alone 
were 41%, 47%, 45%, 20%, 18% and 14% for each year from 2006 to 2011, 
respectively. 
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Abnormal visual field test. 
84 referrals from community optometrists were for an abnormal VF alone, of 
which 51% were discharged by the OSI. Of those referred on by the OSI, 46% 
were discharged by the consultant, giving a total discharge proportion of 74%. 
The percentage of low-risk referrals made for only an abnormal VF were 8%, 
13%, 21%, 6%, 8% and 12% each year from 2006 to 2011, respectively.  
 
Figure 3-2. Temporal trend in reason for referrals as a percentage of total low-
risk referrals 
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Outcomes and temporal trends of high-risk referrals from community 
optometrists reviewed directly by the hospital glaucoma service. 
 
IOP > 28mmHg only 
494 referrals (22.9% of all high-risk referrals) from community optometrists 
were for an IOP > 28mmHg, of which an average of 22% were discharged by 
the consultant over the years 2006 to 2011. The percentage of high–risk 
referrals each year from 2006 to 2011 for this criterion was 22%, 19%, 25%, 
25%, 15% and 29%, respectively (see figure 3-3). 
 
Raised IOP and abnormal optic disc and visual field 
429 referrals (19.9% of all high-risk referrals) were for a raised IOP and 
abnormal optic disc and VF, of which 26% were discharged by the consultant. 
The percentage of high–risk referrals each year from 2006 to 2011 for this 
criterion was, 35%, 29%, 29%, 17%, 17% and 14%, respectively. 
 
Raised IOP and abnormal visual field 
187 referrals (9% of high-risk referrals) were for a raised IOP and abnormal 
VF, of which 54% were discharged by the consultant. The percentage of 
high–risk referrals each year from 2006 to 2011 for this criterion was 10%, 
7%, 7%, 8%, 11% and 9%, respectively. 
 
Raised IOP and abnormal optic disc 
448 referrals (21% of high-risk referrals) were for a raised IOP and abnormal 
optic disc, of which 32% were discharged by the consultant. The percentage 
of high–risk referrals each year from 2006 to 2011 for this criterion was 20%, 
20%, 17%, 22%, 25% and 20%, respectively. 
 
 
 
Shallow anterior chamber 
493 referrals (23% of high-risk referrals) were for a shallow anterior chamber, 
of which 25.8% were discharged by the consultant. The percentage of high–
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risk referrals each year from 2006 to 2011 for this criterion was 13%, 27%, 
16%, 22%, 27% and 23%, respectively. 
 
Few patients were referred on the basis of an optic disc haemorrhage, the 
presence of signs of pseudoexfoliation or pigment dispersion.  74 referrals 
(3% of high-risk referrals) were for an optic disc haemorrhage, of which 41% 
were discharged by the consultant. The percentage of high–risk referrals each 
year from 2006 to 2011 for this criterion was 0%, 0%, 4%, 5%, 3% and 3%, 
respectively. 22 referrals (1% of high-risk referrals) were for pigment 
dispersion, of which 64% were discharged by the consultant. The percentage 
of high–risk referrals each year from 2006 to 2011 for this criterion was 0%, 
0%, 0%, 1%, 2% and 2%, respectively. 7 referrals (0% of high-risk referrals) 
were for pseudoexfoliation, of which 57% were discharged by the consultant. 
The percentage of high–risk referrals each year from 2006 to 2011 for this 
criterion was 0%, 0%, 1%, 0%, 0% and 0%, respectively. 
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Figure 3-3. Temporal trend in reason for referrals as a percentage of total 
high-risk referrals 
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Modelling of referrals based on Joint College Group Guidance 
 
A total of 282 patients had been referred by OSIs to the HES due to an IOP 
between 22-28 mmHg. 70 (25%) of patients were 65 - 80 years old, and 10 
(4%) were over 80. Modelling of the JCG guidance to this sample based on 
age and the IOP findings at the OSI review demonstrated that 51 of the 70 
(73%) patients who were aged between 65-80 and had been referred on the 
basis of raised IOP only would have satisfied the JCG criteria for non-referral. 
For the over 80 age category 6 of the 10 (60%) would have satisfied the JCG 
criteria for non-referral. In addition, all 6 of these patients aged over 80 would 
also have not been referred under the 65-80 JCG group criteria had no upper 
age limit been set as the IOPs were all < 25mmHg.   
 
 
Modelling referrals based on NICE commissioners guide ‘services for 
people at risk of developing glaucoma’. 
 
494 patients had been referred by community optometrists for an IOP > 
28mmHg in the presence of a normal optic disc and visual field. 28 (6%) fewer 
patients would have been referred direct to the HES if the threshold were 
increased to > 30mmHg as recommended by the NICE commissioners guide. 
 
Financial analysis of the CHANGES scheme.  
 
In 2010, a total of 701 patients were seen as part of the CHANGES scheme. 
470 (67%) were deemed to be high-risk referrals and were seen directly by 
the HES and 231 (33%) were low-risk and seen by the OSI of which 101 
(44%) were subsequently discharged. Therefore this scheme reduced the 
numbers of patients attending the hospital by 15% (33% x 44%) in 2010. The 
cost saving of the CHANGES scheme was £16,258, which represents a 13% 
reduction compared to if all patients were seen directly by the HES. A 
breakdown of these costs is found in table 3-1. Ophthalmology outpatient tariff 
was based on the Department of Health’s 2010-2011 national tariffs 
(Department of Health, 2009). The cost of an OSI appointment was £50.  
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Table 3-1. Cost analysis for the CHANGES scheme for 2010 compared with 
the costs if all patients were seen by the Hospital Eye Service (HES).  
Monitoring costs used Parkins and Edgar’s estimation of 1.10 HES follow ups 
prior to HES discharge of 55% of glaucoma suspects (Parkins and Edgar, 
2011). 
 
 
CHANGES scheme in 2010 (701 patients) 
 
 
Low-risk (231 patients)  
OSI costs £10,650 
Onward referral costs (130 x £141) £18,330 
Monitoring costs prior to discharge+ [1.10 x (55% x 130) x £67] £5,270 
High-risk (470 patients)  
New glaucoma out-patient and visual field clinic cost £66,270 
Monitoring costs prior to discharge+ [1.10 x (55% x 470) x £67] £10,478 
TOTAL £110,998 
  
Equivalent HES costs (701 patients) 
 
 
New glaucoma out-patient clinic cost £98,841 
Monitoring costs prior to discharge+ [1.10 x (55% x 701) x £67] £28,415 
TOTAL £127,256 
  
SAVING £16,258 (13%) 
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3.2.5 Discussion 
 
Referrals involving a raised IOP alone were the most common reason for 
referral, with a temporal increase in their proportion particularly for the low-risk 
group. Within the low-risk group, a considerable increase in referrals was 
demonstrated between 2008 and 2009 (31 to 112), and this is likely to be 
related to the introduction of the NICE guidelines and the AOP/ABDO/FODO 
response to these guidelines (Association of Optometrists, 2010). 
 
The proportion of referrals for an IOP > 28mmHg, or referrals for IOP and a 
suspicious optic disc or visual field, generally increased steadily from 2006, 
with an overall FVDP of 22%, 32% and 54% respectively. The high FVDP for 
referrals for IOP and visual fields (54%), coupled with the fact that OSIs in this 
scheme use equipment that is consistent with that used in the hospital eye 
services (calibrated Goldmann tonometry and Humphrey visual field 
analysers), would suggest that re-categorisation of this group of referrals as 
low-risk rather than high-risk would improve the efficiency of the CHANGES 
scheme. The numbers of referrals involving abnormal IOP and optic disc and 
visual field demonstrated little variation with a FVDP of 26%, however their 
proportion of the total referrals reduced particularly from 2009 largely due to 
an increased proportion of referrals for IOP > 28mmHg and shallow anterior 
chamber.  
 
34% of patients referred by community optometrists on the basis of an IOP 
22-28mmHg alone were discharged directly by the OSI. If the OSI adopted 
JCG as onward referral criteria (rather than IOP > 21mmHg) this figure that 
would have increased to 48%.  
 
Calibration of IOP based on CCT using pachmetry is routinely carried out in 
the HES, especially the first-visit. The use of pachymetry to further improve 
the quality of OSI referrals is still largely unexplored. Sandhu et el, 
demonstrated significant reductions in referrals of suspected ocular 
hypertensive patients through retrospective modelling (Sandhu et al., 2011). 
The use of pachmetry by OSIs does raise many questions. The remit of an 
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OSI is to refine the quality of the referrals and to safely discharge normal 
patients. It can be argued that the use of pachymetry to discharge a patient 
that would otherwise have been referred to the HES actually substantiates to 
a diagnosis of low-risk ocular hypertension, and is out of the remit of GRR. 
  
A survey of current and anticipated use of standard and specialist equipment 
by UK optometrists showed optometrists are increasingly employing modern 
equipment and IT services to enhance patient care, although questions were 
raised as to whether this actually was cost effective (Dabasia et al., 2014). 
Certainly the cost effectiveness of GRRS will be reduced if additional 
instrument costs are required, and OSI would not want to shoulder the cost of 
purchasing the pachymeter as their profit margins are minimal at present, and 
certainly less profitable than dispensing spectacles (Ratnarajan et al., 2013a, 
Parkins and Edgar, 2011).  
 
Whilst the HES acknowledges that GRRS are needed to improve the quality 
of referrals and prevent inappropriate referrals, from an economic standpoint 
new referrals to the HES are an important source of revenue and crucial to its 
sustainability.  
 
The reverse argument is that the OSI will already be anaesthetising the 
cornea to carry out GAT, and therefore why not measure the CCT to further 
increase the accuracy of the IOP measurement. 
 
Modelling based on NICE commissioners guidance would have prevented 28 
(5.7%) referrals to HES. Despite its modest impact, its inclusion into the low-
risk category will crucially, from a medico-legal aspect, enable the OSI to 
practise within the remit of a national guidance. 
  
The low FVDP for shallow anterior chamber referrals suggests it is 
appropriate for this to remain a high-risk criterion. This is particularly as this 
subset of patients can have rapidly progressing pathology and represent a 
source of preventable visual field loss if treated in a timely manner. It would 
seem the use of the van Herick test by community optometrists is associated 
 70 
with a relatively low false positive proportion when compared to the 
gonioscopic finding of the consultant (Foster et al., 2000, Dabasia et al., 
2015a, Jindal et al., 2015). 
 
The 3 least common groups of high-risk referral letters involved patients with 
suspected optic disc haemorrhage, pigment dispersion or pseudoexfoliation 
but in the absence of a raised IOP, abnormal visual field or suspicious optic 
disc. Referral refinement by the OSIs may successfully lower the number of 
inappropriate referrals for these patients that are currently classified as high-
risk.  
 
Bourne et al reported an 8% reduction in referrals to the hospital as a result of 
the CHANGES scheme in a pre-NICE glaucoma guideline time period (2006 
and 2007) (Bourne et al., 2010). Using identical referral and triaging criteria, 
this report has shown a 15% reduction in referrals to the hospital in a post-
NICE time period (2010) suggesting a greater benefit of this glaucoma referral 
refinement scheme in the context of current referral patterns for suspected 
glaucoma. This translated into an annual saving of £16,258 (13%).  
 
 
Recommendations  
The following recommendations from this study aim to reduce the demand on 
the hospital glaucoma service whilst simultaneously not reducing the quality of 
care received by patients in the CHANGES scheme. 
 
It is recommended the general organisation of this referral refinement scheme 
remain unchanged, with risk stratification of the patient based on the referral 
form into low- and high-risk categories and with low-risk referrals being 
directed to an OSI and the high-risk referrals being directly assessed by the 
hospital glaucoma service. However, the criteria for categorisation into low- 
and high-risk could be adjusted. The category of referrals that is deemed low-
risk (currently either a suspicious optic disc, abnormal VF, raised IOP (22-
28mmHg) or IOP asymmetry (>5mmHg) could be widened to include patients 
with: 
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a. an IOP ≤ 30mmHg (currently ≤28mmHg) in conjunction with a normal 
optic disc and VF, thus complying with NICE commissioners guidance.  
b. an IOP ≤ 30mmHg in conjunction with an abnormal VF. 
c. an optic disc haemorrhage, evidence of pigment dispersion and 
pseudoexfoliation in conjunction with a normal IOP, normal VF and no 
evidence of glaucomatous optic disc cupping.  
 
In addition, the OSI should partially adopt the JCG referral criteria, whereby 
an OSI need not refer a patient aged ≥ 65 years with an IOP < 25mmHg in 
both eyes with an otherwise normal ocular examination (currently IOP > 
21mmHg). This report suggests increasing the IOP threshold to < 26 for the 
over 80’s has little impact on further reducing referrals. The role of CCT 
measurements in GRRS also needs further exploration. 
 
To ensure the revised criteria of this scheme is both safe and effective, all 
low-risk patients that are discharged by the OSI will have an additional review 
by the Consultant in the hospital eye service for the initial two months to 
confirm the appropriateness of discharge and hence the false negative 
proportion. 
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3.3. Multi-site review of glaucoma referral refinement 
schemes 
 
3.3.1. Background 
 
Glaucoma is the world’s leading cause of irreversible blindness (Quigley, 
1996). This progressive optic neuropathy is characterised by damage to the 
optic nerve head and nerve fibre layer, with visual field loss which is usually 
asymptomatic until the disease becomes advanced. Twenty percent of 
referrals to ophthalmology clinics are for suspected glaucoma, with the annual 
cost for monitoring patients with this chronic condition estimated to be 
£22,469,000 (Davey et al., 2011, NICE, 2009b).  
 
In the UK, most referrals for suspected glaucoma are generated through 
opportunistic surveillance during sight-tests by community-based optometrists 
(hereafter referred to as an Optometrist with no Specialist Interest in 
glaucoma, non-OSI) (Bowling et al., 2005, Burr et al., 2007, Davey et al., 
2011).  
 
As part of a sight-test, the non-OSI is required to perform an internal 
examination of the eye including the optic disc. If clinically indicated VF testing 
and IOP measurements are performed. IOP is typically measured using ‘air 
puff’ non-contact tonometry (NCT) which is prone to higher variability and 
over-estimating the IOP (in individuals with thick corneas) compared to 
Goldmann contact tonometry used in hospital ophthalmology departments 
(Vincent S J et al., 2012). Visual field testing is also carried out if clinically 
indicated and completes the established triad of examinations/tests to detect 
glaucoma. 
 
The number of patients being referred to ophthalmology departments is 
rapidly increasing due to an ageing population, advances in diagnostic and 
screening tools such as visual field testing, and changes in national and 
professional guidance with regard to glaucoma care.   
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The NICE guidelines for the diagnosis and management of COAG and OHT 
were published in April 2009 (NICE, 2009a). These guidelines however did 
not include in their remit guidance on the detection and referral of suspected 
glaucoma by community optometrists as it was felt this would make the 
guidelines unmanageably large (Sparrow, 2012). 
 
As mentioned in the introduction, the professional representative 
organisations for optometry practice (AOP, ABDO and FODO) response to 
these guidelines was as follows: 
 
“English and Welsh PCTs and Health Boards may not have the 
resources to cope with the numbers of referrals – many of which, because 
they will have had their pressures taken using NCT, will be false positives. 
Nevertheless, in the absence of funding to repeat pressures using Goldmann, 
the AOP believes strongly that optometrists have no choice other than to refer 
a patient who has a sign of ocular hypertension – e.g. pressures measured at 
over 21 mmHg, using whatever tonometer they choose. To identify a sign of 
OHT and then not to act on it could be considered to be unprofessional, 
especially when the correct course of action has been well researched, by a 
panel of experts in the field, using evidence-based methods, and has been 
officially published by NICE.” (Association of Optometrists, 2010).  
This response by the AOP meant optometrists had no choice but to 
refer patients that previously may not have required a hospital review after 
other factors such as age and family history were taken into consideration. 
The result was a surge in the number of referrals for suspected glaucoma 
and, consequently, an increase in first-visit discharges (Edgar et al., 2010 , 
Ratnarajan et al., 2012, Ratnarajan et al., 2013a, Shah and Murdoch, 2011). 
The aforementioned JCG of December 2009 was an attempt by the Royal 
College of Ophthalmologists and College of Optometrists to reduce the total 
number of first-visit discharges. It targeted ocular hypertensive patients with 
low-risk of significant visual field loss in their lifetime, recommending that 
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optometrists consider not referring patients aged over 80 years with an IOP of 
less than 26mmHg with an otherwise normal ocular examination. For patients 
aged between 65 and 80 this IOP criterion was less than 25mmHg, as NICE 
guidance does not recommend offering treatment to these subsets of patients. 
For the latter group, it was recommended that these individuals be reviewed 
annually by a community optometrist (College of Optometrists, 2010). The 
most recent JCG, published in March 2013, recommended introduction of 
repeat IOP measurement schemes to reduce false-positive referrals to the 
hospital eye service, and recommended where possible to facilitate the 
implementation of glaucoma referral refinement schemes (GRRS) to further 
reduce the false-positive referral proportion (Royal College of 
Ophthalmologists and College of Optometrists, 2013b).   
 
In order to provide a local service for patients and to direct patients requiring 
review to the hospital eye service the concept of refining referrals for 
suspected glaucoma has been developed and GRRS have been shown to 
successfully reduce first-visit discharges for suspected glaucoma to 
secondary care (Bourne et al., 2010, Devarajan et al., 2011, Henson et al., 
2003, Local Optical Committee Support Unit, 2012, Parkins and Edgar, 2011, 
Syam et al., 2010, Ratnarajan et al., 2013a). Opinion is however still divided 
on optimal pathway design, triaging and referral criteria, to ensure efficiency 
but also patient safety. 
 
 
3.3.2. Purpose 
 
The aim of this study was to conduct a multi-site review of established 
organisationally distinct GRRS in England, with the objective of helping to 
establish a national framework for glaucoma referral refinement. 
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3.3.3. Methods 
 
The outcomes of GRRS in Huntingdon, Manchester, Gloucestershire and 
Nottingham were retrospectively analysed during four 2 month time periods: 
pre NICE (March and April 2009), post NICE (November and December 
2009), post JCG (August and September 2010) and current practice (March 
and April 2011). Seasonal variation was not taken into account and this study 
was looking specifically at open angle glaucoma. 
This work was classified as an audit/service review. Each participating Trust 
gained approval by the Trust Caldicott Guardian and audit department. This 
work did not require research and ethics approval as no patient identifiable 
information was used. 
 
Each scheme is organisationally distinct and reflects the range of variation 
between schemes in England. See section 2.2.5 and Figure 3-4 for more 
details.  
 
Each scheme requires participating optometrists to gain local accreditation of 
core optometric competencies (such as Goldmann contact tonometry, slit-
lamp binocular indirect ophthalmoscopy and visual field interpretation) through 
a hospital approved training scheme. A specialist qualification in glaucoma is 
not a prerequisite (City University, 2012, College of Optometrists, 2011a, 
WOPEC, 2012). 
 
In Huntingdon and Nottingham the data from the non-OSI referral as well the 
subsequent findings from the next eye health professional were collected (for 
Nottingham and low-risk Huntingdon patients this was the OSI and for high-
risk Huntingdon patients this was a glaucoma consultant). In Manchester and 
Gloucestershire the data from the OSI referral and the hospital visit were 
analysed.  
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Figure 3-4. Schematic flow chart of the organisational structure of each of the 
4 glaucoma referral refinement schemes (HES = Hospital Eye Service) 
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Statistical Analysis 
 
Data from electronic and paper patient records and paper referral letters were 
collated using Microsoft Excel; statistical analysis was performed in R (version 
2.15.1, R foundation for statistical computing). Percentages of FVDP were 
compared using Fisher’s exact test, and confidence limits for the differences 
between percentages were calculated using Newcombe’s Hybrid Score 
Interval Method. Confidence limits and p values within a set of factor levels 
have been corrected for multiplicity using the Dunn-Sidak method.  
 
 
The FVDP was defined as the percentage of referrals from an OSI or a non-
OSI that was discharged at the first visit to the final provider. Agreement rate 
proportions on diagnostic accuracy and referral appropriateness always use 
the diagnosis given by the final clinician and assumes their finding to be the 
gold standard.  
 
 
3.3.4. Results 
 
Data of 1086 patients were analyzed: 190 (17.5%) pre NICE, 338 (35.7%) 
post NICE, 287 (26.4%) post JCG and 271 (25.0%) from the current practice 
group. 434 (40.0%) patients were from Huntingdon (304 high and 130 low-
risk), 179 (16.5%) from Manchester, 204 (18.8%) from Gloucestershire and 
269 (24.8%) from Nottingham. 
 
56.1% of patients referred from OSIs were male as compared to 43.7% from 
non-OSIs.  Mean age of patients referred by the OSIs was 63.2 years 
compared to 62.0 years for non-OSIs. 
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Reason for Referral from non-OSI and OSI optometrists 
 
The most common reason for non-OSI referral across all observation periods 
was for an elevated IOP-only (36.1%). In the pre NICE timeframe, there were 
24 referrals for IOP-only, which accounted for 19.0% of referrals. This 
increased to 96 referrals in the post NICE period, which accounted for 45.1% 
of referrals. This was coupled with a decrease in many other stated reasons 
for referral by the non-OSI, particularly those not including IOP, exemplified by 
disc only referrals which reduced from 20 (15.9%) pre NICE to 13 (6.1%) post 
NICE (see table 3-2, table 3-4 and figure 3-5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 79 
 
Figure 3-5. The percentage of non-OSI referrals by Guideline period. 
Bar widths are proportional to the number of referrals 
 
 
 
 
 
 
 
 
The most common reason for OSI referral across all observation periods was 
also for raised IOP only. In the pre NICE time period 7 referrals (10.9%) were 
for IOP only increasing to 35 referrals (28.0%) post NICE,(see table 3-2, table 
3-3 and figure 3-6). 
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Table 3-2. Reason for non-OSI and OSI referral by time period. 
  
Guideline period 
Pre NICE Post NICE Post JCG Current 
Practice 
Total  
 
Reason for 
referral Non-
OSI 
(%) 
OSI 
(%) 
Non-
OSI 
(%) 
OSI 
(%) 
 
Non-
OSI 
(%) 
OSI 
(%) 
Non-
OSI 
(%) 
OSI 
(%) 
Non-
OSI 
(%) 
OSI (%) 
IOP only 19.0 10.9 45.1 28.0 32.0 41.5 41.3 27.6 36.1 28.8 
Disc only 15.9 18.8 6.1 20.0 18.8 15.1 12.0 18.4 12.6 18.1 
VF only 6.3 4.7 2.8 2.4 5.5 5.7 7.1 5.7 5.2 4.5 
IOP+Disc 15.9 20.3 15.5 21.6 10.5 16.0 9.8 20.7 12.8 19.6 
IOP+VF 4.0 6.2 4.2 6.4 4.4 3.8 3.3 2.3 4.0 4.7 
Disc+VF 11.1 12.5 6.1 15.2 11.6 11.3 12.0 16.1 9.9 13.9 
IOP+Disc+VF 7.1 26.6 13.1 6.4 3.9 3.8 2.7 6.9 7.0 9.2 
Other 20.6 0.0 7.0 0.0 13.3 2.8 12.0 2.3 12.4 1.3 
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Table 3-3. Reason for OSI referral with percentages and counts for each time 
period. 
 
Guideline period 
Pre NICE Post NICE Post JCG Current 
Practice 
Total  
 
Count % Count % Count % Count % Count % 
IOP only 7 10.9 35 28.0 44 41.5 24 27.6 110 28.8 
Disc only 12 18.8 25 20.0 16 15.1 16 18.4 69 18.1 
VF only 3 4.7 3 2.4 6 5.7 5 5.7 17 4.5 
IOP+Disc 13 20.3 27 21.6 17 16.0 18 20.7 75 19.6 
IOP+VF 4 6.2 8 6.4 4 3.8 2 2.3 18 4.7 
Disc+VF 8 12.5 19 15.2 12 11.3 14 16.1 53 13.9 
IOP+Disc+VF 17 26.6 8 6.4 4 3.8 6 6.9 35 9.2 
Other 0 0.0 0 0.0 3 2.8 2 2.3 5 1.3 
Other than 
IOP alone* 
57 89.1 90 72.0 62 58.5 63 72.4 272 71.2 
Total 64 100.0 125 100.0 106 100.0 87 100.0 382 100.0 
* This row does not contribute to the column totals 
 
 
Table 3-4. Reason for Non-OSI referral with percentages and counts for each 
time period. 
Guideline period 
Pre NICE Post NICE Post JCG Current 
Practice 
Total  
 
Reason for 
referral Count % Count % Count % Count % Count % 
IOP only 24 19.0 96 45.1 58 32.0 76 41.3 254 36.1 
Disc only 20 15.9 13 6.1 34 18.8 22 12.0 89 12.6 
VF only 8 6.3 6 2.8 10 5.5 13 7.1 37 5.2 
IOP+Disc 20 15.9 33 15.5 19 10.5 18 9.8 90 12.8 
IOP+VF 5 4.0 9 4.2 8 4.4 6 3.3 28 4.0 
Disc+VF 14 11.1 13 6.1 21 11.6 22 12.0 70 9.9 
IOP+Disc+VF 9 7.1 28 13.1 7 3.9 5 2.7 49 7.0 
Other 26 20.6 15 7.0 24 13.3 22 12.0 87 12.4 
Other than 
IOP alone* 
102 81.0 117 54.9 123 68.0 108 58.7 450 63.9 
Total 126 100.0 213 100.0 181 100.0 184 100.0 704 100.0 
* This row does not contribute to the column totals 
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Figure 3-6. The percentage of OSI referrals by Guideline period. 
Bar widths are proportional to the number of referrals 
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First-visit discharge proportion associated with non-OSI and OSI 
optometrists 
 
The overall FVDP for non-OSI referrals was 36.1% and for OSI referrals was 
14.1% (difference 22%, CI 16.9% to 26.7%; p<0.001). FVDP pre-NICE was 
21.9% compared with 35.4% in the current practice time period (difference 
13.5%, CI −23.8% to −2.4%; p=0.006). For OSIs, FVDP was 6.3% pre-NICE 
and 17.2% current practice (difference 11.0%, CI −24.7% to 4.3%; p=0.18) 
and for non-OSIs FVDP was 29.2% pre-NICE and 43.9% current practice 
(difference 14.7%, CI −27.8% to −0.30%; p=0.03).  
 
The FVDP for each site for each time period is given in Table 3-5. and figure 
3-7. When interpreting these data it is important to note that for Nottingham 
and Huntingdon the FVDP is for referrals from a non-OSI, while for 
Manchester and Gloucestershire the FVDP is that of referrals from an OSI. 
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Table 3-5. First-visit discharge proportion (percentage of referrals) by site and 
by time period.  
 
Period  
Site (professional 
initiating referral) 
Pre 
NICE 
Post 
NICE 
Post 
JCG 
Current 
practice 
 
All periods 
Nottingham (non-
OSI) 
19.5 32.8 25.3 53.7 33.5 
Huntingdon (non-
OSI) 
33.3 37.6 42.1 38.3 38.0 
Mean non-OSI 29.2 35.0 34.7 43.9 36.1 
Manchester (OSI) 4.9 6.5 16.9 3.0 8.9 
Gloucestershire 
(OSI) 
8.7 20.3 12.5 25.9 18.6 
Mean OSI  6.3 15.2 15.0 17.2 14.1 
 
Mean overall 21.9 27.8 27.6 35.4 28.6 
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Figure 3-7. Graph showing first-visit discharge proportion by site and time 
period 
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Outcomes of referrals from non-OSI and OSI optometrists based on 
reason for referral 
 
A referral for suspected glaucoma is characteristically based on the finding of 
an elevated IOP, an abnormal optic disc appearance, an abnormal visual field 
or a combination of these findings. These patients are then classified as either 
having glaucoma, a suspicion of glaucoma (‘glaucoma suspect’) or as being 
normal. The largest source of first-visit discharges for both non-OSIs and 
OSIs were for IOP-only related referrals, with 83.5% and 55.0% of these, 
respectively, being discharged. Referrals based on more than one criterion, 
such as those for abnormal IOP, optic disc and visual fields, resulted in fewer 
first-visit discharges (40.8% non-OSI and 25.7% OSI). More details are given 
in Figure 3-8. 
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Figure 3-8. The outcomes of patients referred by non-OSIs (top) and OSIs 
(bottom). The width of each bar is representative of the proportion of the total 
referral base. 
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3.3.5. Discussion  
 
The main rationale for the refinement of referrals for suspected glaucoma has 
been to reduce the overall number of referrals to the HES whilst 
simultaneously increasing the quality and accuracy of the referral process.  
 
Reason for Referral from non-OSI and OSI optometrists 
 
Both non-OSIs and OSIs demonstrated a similar trend for the stated reasons 
for referral with IOP-only referrals being the largest category for referral, 
36.1% and 28.8% respectively, followed by referrals for elevated IOP and 
abnormal optic disc, 12.8% and 19.6% respectively. Disc-only referrals and 
disc and VF referrals were the next largest categories in both groups, with the 
smallest category being for elevated IOP and a suspicious VF.  
 
The temporal trend observed among the stated reasons for referral for the 
non-OSI and OSI displayed considerable variation. All referral categories by a 
non-OSI not involving IOP as a referral criterion demonstrated a decline post 
NICE compared to pre NICE, most notable disc only referrals which dropped 
from 20 referrals (15.9%) pre NICE to 13 (6.1%) post NICE. The reverse was 
seen for referrals involving IOP, particularly IOP-only referrals which 
increased from 24 referrals (19.0%) pre NICE to 96 referrals (45.1%) post 
NICE. The AOP’s response to the NICE Guidelines seems to have had less 
effect on the temporal trend in referrals generated by OSIs. Exceptions being 
IOP-only referrals which increased from 7 (10.9%) pre NICE to 35 (28.0%) 
post NICE and referrals citing IOP, optic disc and visual fields which 
decreased from 17 referrals (26.6%) to 8 (6.4%). This would suggest that, 
post-NICE, optometrists initiating referrals concentrate more on IOP as a 
reason for referral with less emphasis being placed on concurrent assessment 
of the optic nerve and visual field. 
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It would seem that the introduction of JCG was successful in reducing the 
proportion of referrals by a non-OSI for only a raised IOP (96 referrals down to 
58; or expressed as a percentage 45.1% to 32.0%) after the large increase 
post NICE. This trend was not observed in the OSI group where the number 
of referrals for raised IOP-only actually increased from 35 (28.0%) to 44 
(41.5%).  
 
First-visit discharge proportion associated with non-OSI and OSI 
optometrists 
 
The overall FVDP for referrals by a non-OSI was statistically significantly 
higher than that for OSIs (particularly the Manchester GRRS), suggesting 
superior concordance of the OSI findings with the final provider.  
 
The lack of legal indemnity for optometrists not complying with the AOP’s 
recommendation interestingly has proved to be a really effective way of 
changing optometry practice, though unfortunately this directly resulted in 
more inappropriate referrals.  
 
The introduction of JCG did not lower the FVDP in either group, as would 
have been expected, with FVDPs unchanged from the post NICE period, 
however there are inter-scheme differences for OSI performance in 
Manchester and Gloucestershire. This may be because the undue perception 
of the importance of IOP over other aspects of the ocular examination still 
remained. However, the current practice FVDP in the Manchester scheme did 
reduce to 3% from 16.9% in the post JCG time period, and may represent a 
delay in the full implementation of JCG criteria by its participating OSIs. It is 
worth noting that despite this drop in the FVDP in the current practice time 
period, the FVDP in Manchester was only 4.9% pre NICE and only 6.5% post 
NICE. Despite this for both OSIs and non-OSIs as a whole, the highest 
FVDPs were in the current practice time period, with the latter group reaching 
a statistical significant increase in FVDP compared to pre-NICE. This 
suggests the need for further multi-stakeholder guidance (such as the JCG) 
regarding detection and referral of suspected glaucoma to be used in 
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conjunction with the NICE guidance on the diagnosis and management of 
glaucoma and OHT. In addition, if the AOP’s recommendation were 
withdrawn, this may have a significant impact on improving the quality of 
referrals and therefore lowering the FVDP. 
 
The lower IOP threshold for referral to ophthalmology recommended in the 
NICE guidelines may explain the rise in the FVDP for the OSI post NICE, but 
also may reflect a culture by optometrists, OSI and non-OSI, to adopt a more 
risk averse approach to the clinical assessment of patients with suspected 
glaucoma with a lower threshold for referral in keeping with the AOP’s 
recommendation. This is speculative, but the maintenance of the FVDP in the 
post JCG and current practice periods, with the exception of Manchester, 
imply that whatever factors caused the increase in first-visit discharges post 
NICE remained there for the duration of this analysis. 
 
 
Features of the ocular examination performed at the referral refinement 
consultation that best predict a diagnosis of glaucoma 
 
The width-adjusted bar graphs of outcome of referral based on reason for 
referral (Figure 3-8) demonstrate the large proportion of IOP-only referrals 
and its low diagnostic yield. In the non-OSI referrals, only 16.5% of these 
patients were given a follow-up appointment, with just 3.5% diagnosed with 
primary open angle glaucoma. These values were considerably higher for the 
OSI-initiated referrals (45% and 14.7%, respectively).  
 
These findings highlight the majority of IOP-only referrals represent a waste of 
hospital out-patient resource. However, 14.7% of these IOP-only referrals 
were subsequently diagnosed with glaucoma implying the referring clinician 
had missed or not examined in sufficient detail to identify glaucomatous optic 
disc pathology, which by definition needs to be present to diagnose glaucoma.  
 
Whether the addition of CCT measurements by the OSI would improve the 
accuracy of referrals, especially for IOP-only referrals, is debatable, and 
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certainly not carried out in the majority of GRRS. The issues surrounding CCT 
in GRRS are described further in 3.2.5 and the discussion. 
 
79.7% of OSI referrals for solely a suspicious optic disc appearance were 
followed up by the hospital, but only 5.8% were diagnosed with glaucoma at 
the first review, the remainder being classified as glaucoma suspect. In 
contrast, only 49.4% of non-OSI disc-suspect referrals were followed-up by 
the hospital. This suggests the extra training received by OSIs resulted in 
more accurate referrals.  
 
Multiple-criterion referrals by the OSI, such as an abnormal IOP, optic disc 
and visual field, resulted a higher percentage of patients being diagnosed with 
glaucoma, 45.7%. This leads me to question the effectiveness of the OSI in 
such referrals, as a substantial proportion will be subsequently referred to 
secondary care. The scheme in Huntingdon has adopted risk stratification 
through a paper triage of the non-OSI referrals carried out by the hospital, 
with only patients found to have one risk factor deemed low-risk and therefore 
suitable for glaucoma referral refinement. Our findings would suggest that the 
stratification of the referral letter according to risk, a strategy that could be 
incorporated across all medical specialities, could be an effective method to 
ensure patients with a high probability of having glaucoma are seen directly 
by secondary care without the need for the additional examination by an OSI. 
This is reflected by the glaucoma publication from NICE in March 2012: The 
NICE commissioners guide ‘services for people at risk of developing 
glaucoma’ which was produced to provide commissioners of eye services 
guidance as to how to safely and effectively manage patients at risk of 
glaucoma (NICE, 2012a). It recommends that patients with an IOP of greater 
than 30mmHg should be referred directly to secondary care.  
 
Limitations 
 
There are some limitations of this study that are important to consider. The 
false negative, or percentage of patients that were inappropriately discharged 
by the non-OSI and OSI, is not known.  
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The final provider in the schemes was not always a consultant 
ophthalmologist, and therefore a reference standard cannot be applied across 
all the schemes that were evaluated.  
 
OSIs are not performing opportunistic screening and therefore their referrals 
are more likely to be appropriate compared to non-OSIs. However, the FVDP 
is the most appropriate metric to measure the ‘added diagnostic value’ an OSI 
introduces to the referral pathway in GRRS compared to the traditional 
referral pathway in which a non-OSI directly refers to the hospital eye service. 
 
The time series for the study was carefully selected to encompass all the 
major changes in clinical guidelines and practice since 2009. However, by 
definition a retrospective observational time series study will not provide data 
on all time points. 
 
An issue to note is that the prevalence of glaucoma does not affect sensitivity 
or specificity but it does affect the positive predictive value. 
 
Recommendations 
 
This research of activity from four established referral refinement schemes of 
differing design has demonstrated that OSIs can successfully refine the 
referrals from non-OSIs for suspected glaucoma leading to a reduction in the 
FVDP. Patients with a high chance of being diagnosed with glaucoma based 
on the examination findings of the non-OSI should be referred directly to 
secondary care and those at lower risk could effectively be reviewed by an 
OSI carrying out a comprehensive eye examination. The results of this 
analysis lead to the recommendation that ‘low-risk’ should be defined as 
referrals based on IOP only, optic disc only, VF only and IOP and VF, with all 
other referrals including any reference to a shallow anterior chamber angle 
better suited to a direct referral to secondary care.  
 
 93 
The inclusion of VF and disc examination is clearly associated with a lower 
FVDP and, therefore a detailed disc and VF examination should form part of 
the referral refinement in conjunction with Goldmann/Perkins tonometry for 
measuring the IOP. Using the referral criteria of the JCG will crucially allows 
the optometrist to operate within a professional and legal framework.   
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3.4. Agreement between eye health professionals   
 
3.4.1. Background 
 
The vast majority of referrals to Ophthalmology departments in the United 
Kingdom for suspected glaucoma are initiated by community-based 
optometrists (Bowling et al., 2005). Detection of glaucoma, a progressive optic 
neuropathy, relies on accurate measurements of the optic disc and also the 
functional consequences of the disease, measured by visual field testing. 
Raised IOP is an important risk factor for glaucoma hence the importance of 
also performing this measurement in primary care. Measuring the IOP with 
Goldmann or Perkins tonometry and slit-lamp binocular indirect 
ophthalmoscopy of the optic disc are core competencies of an optometrist’s 
training, although in day-to-day clinical practice these examination techniques 
are often not used by community optometrists as part of a routine eye 
examination (College of Optometrists, 2011b, Myint et al., 2011). The 
published literature also reports a wide variation in the agreement of 
examination and management between optometrists and ophthalmologists 
(Abrams et al., 1994, Spry et al., 1999, Harper et al., 2000, Marks et al., 2012, 
Azuara-Blanco et al., 2007). 
 
As previously mentioned, there are numerous GRRS operating successfully in 
the UK, though, being locally commissioned, they have marked differences in 
organisation set-up and referral criteria (Ang et al., 2009, Azuara-Blanco et 
al., 2007, Bourne et al., 2010, Devarajan et al., 2011, Henson et al., 2003, 
Local Optical Committee Support Unit, 2012, Parkins and Edgar, 2011, Syam 
et al., 2010). A Diploma in glaucoma or accreditation by a local hospital 
Ophthalmology department is often a pre-requisite before an optometrist can 
undertake glaucoma referral refinement (City University, 2012, College of 
Optometrists, 2011a, WOPEC, 2012) . 
 
The Community and Hospital Allied Network Glaucoma Evaluation Scheme 
(CHANGES) involves both a triage of the referral letter from the original 
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primary care optometrist into a high or low-risk category and subsequent 
clinical refinement of referrals for suspected POAG. It has demonstrated that 
community based OSIs can effectively reduce the number of unnecessary 
referrals attending the hospital glaucoma service in low-risk patients (Bourne 
et al., 2010). Good agreement between the examination findings of a 
specialist optometrist in glaucoma and the hospital were reported with this 
and other schemes before the National Institute for Health and Clinical 
Excellence (NICE) glaucoma guidelines were published in April 2009 (Bourne 
et al., 2010, Devarajan et al., 2011, Harper et al., 2000, Marks et al., 2012, 
Syam et al., 2010). The publication of the NICE guidelines prompted a 
recommendation from the AOP, Association of British Dispensing Opticians 
(ABDO) and the Federation of Ophthalmic and Dispensing Opticians (FODO) 
to refer all patients with an IOP of greater than 21mmHg regardless of the 
method of measurement (NICE, 2009a, Association of Optometrists, 2010).  
 
Subsequently in December 2009, the Royal College of Ophthalmologists and 
College of Optometrists released JCG guidance, which was updated in 
December 2010. It was recommended that a practitioner may consider not 
referring a patient aged 80 years and over with an IOP of less than 26mmHg, 
or for patients aged 65 years and older with IOP less than 25mmHg, if the 
remainder of the ocular examination is normal (Royal College of 
Ophthalmologists and College of Optometrists, 2009).  
 
The impact of both of these guidelines on GRRS, including agreement in 
examination findings, has not been reported.  
 
3.4.2. Purpose 
 
The aim of this study was to assess the effect on agreement in clinical 
findings between clinicians in the referral pathway since the publication of the 
NICE guidelines and AOP/ABDO/FODO response. 
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3.4.3. Methods 
 
Outcomes of all patients referred under the CHANGES scheme from its 
introduction in August 2006 until June 2011 were analyzed. This constituted a 
local audit/service review and was approved by the Trust Caldicott Guardian 
and audit department. This work did not require research and ethics approval 
as no patient identifiable information was used. 
 
CHANGES scheme 
See 3.2.3 
 
Present study organisation 
See 3.2.3 
 
Outcomes measured 
An IOP measurement of greater than 21mmHg in either eye was considered 
‘abnormal’ IOP and an optic disc that had an appearance that was considered 
suspicious for glaucoma, was considered an ‘abnormal’ optic disc.  
 
Inter-professional agreement for components of the examination was 
assessed for OSI and consultant (Part 1) and non-OSI and a specialist 
clinician, be it OSI or consultant (Part 2). 
 
Part 1: Agreement between the Optometrist with Specialist Interest and 
the Consultant Ophthalmologist specialising in glaucoma. 
 
Data from all new patients seen by the OSI since the scheme started in 
August 2006 until June 2011 were analysed. The pre NICE and post NICE 
agreement between the OSI and one of 2 consultant ophthalmologists 
specialising in glaucoma (RB and LC) for the identification of an abnormal IOP 
and optic disc was undertaken. The analysis consisted of all referred patients 
by the OSI as well as a sample of discharged patients in order to calculate the 
appropriate-referral proportion as well as an estimate of the inappropriate-
referral proportion. 
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An appropriate referral is defined as one where the consultant agreed with the 
decision to refer to the hospital, on account of one or more abnormal 
glaucoma examination findings.  
 
Part 2: Agreement between the original primary care optometrist (non-
OSI) with a clinician with specialist glaucoma training (either the OSI or 
the consultant ophthalmologist). 
The examination data from the referral forms of non-OSIs were collected for 
all new patients in four 2 month time periods: pre NICE (March and April 
2009), post NICE (November and December 2009), post JCG (August and 
September 2010 and current practice (March and April 2011).  
 
The agreement between the gold standard professional (consultant 
ophthalmologist for Part 1 and either the OSI or the consultant 
ophthalmologist for Part 2), was expressed as a percent positive predictive 
value (PPPV) of the referring clinicians findings (IOP and disc assessment), 
and represents the proportion of referrals that were true positives based on 
the same clinical parameters. 
 
 
 
Data management and Statistical Analysis 
Data from electronic patient records and paper copies of referral letters were 
collated on Microsoft Excel; statistical analysis was performed in R (version 
2.15.1, R foundation for statistical computing). 
Fischers exact test was used to test for statistical significance, as the samples 
were non-matched. 
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3.4.4. Results 
 
Part 1: Agreement between the Optometrist with Specialist Interest and 
the consultant ophthalmologist specialising in glaucoma. 
 
A total of 850 patients with low-risk referral letters were sent an appointment 
to see the OSI, of which 760 attended (277 pre and 483 post NICE). The 
average age of attendees was 59.5 years and 46% were male. 
 
In the 32 months from the scheme’s introduction to the publication of the 
NICE guidelines a total of 277 patients were seen by an OSI (8.7 per month), 
of which 184 (66%) were referred to the hospital and 93 (34%) discharged.  
In the 19 months post NICE 483 patients were seen (25.4 per month), of 
which 289 (60%) were referred to the hospital and 194 (40%) discharged.  
This increase in the discharge percentage from 34% pre NICE to 40% post 
NICE is not statistically significant using Fisher’s Exact test (P = 0.07). 
 
Agreement for abnormal IOP assessment  
The PPPV for correct identification of an abnormal (>21mmHg) IOP in either 
eye was 61% pre NICE compared to 61% post NICE (p=0.51, Fisher’s exact 
test).  
 
Agreement for abnormal optic disc assessment  
The PPPV for the correct identification of an abnormal optic disc was 61% pre 
NICE compared to 43% post NICE (p=0.02, Fisher’s exact test). 
 
Agreement for outcome of OSI appointment 
The appropriate referral proportion for all patients referred by an OSI to the 
hospital was 70% pre NICE and 61% post NICE (p=0.07, Fisher’s exact test). 
 
92% (11/12) of patients that were sampled and clinically reviewed by the 
consultant after a normal OSI assessment were confirmed as being normal 
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and discharged after this hospital visit, with 1 patient being retained for further 
follow-up and given a diagnosis of glaucoma suspect. There were no cases 
where the consultant diagnosed glaucoma through this sampling process.  
 
 
Part 2: Agreement between the original primary care optometrist (non-
OSI) with a clinician with specialist glaucoma training (either the OSI or 
the consultant ophthalmologist). 
 
A total of 434 patients were referred by the non-OSI during the 4 two-month 
periods of data collection, with an average age of 62.1 years and 42% were 
male. 304 of these patients (39% male) were deemed to be high-risk, with an 
average age of 64.0 years. The remaining 130 patients were classified as low-
risk (44% male), with an average age of 57.4 years. Patients with high-risk 
referrals were significantly older than low-risk (p=0.01, independent t test), 
while there was no significant gender difference. 
 
 
Agreement for IOP assessment 
The non-OSI had documented the IOP in 88% (380/434) of referral letters for 
suspected glaucoma (90% in the low-risk group and to 87% in the high-risk 
group), with the use of Goldmann applanation tonometry documented in 46 
(12%) of referrals and ‘air puff’ non contact tonometry or no documentation of 
method of tonometry in the remainder. 
 
The PPPV for correct identification of an abnormal IOP in either eye was 63% 
pre NICE compared to 51% post NICE (p=0.12, Fisher’s exact test).  
 
Where the non-OSI noted an IOP between 22 and 28mmHg the OSI agreed 
that the IOP was abnormal in 49% (40/81). Where the non-OSI noted an IOP 
greater than 21mmHg (in conjunction with another examination finding 
suspicious of glaucoma or where the only abnormal finding was an IOP 
greater than 28mmHg) the consultant noted an IOP greater than 21mmHg in 
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56.0% (28/50). This increased to 75% when the non-OSI found the IOP to be 
greater than 28mmHg.  
 
A temporal trend was observed where low-risk and to a lesser extent high-risk 
groups demonstrated a decline in the PPPV more recently, though an 
increase in the PPPV was noted in current practice time period (these are 
detailed in Table 3-6 and Figure 3-9). 
 
Agreement for optic disc assessment 
The non-OSI had documented the optic disc appearance in 79% (342/434) of 
all referral letters. Among the letters triaged as ‘low-risk’, 83% had optic disc 
appearance documented, while this was noted in 77% of high-risk letters. 
 
The PPPV for the correct identification of an abnormal optic disc was 70% pre 
NICE compared to 53% post NICE (p=0.04, Fisher’s exact test). 
 
A temporal trend was observed in which the low-risk group demonstrated a 
larger reduction in PPPV post NICE than the high-risk, with both groups 
improving post original JCG and declining once more in current practice 
(these are detailed in Table 3-6 and Figure 3-9). 
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Table 3-6. Percent positive predictive values for an abnormal IOP and 
abnormal optic disc assessment for each referral letter risk group by time 
period. 
 
  
Abnormal IOP assessment 
Abnormal Optic Disc 
assessment 
  Low-risk 
group 
High-risk 
group 
Low-risk 
group 
High-risk group 
 PPPV (n) PPPV (n) PPPV (n) PPPV (n) 
All times 
frames 
49 81 56 50 43 53 61 93 
Pre 
NICE 
100 6 56 8 57 16 73 24 
Post 
NICE 
46 27 59 12 43 5 52 29 
Post  
JCG 
31 20 44 12 50 16 65 19 
Current 
practice 
56 28 59 18 17 16 55 21 
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Figure 3-9. Percent Positive Predictive Value for identification of abnormal 
IOP and optic disc assessment for each time period. 
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3.4.5. Discussion  
 
A dramatic increase in the number of glaucoma referrals has occurred since 
the introduction of the NICE guidelines, which has placed an increased 
burden on ophthalmology out-patient departments nationally (Shah and 
Murdoch, 2011). This is reflected in the observation of increased scheme 
activity from a mean of 8.7 patients per month pre NICE to 25.4 per month 
post NICE, coupled with an increased discharge proportion from 34% to 40%. 
These changes in referral activity suggest that the NICE guidelines and, more 
specifically, the response of the AOP to these guidelines has resulted in an 
increase in the numbers being referred by non-OSIs for suspected glaucoma 
coupled with a reduction in the diagnostic accuracy of these referrals. The 
reduction in appropriate referral proportion from an OSI to the hospital 
reduced (from 70% pre NICE to 61% post NICE) would appear to be a 
consequence of this change in referral activity. 
 
There was no change in the PPPV for the identification of an abnormal IOP 
between an OSI and a consultant in the post NICE period compared to pre 
NICE, explained by the standardisation of techniques employed by both the 
OSI and the consultant to measure the IOP. It is has been reported that in the 
period post NICE guideline introduction the total number of referrals for only 
raised IOP and the FVDP associated with these referrals has increased (Khan 
et al., 2012, Ratnarajan et al., 2013a, Shah and Murdoch, 2011). The results 
indicate that the probability of a consultant reproducing the non-OSIs finding 
of a moderately raised IOP (22-28mmHg) is lower than that of a significantly 
raised IOP (>28mmHg). This is not unexpected but it demonstrates how 
stratification of risk on the basis of IOP is an important aspect of this and other 
referral refinement schemes, with the effect of such a stratification on inter-
professional agreement reported for the first time in this study. The finding of 
improved PPPV for the identification of an abnormal IOP between OSI and 
consultant, than between non-OSI and OSI can at least in part be explained 
by the standardisation of IOP measurement technique (Goldmann tonometry) 
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between OSI and consultant in this scheme. The original JCG did not improve 
the PPPV for abnormal IOP assessments for both low and high-risk referrals, 
although the updated JCG, where clearer guidance was given to referring 
optometrists on how IOP should be measured with both Goldmann and non-
contact tonometry, did lead to an improvement in the PPPV in both groups. 
 
PPPV between the OSI and consultant for identification of an abnormal optic 
disc demonstrated a statistically significant decline post NICE (61% to 43%). 
This is an interesting finding as dilated disc assessment with indirect slit-lamp 
based ophthalmoscopy has been used since the introduction of this particular 
scheme. The lack of legal indemnity for optometrists not complying with the 
AOP’s recommendation to the NICE guidelines may have led optometrists to 
adopt a more risk averse and medico-legally defensive approach to practice. 
The above finding suggests this may also be true for the OSI group with 
respect to optic disc assessment though not for IOP assessment. Agreement 
levels in the assessment of optic disc are known to variable (Reus et al., 
2010, Andersson et al., 2011, Kong et al., 2011, van der Schoot et al., 2013), 
and may help to explain decline in disc assessment in the post NICE period, 
although the OSIs in the scheme were unchanged pre and post NICE . In 
addition, continued education and training of OSI is important to maintain high 
clinical standards.  
 
The good agreement between OSI and consultant for the sample of 
discharged patients implies that normal observations are being correctly 
identified, however a larger sample is needed to make firm conclusions. 
 
There are some limitations that warrant discussion. It has been assumed that 
the findings of the consultant ophthalmologists with specialist interest in 
glaucoma are the gold standard and therefore are correct. A similar 
assumption is made for the OSI in the review of low-risk referrals from a non-
OSI. The patient population seen by the OSIs and Consultant is an enriched 
population with a higher prevalence of glaucoma compared to that of the non-
OSIs, who are performing opportunistic surveillance. Additionally, the analysis 
of non-OSI and OSI agreement for the pre NICE period was based on only 16 
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patients, which is a smaller sample size than the other 2 month periods 
analysed. This relatively small sample reflects the lower activity of the 
CHANGES scheme in this period compared to the post-NICE period. In 
addition the sample used to calculate agreements for normal examination 
findings can only be an estimate as information was only gathered from 
patients that were referred to secondary care, therefore not representative of 
the total patient population seen by the OSI and non-OSI. 
 
Another potential limitation to the study, but one that does reflect clinical 
practice is that the examination techniques employed by the non-OSI may 
differ from that of the OSI or consultant. Typically a non-OSI will not dilate the 
pupil to perform an examination of the optic disc, whereas the OSI and 
consultant would always dilate the pupil except in the presence of an 
occludable anterior chamber angle.  By way of a national survey of UK 
community optometrists, Myint et al reported that 25% of optometrists used 
direct ophthalmoscopy alone and a further 62% used a combination of direct 
ophthalmoscopy and slit-lamp binocular indirect ophthalmoscopy, whereas 
the OSI or consultant in the CHANGES scheme only used slit-lamp binocular 
indirect techniques (Myint et al., 2011). A difference in the method used for 
measuring IOP also exists, with the OSI and consultant solely using 
Goldmann applanation tonometry. Therefore the agreement values involving 
the non-OSI in this report are not necessarily a comparison of two comparable 
examination techniques. 
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3.5 The experience of care and awareness of sight testing 
entitlements in patients referred for suspected glaucoma. 
 
3.5.1 Background 
Glaucoma affects more than 67 million people worldwide, and is one of the 
world’s leading cause of irreversible blindness (Quigley, 1996). Up to twenty 
percent of referrals to ophthalmology clinics in the UK are for suspected 
glaucoma, with the annual cost for monitoring patients with this chronic, and 
potentially blinding condition estimated to be £22,469,000 (Davey et al., 2011, 
National Institute for Health and Clinical Excellence, 2009). Despite this, over 
fifty percent of patients in the UK with glaucoma are believed to remain 
undiagnosed (Burr et al., 2007).   
 
It is known that follow-up patients accessing eye care would like to travel a 
short distance and patients living furthest from hospital or with severe visual 
disability prefer a minimum of visits to complete a care episode (Bhargava et 
al., 2008, Gray et al., 1997). In addition, two studies in the UK have shown 
that patients presenting with advanced glaucoma are more likely to come from 
areas of greater social deprivation (Day et al., 2010, Fraser et al., 2001). 
 
The NICE guidelines for glaucoma diagnosis and management were 
published in April 2009 (NICE, 2009a). After an initial scoping exercise it was 
decided not to include case-finding within the remit of this guidance to prevent 
the guidance from becoming unmanageably large (Sparrow, 2012). As 
previously mentioned, the professional representative organizations for 
optometry practice, the AOP, ABDO and FODO, responded to these 
guidelines by recommending an ophthalmology referral for all patients with an 
IOP of greater than 21mmHg irrespective of tonometry method. This resulted 
in a large and sudden increase in referral numbers to the HES, nearly half of 
which were discharged after only a single visit (Edgar et al., 2010 , Ratnarajan 
et al., 2014, Shah and Murdoch, 2011) 
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Given this rapid transformation of glaucoma referral clinical care pathways 
there is interest in understanding the outcomes of patients attending both the 
initial optometrist visit and the hospital visit using a range of clinical and 
patient reported outcome measures as well as their experience of care and 
the costs associated with providing it (Sharma et al., 2010, Sharma et al., 
2012, Prior et al., 2011). Several frameworks defining important dimensions of 
patient experience exist (Gerteis M et al., 1993) and instruments to measure 
the patients’ experience of care (patient reported experience measures, 
PREMs) which provide information about experiences of care have been 
reported (Schuman, 2008, Somner et al., 2012). Recent qualitative work 
indicated that both outcomes and experience are of importance to patients 
and a short combined patient outcomes and experience measure (POEM) 
instrument was proposed (Somner et al., 2012). 
 
 
3.5.2 Purpose 
 
The purpose of this study was to explore the reported experience of care of 
new patients attending a glaucoma clinic appointment as well as their 
awareness of sight testing entitlements. Factors associated with experience of 
care in glaucoma have not previously been reported for new patients to a 
glaucoma clinic. 
 
 
3.5.3 Methods 
 
Three hundred and thirty five consecutive new patients who attended a 
glaucoma clinic appointment at Hinchingbrooke Hospital between August 
2011 and April 2012 were prospectively reviewed after Trust approval was 
obtained. All patients were seen by a single consultant ophthalmologist 
specialising in glaucoma.  
After informed consent was obtained, patients completed a two-part non-
identifiable anonymised questionnaire after the hospital clinic visit. The first 
part involved questions related to patient demographics, reasons for attending 
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the optometrist, awareness at the time of sight testing of eligibility for free 
sight-tests and what a sight-test entails. The travel arrangements required to 
attend both the optometrist and hospital visit, including cost, were collected 
and compared, with a further sub-group analysis in which subgroups were 
based on the diagnosis made by the hospital. A second part of the 
questionnaire rated the knowledge, thoroughness, explanation and time spent 
by the consultant during the hospital visit. A rating of excellent scored 5 
points, with ratings of good, average, below average and poor scoring 4,3,2 
and 1 respectively. The second part of the questionnaire also asked which of 
the two appointments, optometrist or hospital, the patient found easier to 
attend.  
 
The questionnaire addressed several of the dimensions developed by Gerteis 
(Gerteis M et al., 1993) and the eight Picker principles (Respect for patients 
values, Preferences and expressed needs, Co-ordination and integration of 
care, Information, communication and education, Emotional support and 
alleviation of fear and anxiety, Involvement of family and friends, Transition 
and continuity, Access to care) (Shaller, 2007) that were recommended by the 
NICE guidelines on patient experience in adult NHS services (NICE, 2012a).  
 
Social deprivation was estimated from the patient’s postcode using the IMD 
2010. The national average IMD for 2010 is 21.7, and is calculated using 38 
separate indicators, organized across seven distinct domains of deprivation 
including income, employment, health and disability, education, housing, 
environment and crime (Communities and Local Government, 2010).  
 
Data Collection and Statistical Analysis: 
 
Data from the questionnaires were entered into Microsoft Excel 2007 whilst 
statistical analysis was performed in R (version 2.15.1, R Foundation for 
Statistical Computing). Ninety-five percent confidence limits for differences 
between means, and P-values for paired and two-sample t-tests were 
obtained using permutations tests. The comparison of independent 
percentages was made using Fisher’s Exact tests, and the comparison of 
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correlated percentages was made using McNemar’s Test with the exact 
binomial probability. 
 
3.5.4 Results 
 
3.5.4.1 General Demographics 
 
Three hundred and thirty five patients newly referred to the hospital glaucoma 
service were included in the analysis of which 48% were male and the median 
age was 62 years  (range, 21 to 89). Ninety six percent of the patients were 
Caucasian, 2% were African Caribbean and 2% were Asian. Thirty one 
percent of patients had a known family history of glaucoma, of which 23% 
were first-degree relatives. 11% of the patients were known to have diabetes. 
Forty eight percent of patients were retired, 84% were homeowners and 87% 
car owners. 
 
3.5.4.2 Reasons for Optometrist visit 
 
Patients most commonly attended the optometrist in response to a reminder 
letter having been seen previously by that practice (44%), but also attended 
when they felt they needed new glasses (18%), were not able to see clearly 
(13%). The remaining 25% attended for a combination of the above reasons 
or specified another reason such as pain or pressure in the eyes. Patients 
chose to attend a specific optometrist because they had previously been seen 
by them (51%), they were close to home or work (17%), had been 
recommended (14%) or a combination of these factors (18%). 
 
 
3.5.4.3 Patient knowledge 
 
Ninety five percent of patients knew that attending a sight-test appointment 
involved an examination of the health of the eye. Eighty percent of patients 
were aware that sight tests are available at no cost to those aged 60 and 
older and 61% patients were aware that this was also the case for those aged 
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40 and older with a family history of glaucoma. Additionally 55% of patients 
were aware that free sight tests are available for patients with a history of 
diabetes. 
 
3.5.4.4 Travel arrangements for hospital and optometrist 
appointments 
 
Ninety percent of patients travelled to the hospital appointment by car, 5% by 
public transport, 3% by foot, 1% by motorcycle and 1% by hospital transport. 
In comparison 76% of patients travelled to the optometrist appointment by car, 
6% by public transport, 15% by foot, and 3% by bicycle. The mean patient 
reported cost to travel to the hospital was £2.08 and £0.91 to the optometrist 
(permutation paired t-test, p < 0.001).  
 
The mean distance travelled by patients to attend the hospital appointment 
was 9.4 miles compared to 5.5 miles for the optometrist (permutation paired t-
test, p < 0.001). The mean time taken to travel to the hospital was 23 minutes 
compared to 17 minutes for the optometrist (permutation paired t-test, p < 
0.001). Nineteen percent of patients lived within 5 miles of the hospital 
compared to 55% for the optometrist (exact McNemar’s test, p < 0.001). 
Forty-four percent of patients were accompanied to the hospital while 32% 
were accompanied when attending the optometrist visit. Overall 62% found 
travelling to the optometrist easier than the hospital, 25% the hospital easier 
and 13% reported equal ease of access. 
 
3.5.4.5 Diagnostic outcome at the hospital visit 
 
The FVDP by the Consultant Ophthalmic Surgeon with a specialist interest in 
glaucoma was 48%.  Diagnoses for the entire group were as follows: 5% 
primary open angle glaucoma, 18% glaucoma suspect, 13% ocular 
hypertension (OHT) not requiring treatment, 43% normal ocular examination, 
21% other. Associations were tested between selected categorical variables 
from the questionnaire results and two subgroups based on the hospital-
based diagnostic outcome (Table 3-7). These two subgroups were patients 
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with glaucoma/suspect glaucoma (n=79), and patients with no evidence of 
glaucoma (n=256). This latter group included patients with OHT not requiring 
treatment. The mean IMD was 9.1 for both glaucoma/suspect glaucoma group 
as well as the no evidence of glaucoma group (permutation two-sample t-test, 
p =0.96). 
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Table 3-7. The association of selected categorical variables from the 
questionnaire results with the hospital-based diagnostic outcome (represented 
as two groups: i) patients with glaucoma/suspect glaucoma, ii) patients with 
no evidence of glaucoma.  
 
Diagnostic group  
 
Variable and category 
Glaucoma or 
suspect (G)  (n = 
79) 
No glaucoma (N) 
(n = 256) 
 
 
 
 
P- value 
Median age (years) 66 60 <0.001 
% aged over 60 years  72% 
 
50% < 0.001 
% aware free sight test if 
> 60 years  84% 
 
79% 0.41 
% aware free sight test if 
> 40 years and FH of 
glaucoma  55% 
 
62% 0.328 
% not visited optometrist 
for at least 12 months 
prior to referral  78% 
 
76% 0.87 
% living within 5 miles 
from referring 
optometrist  57% 
 
54% 0.79 
% living within 5 miles 
from hospital 10% 
 
21% 0.030 
% paid < £2 for 
optometrist visit  83% 
 
89% 0.243 
% paid < £2 for hospital 
visit  26% 
 
24% 0.75 
 
For age the P-value was obtained using a two-sample permutation test. For the percentages the P-
values were obtained using Fisher’s Exact test. 
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3.5.4.6 Satisfaction score and overall preference 
 
The mean satisfaction score for the hospital consultation was 4.6 out of 5 (4.3 
for glaucoma and suspect glaucoma and 4.7 for no glaucoma (permutation 
two-sample t-test, p = 0.01)) with the overall component satisfaction scores 
for knowledge, thoroughness, explanation and time spent of 4.8, 4.8, 4.6 and 
4.5 respectively. The mean wait to see the consultant was 65 minutes.  
 
3.5.5 Discussion 
 
Reasons for attending a sight-test are complex and multifactorial. Experience 
from Scotland suggests universal free sight testing does increase attendance 
although the under-privileged are still under represented (Dickey H, 2012). 
The Royal National Institute of Blind People (RNIB) Community Engagement 
project had identified limited community awareness of eye health and 
symptom-led demand for eye examinations as barriers for uptake of sight 
testing (Hayden C, 2012); a finding supported by this study. The results of this 
study highlight the need to increase awareness and promote patient 
education about free-sight testing, particularly in those with a family history of 
glaucoma as just over half of those with glaucoma were aware of it. 
Awareness of free sight testing for those over 60 years of age was higher in 
the patients diagnosed with glaucoma but this may be a reflection of the 
higher median age of this group compared to those without glaucoma.  
 
Symptom led demand for sight testing was also evident in this study as 31% 
waited until they could not see clearly or felt they needed new glasses before 
attending the optometrist. Optometrists routinely send reminder letters to 
patients when sight-tests are due, however this was the reason for attendance 
in only 44% of cases. With 57% of those with glaucoma living within 5 miles of 
an optometrist and 83% paying less than £2 to travel to the optometrist, other 
barriers to uptake of sight tests, such as the association of sight testing with 
buying spectacles, appear to be involved. This highlights the need to further 
explore cost effective, non-commercial models for sight testing and screening 
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(Burr et al., 2011, Burr et al., 2007, Hernandez et al., 2008a, Hernandez et al., 
2008b, Mowatt et al., 2008, Prior et al., 2012).  
 
Ease of access to health care is important to patients (Gray et al., 1997), and 
this study clearly shows the statistically significant reduction in costs and 
travel distance for those attending the community optometrist compared to the 
hospital. Slightly over half the patients in this study live within 5 miles of their 
optometrist with no statistically significant difference between those with 
glaucoma or suspect glaucoma to those with no evidence of glaucoma. 
However, a statistically significant percentage of patients with glaucoma or 
suspect glaucoma live greater than 5 miles from the hospital compared to 
those with no glaucoma. Whilst it may be acceptable for a patient to travel a 
greater distance and pay more money to attend a new outpatient 
appointment, it may be more convenient to the patient if long-term review was 
not carried out in the hospital.  
 
Patients from more deprived areas have been shown to present with more 
advanced glaucoma (Day et al., 2010, Fraser et al., 2001). In this population, 
which is more affluent than the national average the IMD was 9.1 in both 
groups.  The severity of glaucoma at diagnosis is unknown in this study.  
 
A FVDP of 48% in this study highlights the need to improve the efficiency of 
the referral pathway, particularly by reducing inappropriate referrals to the 
hospital eye service. Enhanced optometry services have been seen as a 
solution and have been developed in many areas in the UK to both refine 
referrals as well as provide follow-up care (Bourne et al., 2010, Devarajan et 
al., 2011, Henson et al., 2003, Local Optical Committee Support Unit, 2012, 
Parkins and Edgar, 2011, Syam et al., 2010, Ratnarajan et al., 2012). Some 
studies have reported that patients with stable glaucoma prefer their follow-up 
in the community, thus supporting the enhanced optometry service model 
(Bhargava et al., 2008, Gray et al., 1997). However, the preference of new 
patients with respect to which eye health professional they see and the 
location is unknown. The results from this study suggest new patients are 
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satisfied with the current model of care despite the extra distance and cost 
associated with the hospital visit.  
 
Clinical outcomes in glaucoma take many years to develop while changes to 
services, have been much more rapid. Patients may want and possibly expect 
to see a consultant after an optometrist has raised the spectre of glaucoma, 
and this report has shown high patient satisfaction with this appointment. The 
Joint College Guidance published in March 2013 has recommended both 
repeat pressure and glaucoma referral refinement schemes as effective ways 
to reduce unnecessary referrals to the hospital (Royal College of 
Ophthalmologists and College of Optometrists, 2013a), however the 
satisfaction of patients within enhanced optometry services needs to be 
evaluated using a validated framework.  
 
This is a single-site sample with a lower than average IMD, meaning the 
results of this paper cannot necessarily be directly applied to other 
populations, and is a limitation of this study that should be considered. 
Despite the patient satisfaction component of the questionnaire being 
anonymous, bias may have been introduced as patients completed the 
questionnaire at the point of care.  
 
To conclude, the results from this study demonstrate high satisfaction in 
referred patients with suspected glaucoma although there is a need to 
increase patient education and awareness of eligibility of free-sight testing to 
increase attendance in primary care, which will result in more effective 
glaucoma case-finding. There is also a need to update national guidance to 
incorporate coherent referral criteria, agreed by both ophthalmologists and 
optometrists, to reduce the number of inappropriate referrals.  
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3.6 The Equity profile of an Enhanced Optometry scheme. 
3.6.1 Background 
 
Hospital episode statistics indicate there were over 5.5 million Ophthalmology 
out-patient attendances in England in 2009, of which 1.5 million were new 
attendances (Hospital Episode Statistics). Up to twenty percent of these 
attendances were referrals for suspected glaucoma, with the annual cost for 
monitoring patients with this chronic, and potentially blinding condition 
estimated to be £22,469,000 (NICE, 2012a).  
 
In the UK, most referrals for suspected glaucoma are generated through 
opportunistic surveillance during sight tests by primary care optometrists 
(PCO) (Bowling et al., 2005, Burr et al., 2007, Davey et al., 2011). The 
location of optometrist practices has been shown to be poorly correlated with 
service demands with fewer optometrists in areas of higher social deprivation 
(Day et al., 2010). Individuals from these deprived areas were also shown to 
present with more advanced disease (Fraser et al., 2001, Day et al., 2010). 
These studies focused on deprived and urban populations, and may not be a 
reflection of the problem nationally. 
 
To reduce the burden on the HES caused by the large increase in referrals, 
enhanced optometry services, such as glaucoma referral refinement, have 
been increasingly carried out in community practices by OSIs. These services 
have been shown to deliver safe and reliable ophthalmic care, whilst 
simultaneously reducing the amount of inappropriate referrals to secondary 
care by 20% compared to referrals directly from optometrists without 
specialist interest (Bourne et al., 2010, Ratnarajan et al., 2012, Ratnarajan et 
al., 2013a, Ratnarajan et al., 2013b).   
 
Glaucoma referral refinement is predominately community-based and has 
been shown to result in less distance travelled and cost saving to the patient 
(Ratnarajan et al., 2014). An example of this is the CHANGES scheme that 
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operates in the semi-rural, predominately Caucasian catchment area of 
Hinchingbrooke Hospital. In this scheme patients are triaged according to risk 
factors on the referral form, with low-risk patients directed to OSI review and 
high-risk patients directly to the hospital. 
 
As stated in 2.5 equity profiling is essential to enable commissioning of 
effective healthcare that is mapped directly to the needs of the population at a 
local level (Day et al., 2010). Equity profiling in the ophthalmic literature has 
focused on socially deprived urban populations (Day et al., 2010). Whilst this 
is undoubtedly a key demographic, it is by no means representative of the 
entire population. Therefore, in this study an equity profile was carried out for 
a semi-rural, relatively affluent population to establish the differences, if any, 
with respect to the provision and distribution of eye health care. Moreover, this 
study is the first equity profile of an enhanced optometry scheme. An analysis 
based on patient proximity to the hospital, OSI or PCO was conducted.  
 
 
3.6.2 Purpose 
 
The purpose of this study was to perform an equity profile for an enhanced 
optometry scheme to establish if effective eye health care was being provided 
to its catchment population.  
 
 
3.6.3 Methods 
 
After Trust approval, the records of all patients referred under the CHANGES 
scheme from its introduction in August 2006 until June 2011 were 
retrospectively audited and analysed.  
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3.6.3.1 CHANGES scheme 
 
All referral letters for suspected glaucoma from the PCO are categorised by 
an experienced hospital-based optometrist as either low- or high-risk 
according to a protocol based on the examination findings listed in the letter. 
A referral was deemed low-risk if only one of the following risk factors was 
noted and high-risk if more than one low-risk factor was present, or 
alternatively if a shallow anterior chamber, IOP >28mmHg, optic disc 
haemorrhage, pigment dispersion or pseudoexfoliation were detected. Low-
risk patients are reviewed by an OSI and high-risk patients are seen directly in 
the hospital glaucoma clinic. For more details on the organisation of the 
CHANGES scheme see 3.2.3 
 
3.6.3.2 Data collection 
 
Anonymised demographic data, the reason for referral, final diagnosis and 
mean deviation of the presenting VF were collated. The road distance from 
the patients’ home postcode to the optometrist, OSI, and Hinchingbrooke 
hospital was calculated using the Geographical Information System (GIS) 
package ArcGIS v10. A digital representation of the road network was 
constructed using the Ordnance Survey Meridian data and network routing 
algorithms were used in the GIS to identify the most direct route along the 
road network from each patient’s home to each of the health services of 
interest, and to calculate the total distance for that route (Survey, 2013). All 
calculations assumed car travel. As a measure of neighbourhood material 
deprivation the IMD 2010 score was calculated for each individual based on 
the Census Lower Super Output Area zone that their postcode was allocated 
to (Communities and Local Government, 2010). The IMD 2010 is calculated 
using 38 separate indicators, organized across seven distinct domains of 
deprivation including income, employment, health and disability, education, 
housing, environment and crime.  
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3.6.3.3 Data management and statistical analysis 
 
Anonymised patient information from the referral forms of the community 
optometrist and the OSI, as well as the hospital patient records, was collated 
on a database in Microsoft Excel; statistical analysis was performed in R 
(version 2.15.1, R foundation for statistical computing). Categorical variables 
have been analysed using Fisher’s Exact Test, and the means of continuous 
variables have been compared using permutations tests which do not require 
the usual distributional assumptions. 
 
 
3.6.4 Results 
 
A total of 2794 patients were included. The estimated median age was 58 
years, and 43% were male. 2078 (74.4%) referrals were classified as high-risk 
and 716 (25.6%) were low-risk.  
 
Table 3-8 compares high and low-risk patients based on diagnosis, and Table 
3-9 compares high and low-risk patients based on distance to PCO or the 
HES. The location of low-risk patients with glaucoma compared to the 
surrounding eye health care services is illustrated in Figure 3-10. 
 
3.6.4.1 Low-risk referrals 
 
The median age of low-risk referrals were 54 and 47% were male. The mean 
IMD was 10.0. The mean distance to the PCO was 9.0 km, to the OSI it was 
8.4 km, and to the HES 12.5 km. 31 (4.3%) were diagnosed with POAG and 
352 (49.2%) as no evidence of glaucoma, with the remaining classified as 
glaucoma suspect or OHT. 
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3.6.4.2 High-risk referrals 
 
The median age of the 2078 high-risk referrals was 60, and 43% were male. 
The mean IMD was 10.6. The mean distance to the PCO was 8.2 km and to 
the HES 13.6 km. 236 (11.4%) were diagnosed with POAG and 780 (37.5%) 
as no evidence of glaucoma, with the remaining classified as glaucoma 
suspect or OHT. 
 
 
Table 3-8. Comparison high and low-risk patients based on diagnosis. 
 
Low-risk referrals 
 
High-risk referrals 
 
 
Diagnosed 
with 
Glaucoma 
(n = 31) 
No 
evidence of 
glaucoma 
(n = 352) 
P value 
for 
difference 
Diagnosed 
with 
Glaucoma 
(n = 236) 
No evidence 
of glaucoma 
(n = 780) 
P value 
for 
difference 
Mean Age 
(years) 
67 53 < 0.01 68 56 < 0.01 
% Male 45 47 1.00 45 42 0.45 
Mean IMD 9.6 9.2 0.75 10.7 10.4 0.56 
Mean distance 
to referring 
optometrist 
(km) 
8.6 8.5 0.96 8.0 8.0 0.97 
Mean Distance 
to specialist 
optometrist 
(km) 
7.6 8.1 0.72 N/A N/A N/A 
Mean distance 
to hospital (km) 
11.7 12.6 0.42 13.7 14.1 0.47 
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Table 3-9. Comparison of high and low-risk patients living closer to the 
primary-care optometrist with those living closer to the hospital. 
 
Low-risk referrals 
 
High-risk referrals 
 
 
 
Closer to 
optometrist 
(n = 295) 
Closer to OSI 
(n=192) 
Closer to 
Hospital 
(n=46) 
P-value for 
difference 
Closer to 
optometrist 
(n=1405) 
Closer to 
Hospital 
(n=311) 
P-value for 
difference 
Mean distance to 
service (km) 
5.2 6.0 8.0 < 0.01 5.6 10.0 < 0.01 
Mean age at audit 
(years) 
55 53 55 0.25 60 57 < 0.01 
% Male 44 48 46 0.56 43 48 0.11 
Mean IMD 9.8 9.6 8.0 0.15 11.0 8.9 < 0.01 
% living in most 
deprived quartile 
21 19 2 < 0.01             30                   13 < 0.01 
% Glaucoma 4 4 7 0.63 12 11 0.69 
% Discharged 40 37 28 0.27 34 34 1.00 
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Figure 3-10. Map showing location of low-risk patients with glaucoma 
compared to the surrounding eye health care services.  
(Each dot corresponds to a geographic location and not necessarily to single patient or eye 
health professional) 
 
 
 
 
3.6.4.3 Visual field at presentation analysis 
 
Amongst the 2078 high-risk patients 1884 had visual field measurements of 
mean deviation, and of these 1651 (87.6%) had a mild VF defect at 
presentation (defined as a mean deviation of less than or equal to -6dB in the 
worse eye). 151 (8.0%) had a moderate VF defect at presentation (defined as 
greater than 6 but less than or equal to -12dB in the worse eye). 82 (4.4%) 
had a severe VF defect at presentation (defined as greater than -12dB in the 
worse eye). Table 3-10 compares the access to eye health care based on 
severity of VF at presentation. 
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Table 3-10. Comparison of high-risk patient access to eye health care based 
on visual field loss at presentation.  
 
 MILD VF LOSS 
(n=1651) 
MODERATE VF LOSS 
(n=151) 
SEVERE VF LOSS 
(n=82) 
P-value 
Mean IMD 10.5 10.8 11.5 0.36 
Distance to primary 
care optom (km) 
8.3 8.6 5.7 0.27 
Distance to 
Hospital (km) 
13.7 12.7 13.5 0.40 
 
 
3.6.5 Discussion 
 
As expected the majority of patients live closer to an optometrist than the HES 
and this ‘care closer to home’ is the main driver towards developing quality 
community based eye health services at a national level. More specifically 
low-risk patients who are found to have glaucoma after HES review live on 
average 4.1km closer to the OSI than the HES. In fact the specialist 
optometrist is often more proximal to the patient’s home than even the 
referring optometrist. This is important as the OSIs in enhanced schemes are 
distributed according to the service needs of its population rather than 
economic considerations as demonstrated in figure 3-10. 
 
In this study there is no association between final diagnosis and distance to 
an eye health professional, in particular the optometrist. The severity of 
glaucoma at presentation is independent of deprivation and distance to the 
optometrist or hospital, with patients who were diagnosed with glaucoma and 
had a severe VF loss actually living closer to the PCO than those with mild or 
moderate VF loss with no significant differences in deprivation scores. This is 
in contrast to Fraser et al who found deprivation to be linked with late 
presentation of glaucoma to the hospital (Fraser et al., 2001). The populations 
from these studies are markedly distinct, with the CHANGES scheme semi-
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rural and relatively affluent compared to urban and deprived in the 
aforementioned studies. 
 
Despite no overall association between diagnosis and distance travelled, 
there was a highly statistically significant difference in the mean distance 
travelled by patients living closer to an optometrist (PCO or OSI) compared to 
those living closer to the HES. High-risk patients living closer to the PCO were 
older and more likely to be from the most socially deprived quartile of the 
sample. Low-risk patients living closer to the PCO or OSI compared to the 
HES also travel a significantly shorter distance, with a larger percentage of 
patients living in the most socially deprived quartile of the sample. Day et al 
showed a scarcity of optometric service provision in a deprived urban 
population (Day et al., 2010), whereas optometry services were accessible to 
the most deprived persons of this semi-rural study. This raises the important 
question of how to develop glaucoma referral models on a national basis if 
access to eye health care varies so widely. This study suggests that whilst 
national standards need to be introduced for glaucoma referral models to 
address factors such as the level of competency and accreditation of the eye 
health professional or the time frame in which the patient is seen, it would be 
wise for details such as number and location of these practices to be decided 
at a local level. 
 
In chapter 3.5 it has been demonstrated that despite the significantly greater 
distances travelled to the HES than the optometrist, patients are satisfied with 
the level of care in the HES and the majority would prefer to see an 
ophthalmologist after the optometrist has raised the spectre of glaucoma 
during a sight-test (Ratnarajan et al., 2014).  
 
Equity profiling is a quick and inexpensive way for health professionals and 
commissioners to understand the need, met or unmet, for their population. 
This is the first equity profile for an enhanced optometrist service, and only the 
second equity profile in glaucoma overall. It has demonstrated that the 
CHANGES scheme does provide a specialist optometric service that is easily 
accessible to its catchment. Comparison with the first published equity profile 
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highlights the stark variations that can be observed with regard to patient 
access to eye health care and the effect of this on the subsequent diagnosis 
of glaucoma. Further equity profiling studies will better inform future national 
guidance on referral models in ophthalmology. 
 
This study was not a formal epidemiological survey, but did use an accurate 
database constructed for the CHANGES scheme. A large number of patients 
were included in the analysis, and the catchment area of the scheme is free 
from alternative secondary eye care providers thus eliminating selection bias. 
 
The main weakness is that this is a single site study on a relatively affluent 
semi-rural population and this might limit the generalisability of the findings to 
other populations.  
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3.7 The false negative proportion and the role for virtual 
review in a nationally evaluated glaucoma referral 
refinement scheme. 
 
3.7.1 Background 
Glaucoma is the world’s leading cause of irreversible blindness (Bourne et al., 
2013), with a recent study demonstrating a marked increase in disease 
burden over the last 20 years (measured in disability adjusted life years) in the 
UK (Murray et al., 2013). Up to twenty percent of referrals to ophthalmology 
clinics in the UK are for suspected glaucoma, with the annual cost for 
monitoring patients with this chronic, and potentially blinding condition 
estimated to be £22,469,000 (National Institute for Health and Clinical 
Excellence, 2009, Davey et al., 2011). 
 
The number of referrals for suspected glaucoma, particularly those 
discharged at the first visit to the Hospital Eye Service (HES), has been 
increasing for many years, though this has been more marked since the 
publication of the National Institute for Health & Clinical Excellence (NICE) 
guidelines ‘Glaucoma: Diagnosis and management of chronic open angle 
glaucoma and ocular hypertension’ in April 2009 and the response of the 
Association of Optometrists (AOP), Association of British Dispensing 
Opticians (ABDO) and the Federation of Ophthalmic and Dispensing 
Opticians (FODO) (Ratnarajan et al., 2012, Vernon, 1998, NICE, 2009a, 
Association of Optometrists, 2010). 
 
As previously mentioned; in an attempt to reduce the number of referrals to 
the HES, the College of Optometrists and Royal College of Ophthalmologists 
released Joint College Group (JCG) referral guidance recommending 
additional criteria: that a practitioner may consider not referring a patient aged 
80 years and over with an IOP of less than 26mmHg, or patients aged 65 
years and older with IOP less than 25mmHg, if the remainder of the ocular 
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examination is normal, as these patients are not recommended for treatment 
under the current NICE guidance (College of Optometrists, 2010). 
 
A more recent guideline published by NICE in March 2012, entitled ‘Services 
for people at risk of developing glaucoma’, was aimed at the commissioning of 
glaucoma services. It recommends that patients with an IOP of greater than 
30mmHg be referred to secondary care without delay suggesting that these 
patients are not suitable for a community-based refinement of the referral 
(NICE, 2012b). 
 
GRRS have proliferated across the country over the past decade, often 
demonstrating marked variation in pathway design, referral criteria as well as 
the level of competency and training required by the participating optometrists 
(Ang et al., 2009, Bourne et al., 2010, Devarajan et al., 2011, Henson et al., 
2003, Parkins and Edgar, 2011, Syam et al., 2010).  
 
In Chapter 3.3 a multi-site review of GRRS in the UK demonstrated that 
involving optometrists with a specialist interest (OSI) in glaucoma in the care 
pathway of patients referred following an initial optometrist assessment for 
glaucoma risk, can decrease the FVDP as compared with traditional pathways 
of direct referral of all at-risk patients from primary to secondary care. This 
reduction in ‘false-positive’ referrals reaching the ophthalmologist-led hospital 
based glaucoma service reduced the burden on the HES (Ratnarajan et al., 
2013b). This paper recommended the triage of referral information from the 
initial optometrist community-based assessment into two groups of patients, 
‘high’ and ‘low’ glaucoma risk, in order to establish much-needed 
standardization of GRRS across the UK. Our work recommended that referral 
information involving one of the following criteria would be suitable for 
assessment by an OSI in advance of (or obviating the need for) a specialist 
glaucoma hospital-based ophthalmologist assessment (Ratnarajan et al., 
2013b): 
• Elevated IOP only (but less than 30mmHg) 
• Abnormal optic disc only 
• Abnormal VF only 
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• Elevated IOP and abnormal VF 
Additionally it was recommended that the OSI subsequently refer to the HES 
if any of the following observations were made: 
• IOP was outside JCG recommendations using Goldmann applanation 
tonometry (GAT) 
• Optic disc pathology found after dilated slit-lamp examination 
• Abnormal visual field (ideally using Humphrey visual field machine) 
 
GRRS allows for the OSI to discharge patients in whom the OSI judges there 
to be no glaucoma risk. The multi-site review and the literature in general, has 
not been able to comment on the safety of GRRS with respect to patients who 
may be inappropriately discharged by the OSI. Given that these patients are 
not seen in the HES there has not been the opportunity to validate the OSI’s 
decision to discharge, hence the first aim of this study, to establish the 
numbers of patients who may be falsely discharged by community-based 
specialist optometrists involved in this GRRS. Virtual review of the OSI 
examination findings in conjunction with an optic disc photograph by a 
hospital-based specialist optometrist or ophthalmologist has been reported as 
an effective method to prevent inappropriate discharges by the OSI (Bourne 
et al., 2010, Devarajan et al., 2011), although its effectiveness compared to 
physical review in the HES by a consultant ophthalmologist specialising in 
glaucoma is unknown. The second aim of this work was therefore to compare 
decision-making between specialist optometrists and consultant 
ophthalmologist when evaluating optic disc images for the presence of 
glaucomatous optic neuropathy. 
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3.7.2 Purpose 
The primary purpose of this study was to establish the numbers of patients 
who may be falsely discharged by community-based specialist optometrists 
involved in this GRRS. The secondary purpose of this work was to compare 
decision-making between specialist optometrists and consultant 
ophthalmologist when evaluating optic disc images for the presence of 
glaucomatous optic neuropathy. 
 
 
3.7.3 Methods 
Infrastructure of the CHANGES scheme 
See 3.2.3 
 
Updated CHANGES scheme 
The referral criteria into the CHANGES scheme was updated in December 
2013 as per the recommendations of the national multi-site review of GRRS 
described in chapter 3.3 (Ratnarajan et al., 2013b).  
 
All patients seen, and subsequently discharged by the OSI during the first 8 
months of this updated scheme were offered an additional review by a 
Glaucoma Consultant at the HES to validate the safety of the updated 
scheme. All examination findings by the OSI were collated on the hospital 
electronic patient record. This constituted an audit/service review and hence 
did not require research and ethics approval. 
 
All patients were seen by the same Glaucoma Consultant and had a full 
ophthalmic examination including IOP measurement using GAT and dilated 
optic disc assessment. Visual fields were not repeated as all OSIs use the 
same machine as the HES, the Humphrey visual field machine using 24-2 
SITA fast testing. The findings, diagnosis and outcome of the visit were 
documented on a database. The ‘false negative’ or ‘inappropriate discharge’ 
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proportion was defined as the percentage of these patients in whom the 
glaucoma consultant judged sufficient glaucoma risk to necessitate a review 
in the HES. The ‘missed glaucoma proportion’ was defined as the percentage 
of patients diagnosed with glaucoma which was initiated on or booked for 
treatment at that visit. 
 
In addition, a masked virtual assessment of the optic disc images sent by the 
OSI was performed before the clinic review by both the Glaucoma Consultant 
as well as the experienced hospital based optometrist who routinely 
scrutinizes the findings (examination and photographic) of all OSI 
assessments. The images were assessed non-stereoscopically on a 
computer screen with resolution of 1600 x 900 pixels for the optometrist and 
1280x1024 pixels for the Consultant.  
 
 
Data management and Statistical Analysis 
Data from electronic patient records and paper copies of referral letters were 
collated on Microsoft Excel; statistical analysis was performed in R (version 
3.1.1, R foundation for statistical computing). 
 
 
3.7.4 Results 
 
3.7.4.1 Study 1 
One hundred and twenty patients were seen by OSIs during the first 8 months 
of the updated CHANGES scheme, of whom 46 were discharged. Thirty-four 
of the 46 (74%) patients agreed to attend a hospital review by the glaucoma 
consultant. 
 
All 34 patients discharged by the OSI had documented GAT IOP lower than 
the threshold for discharge set by the JCG recommendations, normal dilated 
slit-lamp optic disc assessment and normal 24-2 Humphrey visual fields. 
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The Glaucoma Consultant also found all 34 patients to have GAT IOP 
measurement below the JCG threshold for discharge. Five of the 34 (15%) 
were found by the Consultant to have a suspicious optic disc or peripapillary 
retinal nerve fibre layer following slit-lamp biomicroscopy through dilated 
pupils. These five patients were classified as ‘glaucoma suspect’ and offered 
a follow-up appointment but none was started on IOP lowering treatment. This 
translates to a ‘missed glaucoma proportion’ of 0% and a false negative 
proportion of 15% for the OSI. It is important to highlight this is the false 
negative proportion of the OSI’s clinical assessment and not the CHANGES 
scheme as the scheme has a hospital optometrist who virtually reviews the 
digital images of all optic discs of patients discharged directly by the OSI. 
 
3.7.4.2 Study 2 
After virtual review of the optic disc photographs of the 34 patients by the 
Consultant, 13 patients were felt to be suspicious of glaucoma and 21 patients 
normal. Comparing this virtual photographic-only review with the clinical 
findings made independently by the same consultant, virtual photographic 
review performed with a sensitivity of 80% (95% CI: 38% to 96%) and 
specificity of 69% (95% CI: 51% to 83%) when compared to the clinic-based 
assessment (see Table 3-11).  
	
Table 3-11. Comparison of Consultant clinic-based assessment to Consultant 
virtual review. 
 
 Clinic-based assessment by Consultant 
 Patient with a suspicious 
optic disc 
Patient without a 
suspicious optic disc 
Patient with a suspicious 
optic disc after virtual 
review 
4 9 
Patient without a 
suspicious optic disc after 
virtual review 
1 20 
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Virtual review by the hospital optometrist resulted in 5 patients being classified 
as suspicious and 29 as normal, with a sensitivity of 80% (95% CI: 38% to 
96%) and specificity of 97% (95% CI: 83% to 99%) compared to the clinic 
review by the Consultant (see table 3-12). 
	
	
	
	
Table 3-12. Comparison of Consultant clinic-based assessment to 
Optometrist virtual review. 
	
 Clinic-based assessment by Consultant 
 Patient with a suspicious 
optic disc 
Patient without a 
suspicious optic disc 
Patient with a suspicious 
optic disc after virtual 
review 
4 1 
Patient without a 
suspicious optic disc after 
virtual review 
1 28 
	
 
When comparing the outcomes of the virtual reviewers against each other, 
there was no difference in the sensitivities, both 0.8. The false positive 
proportion for the Consultant virtual review was 31.0% (95% CI: 17% to 49%) 
compared to 3.4% (95% CI: 0.6% to 17.2%) for the optometrist. 
 
3.7.5 Discussion 
The CHANGES scheme was updated in December 2013 in accordance with a 
multi-site review of GRRS. During the first 8 months of the scheme 38% 
(46/120) of new low-risk referrals from the high street optometrist were 
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discharged after community based review by the OSI. The majority of these 
patients were seen by the OSI within 2 to 4 weeks of the initial referral, which 
is substantially shorter than the waiting time for a HES outpatient 
appointment. Chapter 3.5.4.4 reports increased convenience and less 
expense for patients to be seen in a local optometrist practice than the HES; 
however this must not impinge on patient safety (Ratnarajan et al., 2014). 
 
The findings of Study 1 showed that the OSI did not miss any cases of 
glaucoma, when comparing the clinical findings of both the OSI and the 
ophthalmologist. This confirms the safety of the OSIs working in the 
CHANGES scheme. However, 15% of optic discs that were classified by the 
OSI as normal were classified by the Consultant Ophthalmologist as being 
suspicious of glaucoma. There may be a variety of reasons for this 
disagreement between health professionals. Certainly even among glaucoma 
specialists there can be considerable disagreement in what constitutes an 
abnormal optic disc (Reus et al., 2010) and the involvement of only one 
glaucoma ophthalmologist could be considered a limitation of this study. 
Additionally the nature of the referral refinement scheme meant that the 
consultant was being compared with multiple OSIs, some of whom may have 
been consistently poor at detecting glaucomatous optic neuropathy despite 
training. A larger study involving larger numbers of eligible patients from each 
of the OSIs would facilitate this enquiry. The experience of a glaucoma 
ophthalmologist in optic disc examination, particularly in examination for 
retinal nerve fibre layer defects, may also part explain the greater number of 
glaucoma suspects detected by the consultant.  
 
 
In chapter 3.4 it was reported the positive predictive value between the OSIs 
and Consultant for the identification of an abnormal optic disc demonstrated a 
statistically significant decline post NICE guideline publication from 60.6% to 
42.7% (NICE, 2009a, Ratnarajan et al., 2012). It was postulated that the lack 
of legal indemnity for optometrists not complying with the Association of 
Optometrist’s response to the NICE guidelines may have led optometrists to 
adopt a more risk averse and medicolegally defensive approach to practice 
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(Association of Optometrists, 2010). The outcome resulted in more false 
positive referrals to the HES, which resulted in more expense and 
unnecessary anxiety for the patients. However, the effect of false negative 
referrals is more serious as patients with glaucoma may not be getting 
referred to the HES.  
 
Whilst a community based Consultant Ophthalmologist review of every 
referral for suspected glaucoma may be portrayed an optimal service design, 
current models of care and infrastructure make this implausible. Virtual review 
of optic disc photographs by both the Consultant and independently by the 
hospital-based specialist optometrist showed high sensitivities of 80%, when 
comparing with ophthalmologist judgment of a suspicious optic disc. However, 
the hospital-based optometrist displayed higher specificity than the Consultant 
resulting in a false positive proportion 9 fold lower (3.4% vs 31.0%). It can 
therefore be inferred that the virtual review of optic disc images of patients 
thought by an OSI to be normal is a useful adjunct in the infrastructure of a 
GRRS, resulting in increased patient safety. The results would also suggest a 
learning curve for virtual review of optic discs exists, with the optometrist who 
regularly reviews all optic disc images for the CHANGES scheme 9 times less 
likely to generate a false positive referral compared to the Consultant. It 
should be remembered however that the virtual review outcomes in this study 
are based on the findings of only one Consultant and one hospital optometrist, 
and that the screen used by the optometrist had superior resolution compared 
to that used by the Consultant, which may be a confounding factor. 
 
 
The updated CHANGES scheme exhibits safe and effective triaging criteria. 
Risk stratification ensure patients at higher risk of glaucoma are seen in the 
HES without the delay of a community based OSI review, and lower risk 
patients are seen by the OSI, with virtual review acting as an additional step 
to ensure patients with glaucoma are not being missed. Virtual review in 
experienced hands can be as effective as clinical review by a Consultant and 
saves both time and resource.  
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4 SECTION IV: Discussion and Summary 
 
4.1 The Impact of glaucoma referral refinement criteria on 
referral proportions and first-visit discharge proportions. 
 
4.1.1. Summary 
 
Referrals involving a raised IOP alone were the most common reason for 
referrals relating to glaucoma, with an increase in the proportion over time, 
particularly for the low-risk group. There was a considerable increase in 
referrals of low-risk patients between 2008 and 2009 (31 to 112) and this is 
likely to be related to the introduction of the NICE guidelines and the 
AOP/ABDO/FODO response to these guidelines (Association of Optometrists, 
2010). 
 
The high FVDP for referrals based on raised IOP plus abnormal visual fields 
(54%), coupled with the fact that OSIs in this scheme use equipment that is 
consistent with that used in the hospital eye services (calibrated Goldmann 
tonometry and Humphrey visual field analysers), would suggest that re-
categorisation of these patients as low-risk rather than high-risk would 
improve the efficiency of the CHANGES scheme. 
 
The following recommendations from this study aim to reduce the demand on 
the hospital glaucoma service whilst simultaneously maintaining the quality of 
care received by patients in the CHANGES scheme. 
 
It is recommended the general organisation of this referral refinement scheme 
remain unchanged, with risk stratification of the patient based on the referral 
form into low- and high-risk categories and with low-risk referrals being 
directed to an OSI and the high-risk referrals being directly assessed by the 
hospital glaucoma service. However, the criteria for categorisation into low- 
and high-risk could be adjusted. Referrals deemed low-risk (currently no more 
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than one of the following: suspicious optic disc, abnormal VF, raised IOP (22-
28mmHg) or IOP asymmetry (>5mmHg) could be widened to include patients 
with: 
a. an IOP ≤ 30mmHg (currently ≤28mmHg) in conjunction with a normal 
optic disc and VF, thus complying with NICE commissioners guidance.  
b. an IOP ≤ 30mmHg in conjunction with an abnormal VF 
c. an optic disc haemorrhage, evidence of pigment dispersion and 
pseudoexfoliation in conjunction with a normal IOP, normal VF and no 
evidence of glaucomatous optic disc cupping.  
 
In addition, the OSI should partially adopt the JCG referral criteria, whereby 
an OSI need not refer a patient aged ≥ 65 years with an IOP < 25mmHg in 
both eyes with an otherwise normal ocular examination (current criterion: IOP 
> 21mmHg). This report found that the JCG suggestion to increase the IOP 
threshold to < 26 for the over 80’s has little impact on further reducing 
referrals. The role of CCT measurements in GRRS also needs further 
exploration. 
 
4.1.2. Implications  
 
It is important the referral criteria implemented in GRRS follow national 
guidance. This study has demonstrated that the lack of legal indemnity for 
optometrists not complying with the AOP’s recommendation has proved to be 
a really effective way of changing optometry practice, though unfortunately 
this directly resulted in a higher FVDP of patients seen in the hospital.  
GRRS must choose entry and referral criteria that comply with the relevant 
optometry professional guidance or JCG if OSIs are to work with full legal 
indemnity. It is at national level that evidence-based criteria for GRSS need to 
be established.  
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4.1.3. Further work  
 
Based on the findings of this study, amendments to the referral criteria were 
suggested. The definitive way to test the safety of these recommendations 
would be for the HES to audit, by way of a HES review, all patients seen by 
the OSI, both those referred as well as those discharged (see sections 3.7 
and 4.6). 
The use of electronic referrals forms can help guide the clinical examination of 
the referring eye health professional and ensure the necessary clinical 
information is filled in. Electronic referral forms, particularly with digital optic 
disc images, have been shown to improve the quality of referrals and reduce 
onward referral to the HES (Cameron et al., 2009). As part of my work with 
the HIEC, I developed an electronic referrals form that is to be used with 
OpenEyes electronic health record (see appendix 1).  
Clinical decision support software that is integrated into an electronic health 
record and referral form can further improve the quality of the referral form. 
Future work to look at clinical decision support and GRRS is in its preliminary 
stages. 
The use of central corneal thickness measurements by OSI to calibrate the 
IOP measurements, as discussed in section 3.2, is not performed routinely. 
Whether this entails diagnosis rather than clinical assessment, and the 
potential impact of purchasing a pachymeter on the cost effectiveness of 
GRRS should be addressed in future work. Community optometrists have 
demonstrated a keenness to want to update specialist equipment to be more 
in line with the HES, as well as move to electronic records and this should be 
encouraged (Dabasia et al., 2014). 
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4.2. Multi-site review of glaucoma referral refinement 
schemes 
 
4.2.1. Summary 
 
In terms of ‘demand management’, review of patients by OSIs can reduce the 
FVDP of patients subsequently reviewed in secondary care. However, in 
terms of patient safety, this study also shows that the overemphasis on IOP 
as a criterion for referral is likely to be having an adverse effect on the ability 
of non-OSIs, and indeed of OSIs, to detect glaucomatous optic nerve 
features, a key clinical skill in the detection of this potentially blinding disease. 
This work has identified the frequency of diagnosed glaucoma in categories 
based on criteria of single and combined features of the ophthalmic 
examination by non-OSIs and OSIs. It recommends that referral letters from 
non-OSIs be stratified for risk using the findings of this report to direct high-
risk patients straight to secondary care, and low-risk patients to OSIs for 
assessment.  
The results of this analysis lead to the recommendation that ‘low-risk’ referrals 
should be defined as those based on abnormal findings in IOP only, optic disc 
only, VF only and IOP and VF together, with all others, including those with 
any reference to a shallow anterior chamber angle, better suited to a direct 
referral to secondary care.  
 
The inclusion of both VF and disc examination is clearly associated with a 
lower FVDP and, therefore a detailed disc and VF examination should form 
part of the referral refinement in conjunction with Goldmann/Perkins 
tonometry for measuring the IOP. Crucially, using the referral criteria of the 
JCG will allow the optometrist to operate within a professional and legal 
framework.   
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4.2.2. Implications 
 
This work has highlighted the large variations in referral criteria and 
organisational set-up for GRRS nationally. This inevitably leads to variations 
in the quality and efficiency of care provided and may impact on patient 
safety.  
The safety and efficacy of GRRS needs to be considered. Once a non-OSI 
has raised the possibility of a diagnosis of glaucoma, the safest option would 
be for a Consultant to review the patient in the HES. However, as previously 
described, with current models of care, this is unsustainable and has placed 
considerable strain on the HES. Alternatives include a Consultant review in 
the community or the use of a virtual Consultant review in either the 
community or HES setting as discussed in section 3.7. 
The inappropriate discharge proportion following OSI review, i.e. the OSI false 
negative proportion, would be the most definitive method to establish a GRRS 
safety. This information is difficult to obtain as the patients are not seen in the 
HES. Section 3.7 and 4.6 consider the false negative proportion of a GRRS. 
 
 
4.2.3. Future work 
 
This evidence contributes to the need for a review of national policy on the 
management of referrals for glaucoma both in terms of referral criteria as well 
as organisational set-up. The situation is compounded by the fractionation 
between optometry and ophthalmology. NICE, The Royal College of 
Ophthalmologists, The College of Optometrists, AOP, ABDO and FODO all 
have to be involved in the process to ensure compliance with national policy.   
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4.3. Agreement between eye health professionals 
  
4.3.1. Summary 
 
A dramatic increase in the number of glaucoma referrals has occurred since 
the AOP’s response to the NICE guidelines, which has placed an increased 
burden on ophthalmology outpatient departments nationally (Shah and 
Murdoch, 2011). This is reflected in the observation of increased scheme 
activity from a mean of 8.7 patients per month pre NICE to 25.4 per month 
post NICE, coupled with an increased FVDP from 33.6% to 40.2%. 
 
The accuracy of examination for detection of an abnormal IOP by the OSI has 
remained unchanged since 2006, which is likely to be explained by the 
standardisation of techniques employed by both the OSI and the consultant. 
However, a decline was observed for detection of an abnormal optic disc by 
the OSI, which is an interesting finding as dilated disc assessment with 
indirect ophthalmoscopy has been used since the introduction of this 
particular scheme.  
 
For the non-OSI, there was a decline in accuracy in detection of both an 
abnormal IOP and optic disc assessment. The probability of a consultant 
reproducing the non-OSIs finding of a moderately raised IOP (22-28mmHg) is 
lower than that of a significantly raised IOP (>28mmHg). This is not 
unexpected but it demonstrates how stratification of risk on the basis of IOP is 
important to ensure patient safety for higher IOPs and efficiency of the GRRS 
with respect to reducing HES FVDP for the lower IOPs. Such a stratification 
on inter-professional agreement’s reported for the first time in this study. 
 
The appropriate referral proportion for an OSI decreased following the 
publication of the NICE glaucoma guidelines, though the appropriate 
discharge proportion increased.  
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4.3.2. Implications  
 
The accuracy for detecting of an abnormal IOP by the OSI has remained 
unchanged since 2006 largely due to the standardisation of techniques to 
measure IOP compared with the HES, namely Goldmann applanation 
tonometry (GAT). The use of GAT or instruments which adjust for the corneal 
biomechanics should be promoted more among non-OSI to improve the 
accuracy of IOP measurement. However, the reality of increased equipment 
costs and decreased patient throughput means that this may not be a popular 
option for high street optometrists (Myint et al., 2011). The lack of uptake of 
GAT by non-OSIs has resulted in the introduction of LOCSU’s repeat IOP 
schemes. With this scheme optometrists are remunerated for the extra-time it 
takes to measure IOP with GAT compared to air-puff tonometry. 
 
The decline in the detection of an abnormal optic disc by the OSI post NICE is 
interesting. Whether this reflects the variation often seen in studies looking at 
optic disc agreement is unknown, but seems unlikely as the same OSIs were 
present throughout the study. Examination techniques used and training 
remained unchanged throughout the entire study period. The decline may be 
due to optometrists adopting a more risk averse and medico-legally defensive 
approach to practice due to lack of legal indemnity following the AOP’s 
recommendation. This, however, remains speculative.  
 
The AOP’s recommendation that immediately followed the NICE guideline 
publication has had significant implications for GRRS, as demonstrated in this 
study. OSIs may have become more risk averse with respect to optic disc 
assessment, resulting in more onward referrals to the HES after OSI 
assessment. Risk stratification of non-OSI referrals and tighter control on 
GRRS criteria will ensure a more efficient service, with referrals seen by the 
most appropriate eye health professional.  
 
 
 
 
 142 
 
4.3.3. Further work  
 
The decreased agreement between the HES assessment of optic discs to that 
of the non-OSIs and OSIs suggest an important role for virtual review of disc 
images. Virtual review is incorporated in the CHANGES scheme, although the 
majority of GRRS nationally do not employ virtual review. Chapters 3.7 and 
4.6 look into this in more detail. 
 
Clinical decision support software in medicine, particularly in General 
Practice, is well established (Fiks, 2011, Malchow-Moller et al., 1996, Mansell 
et al., 2011). The evaluation of clinical decisions made by optometrists is an 
expanding area of clinical research (Corliss, 1995, Myint et al., 2014), 
however, thus far, this has not translated into the adoption and integration of 
clinical decision support software in improving the quality of referrals based on 
guideline adherence, and this is the subject of future planned work. The 
methods used to train OSIs are changing with a shift towards practice based 
teaching and active learning rather than didactic teaching, and should be 
encouraged (Myint et al., 2014).  
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4.4. The experience of care and awareness of sight testing  
          entitlements in patients referred for suspected     
          glaucoma. 
 
4.4.1.     Summary 
 
Reasons for attending a sight-test are complex and multifactorial. The results 
of this study highlight the need to increase awareness and promote patient 
education about free-sight testing, particularly in those with a family history of 
glaucoma. In this study only 55% of patients diagnosed with glaucoma were 
aware of sight testing entitlements with regard to glaucoma. Symptom led 
demand for sight testing was also evident as 31% waited until they could not 
see clearly or felt they needed new glasses before attending the optometrist.   
 
Whilst the cost to the patient to attend the HES is significantly more than 
visiting the community optometrist, new patients are satisfied with the current 
model of care despite the extra distance and cost. 
 
 
4.4.2. Implications 
 
More has to be done to increase awareness of, and promote patient 
education about, free-sight testing, particularly in those with a family history of 
glaucoma. In the UK, glaucoma is the second largest cause of both severe 
sight impairment and sight impairment registrations, 8.4% and 7.4% 
respectively (Bunce et al., 2010). More effective case-finding will result in less 
glaucoma associated blindness and its far reaching impact on both the 
individual as well as the health system. 
 
Ease of access to health care is important to patients (Gray et al., 1997), and 
this work shows the statistically significant reduction in costs and travel 
distance for those attending the community optometrist compared to the 
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hospital. Whilst it may be acceptable for a patient to travel a greater distance 
and pay more money to attend an outpatient appointment as a new patient, it 
may be more convenient to the patient if long-term review was not carried out 
in the hospital.  
 
 
4.4.3. Future Work 
 
Further promotion of regular sight-testing needs to be carried out. This can be 
at a national level through government campaigns or more locally by general 
practitioners, especially if this was built into their Quality and Outcomes 
Framework.  
 
The RNIB’s ‘Community Engagement Project’ reported the main barriers to 
accessing sight-tests were the perceived cost of the sight test (even amongst 
those eligible for free sight-tests) and cost of glasses (Hayden, 2012). Future 
work to overcome these barriers, especially in socio-economically deprived 
populations, must be carried out. In conjunction, there is a need to further 
explore cost effective, non-commercial models for sight testing and screening 
(Burr et al., 2011, Burr et al., 2007, Hernandez et al., 2008a, Hernandez et al., 
2008b, Mowatt et al., 2008, Prior et al., 2012). With new technology case-
finding could potentially take place within GP practices and community 
hospitals, and not necessarily restricted to optometry practices (Dabasia et 
al., 2015b). 
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4.5. Equity Profile of an Enhanced Optometry scheme. 
 
4.5.1. Summary 
 
As expected, the majority of patients live closer to an optometrist than the 
HES and this ‘care closer to home’ is the main driver towards developing high 
quality community based eye health services at a national level. More 
specifically, low-risk patients who are found to have glaucoma after HES 
review live on average 4.1km closer to the OSI than the HES. In fact, the 
specialist optometrist is often nearer to the patient’s home than even the 
referring optometrist. This is important as the OSIs in enhanced schemes are 
distributed according to the service needs of its population, rather than 
according to economic considerations. 
 
In this study there is no association between final diagnosis and distance to 
an eye health professional, in particular the optometrist. The severity of 
glaucoma at presentation was independent of deprivation and distance to the 
optometrist or hospital; patients who were diagnosed with glaucoma and had 
severe VF loss actually live closer to the PCO than those with mild or 
moderate VF loss and there were no significant differences in deprivation 
scores. This is in contrast to Fraser et al who found deprivation to be linked 
with late presentation of glaucoma to the hospital (Fraser et al., 2001). The 
populations from these studies are markedly distinct, with the CHANGES 
scheme semi-rural and relatively affluent compared to urban and deprived. 
 
 
4.5.2. Implications 
 
Equity profiling is a relatively quick and inexpensive way for health 
professionals and commissioners to understand the need, met or unmet, for 
their population. 
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This study demonstrates that the CHANGES scheme does provide a local, 
easily accessible enhanced optometry service for its population. This may 
contrast with the provision of ‘high street’ optometrists nationally, which are 
private providers and, therefore, priority is more towards economic viability 
rather than service needs of its population. The geographic locations of OSIs 
need to be considered when planning an enhanced optometry scheme. 
 
 
4.5.3. Future Work 
 
Comparison of this equity profile with the first published equity profile (Day et 
al., 2010) highlights the stark variations that can be observed with regard to 
patient access to eye health care and the effect of this on the subsequent 
diagnosis of glaucoma. Further equity profiling studies will better inform future 
national guidance on referral models in ophthalmology. These models, 
however, must be flexible in the delivery of care to allow for the varying 
demands for the local population and, therefore, must be tailored at a local 
level to best serve its population. 
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4.6. The false negative proportion and the role of virtual 
review of a nationally evaluated glaucoma referral refinement   
scheme. 
 
4.6.1. Summary 
 
Consultant Ophthalmologist review of patients discharged by the OSIs did not 
miss any cases of glaucoma, when comparing the clinical findings the OSI 
and the Ophthalmologist. However, 15% of individuals who were classified by 
the OSI as normal were classified by the Consultant Ophthalmologist as being 
suspicious of glaucoma, based on optic disc appearance.  
 
Virtual review of optic disc photographs by either the Consultant or hospital-
based specialist optometrist showed a high sensitivity of 80% to identify a 
suspicious optic disc, when comparing with the reference standard Consultant 
ophthalmologist clinical slit-lamp examination. However, the hospital-based 
optometrist displayed higher specificity than the Consultant resulting in a false 
positive proportion 9 fold lower (3.4% vs 31.0%). 
 
 
4.6.2. Implications 
 
OSIs working in the CHANGES scheme did not miss any cases of glaucoma 
as verified by further clinical review by the Consultant. Although this finding 
cannot be generalised to OSIs nationally as levels of training and 
accreditation vary, it would suggest that GRRS, in addition to being an 
effective way of reducing referrals to HES, are also safe. The disagreement 
between eye health professionals was also demonstrated in chapter 3.4 & 4.3  
 
Virtual review of optic disc images of patients thought by an OSI to be normal 
is a useful adjunct in the infrastructure of a GRRS, resulting in increased 
patient safety. The results would also suggest that there is a learning curve for 
virtual review of optic discs, with the optometrist who regularly reviews all 
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optic disc images for the CHANGES scheme 9 times less likely to generate a 
false positive referral compared to the Consultant Ophthalmologist.  
  
 
4.6.3. Future Work 
 
A standardised and nationally approved framework of competencies for all 
OSIs wishing to work within GRRS and other enhanced optometry services 
needs to be established with the help of the College of Optometrists and the 
Royal College of Ophthalmologists. As chapter 3.4 and 3.7 have shown, even 
OSIs in possession of a nationally recognised postgraduate certificate in 
glaucoma shared care (City University London) show significant variation in 
optic disc assessment. 
 
This variation in optic disc assessment highlights the potential role for virtual 
review before OSI discharge. This study has highlighted that this can be 
effective although a learning curve may exist.  
 
Clinical decision support software and telemedicine are also options that can 
be utilised to improve accuracy and safety of optometry referrals. This is the 
subject of future planned work. 
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4.7. Concluding Remarks  
 
Identifying people at risk of glaucoma is important, and is performed largely by 
opportunistic surveillance by optometrists (Bowling et al., 2005). The increase 
in the number of referrals to the HES after the AOP response to the NICE 
guidelines placed unsustainable demands on capacity within the HES. As a 
result GRRS were developed and the work from this thesis has shown that 
OSIs working in GRRS have been able to both reduce the FVDP of patients 
seen in the HES as well as maintain safety with a missed glaucoma 
proportion for discharged patients of 0%. Whilst efficacy and safety are 
paramount for a successful GRRS, this thesis has also shown that after the 
publication of the NICE guidelines both OSIs and non-OSIs have placed an 
overemphasis on IOP as a criterion for referral and this is having an adverse 
effect on the detection of glaucomatous optic disc features. The reasons for 
this are unknown but may be due to optometrists adopting a more risk averse 
and medico-legally defensive approach to practice due to lack of legal 
indemnity following the AOP’s recommendation. Despite publication of JCG, 
FVDP remain higher than pre NICE. 
 
The studies addressing equity profiles and patient awareness of sight-testing 
entitlements in this semi-rural and affluent population show a stark contrast to 
previously published work looking at urban and deprived populations (Day et 
al., 2010, Fraser et al., 2001). This highlights the importance of equity profiles 
and increasing population awareness of sight-testing entitlements, but also 
demonstrates the need for local level planning and implementation of GRRS.  
 
GRRS should ideally follow nationally agreed guidance with respect to 
scheme infrastructure and referral criteria and this thesis contributes to the 
evidence base. There has been much recent attention within the HES given to 
the development of virtual review of glaucoma patients and this thesis 
suggests this can be a safe alternative to clinic review in appropriate patients. 
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My thesis has tried to systematically evaluate and optimise the refinement of 
glaucoma referrals into the HES, however, with 50% of glaucoma still 
undiagnosed, a greater emphasis is needed in increasing case detection. The 
barriers to attending sight-tests remain and a cost-effective screening test 
remains elusive. Alternative models of care for case detection and screening 
need further exploration. As GP surgeries expand in both size and the 
services they offer, it would be interesting to evaluate a GP-based, technician-
led screening programme and compare this to optometrist-based and -led 
care. Increased case detection would mean the role of GRRS will become 
even more important. 
 
There is a drive by commissioners to transfer the care of stable glaucoma and 
OHT patients out of the hospital and into the community setting, often 
described as ‘shared care’. My work with the HIEC and the studies within this 
thesis has shown to me that GRRS is not only an effective way to reduce the 
FVDP to the HES but serves as a crucial intermediary step to the 
development of ‘shared care’ in terms of identifying and training OSIs. 
 
Ophthalmologists, optometrists, GPs, commissioners of services, glaucoma 
charities and patient representative groups must continue to work closely and 
synergistically with one another to continue to improve the care we provide to 
patients with glaucoma or at risk of developing glaucoma.  
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5.2 Abbreviations  
 
 
ABDO - Association of British Dispensing Opticians 
AOP - Association of Optometrists  
CVI – Certificate Visual Impairment 
CCT – Central Corneal Thickness 
CG – Congenital Glaucoma 
CHANGES - Community and Hospital Allied Network Glaucoma Evaluation Scheme 
CIGTS - Collaborative Initial Glaucoma Treatment Study  
CNTGS - Collaborative Normal Tension Glaucoma Study  
COAG – Chronic Open Angle Glaucoma 
EMGT - Early Manifest Glaucoma Trial  
FODO - Federation of Ophthalmic and Dispensing Opticians 
FVDP - First-visit discharge proportion 
GAT – Goldmann Applanation Tonometry 
GOS - General Ophthalmic Services 
GP – General Practitioner 
GRRS – Glaucoma Referral Refinement Scheme 
HES – Hospital Eye Services 
HIEC – Health Innovation and Education Cluster 
HTG - High Tension Glaucoma 
IMD - Index of Multiple Deprivation 
IOP - Intra-ocular pressure 
JCG – Joint College Guidance 
LOCSU – Local Optical Committee Support Unit 
LoGTS - Low-pressure Glaucoma Treatment Study 
LOXL1 - Lysyl oxidase-like 1 
MREH - Manchester Royal Eye Hospital 
MYOC - Myocilin 
NCT – Non Contact Tonometry 
NHS – National Health Service 
NICE - National Institute for Health and Clinical Excellence 
Non-OSI – Optometrist with no Specialist Interest in glaucoma 
NTG - Normal Tension Glaucoma 
 154 
OHT - Ocular Hypertension 
OPTN - Optineurin 
OSI – Optometrist with Specialist Interest in glaucoma 
OHTS - Ocular Hypertension Treatment Study  
PACG - Primary Angle Closure Glaucoma 
POAG - Primary Open Angle Glaucoma 
PCO – Primary Care Optometrists 
RNIB – Royal National Institute for Blind People 
TIGR - Trabecular meshwork-inducible glucocorticoid response factor 
UKGTS – United Kingdom Glaucoma Treatment Study 
VF – Visual Field 
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Introduction:  
 
THE BURDEN OF GLAUCOMA IN THE UK 
 
Approximately 10% of UK blindness registrations are attributed to glaucoma. 
Approximately 2% of people older than 40 years have primary open angle 
glaucoma (POAG), which rises to 10% in people older than 75 years in white 
Europeans [REF 1]. The prevalence is higher in people with risk factors such as 
black African or black Caribbean descent or in those with a family history of 
glaucoma. Approximately 480,000 people are currently affected by POAG in 
England though this number is expected to increase significantly with changes in 
population demographics.  
 
There are over a million glaucoma-related outpatient visits to the hospital eye 
service annually in the UK. This places an unsustainable demand on 
Ophthalmology out patient departments. Consequently, patients already under 
review for glaucoma often do not receive their follow-up clinic visits in the time 
frame specified by their Ophthalmologist. This can and has already resulted in 
avoidable visual loss. National Patient Safety Agency figures from June 2009 
revealed that 44 patients lost part of their sight as a result of delayed follow-up 
appointments and a further 13 were rendered blind [REF 2]. 
 
 
CURRENT SERVICE PROVISION FOR PATIENTS REFERRED AS 
GLAUCOMA SUSPECTS 
 
The National Institute of Clinical Excellence (NICE) guidelines for patients 
suspected of having glaucoma and ocular hypertension (published in April 2009 
[REF 1] and the subsequent advice by the Association of Optometrists [REF 3] 
have resulted in a marked increase in patients referred with a suspicion of 
glaucoma or ocular hypertension (a risk factor for glaucoma). Approximately 
40% of these referrals made directly to the hospital service (the 'traditional 
pathway') are subsequently found to not have glaucoma and are subsequently 
discharged ('false positive referrals'). This inefficient system constitutes a waste 
of resources and is less than ideal for patients where a provisional diagnosis of 
glaucoma or ocular hypertension can provoke considerable anxiety. 
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In December 2010 a joint college guidance (JCG) was provided by the Royal 
College of Ophthalmologists and College of Optometrists in relation to ocular 
hypertensive patients with low-risk of significant visual field loss in their lifetime. 
It was recommended that optometrists consider not referring patients aged over 
80 years with an IOP of less than 26mmHg with an otherwise normal ocular 
examination. For patients aged between 65 and 80 this IOP recommendation 
was 25mmHg, as this subset of patients does not qualify for treatment under the 
current NICE guidance. For the latter group, it was recommended that these 
individuals be reviewed annually by a community optometrist [REF 4]. 
 
The most recent guideline published by NICE (March 2012) was aimed at the 
commissioning of glaucoma services and was titled ‘Services for people at risk 
of developing glaucoma [REF 5]. It recommends patients with an IOP 30mmHg 
or greater should be referred to secondary care without delay suggesting that 
these patients are not suitable for a community-based refinement of the referral. 
 
 
 
ORGANISATIONAL INTERVENTIONS TO MANAGE OR DIVERT REFERRALS 
OF PATIENTS SUSPECTED TO HAVE GLAUCOMA. 
 
The UK Government has an ambition for community care, enabling of health, 
independence and well being, better access to community services, support for 
people with longer term needs, and care closer to home [REF 6]. The NICE 
Guidelines for glaucoma stated Service Provision as one of its research 
recommendations. Within the UK there are several examples of glaucoma 
referral refinement schemes (GRRS) [REF 7-13] where an accredited 
optometrist will examine the patient that was referred from the original 
optometrist and according to pre-determined criteria and protocol may either 
discharge the patient back to the original referring optometrist or refer the patient 
to the hospital eye service. if there is a genuine cause for concern. GRRS offers 
a different pathway to the traditional pathway in which an optometrist refers all 
patients suspected of glaucoma direct to the hospital service. GRRS carry 
potential advantages in terms of reducing 'false positive' referrals, possible cost 
savings to hospitals and patients, and potentially improved access to care for 
patients. 
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However, there is much variation in how GRRS are organised within the UK and 
much of the basis for shared care of glaucoma with the community lacks a 
scientific evidence base. Little is also known about the cost-effectiveness, 
access to care and patient satisfaction with such schemes, which offer an 
alternative to the traditional hospital-based pathway for managing glaucoma. 
 
 
 
 
National Multi-site Glaucoma Referral Refinement 
Analysis: 
 
The North East, North Central London and Essex Health Innovation and 
Education Cluster (NECLES HIEC) Eyes and Vision work stream has conducted 
a review of 4 established organisationally and clinically distinct GRRS in 
England to establish a national framework for glaucoma referral refinement in 
terms of pathway design and patient safety [REF 14,15]. 
 
The four chosen schemes were Manchester, Nottingham, Gloucestershire and 
Huntingdon. Each scheme is organisationally distinct and reflects the range of 
variation between schemes nationally. 
 
 
Overview of the schemes: 
 
Manchester 
The Manchester glaucoma referral refinement scheme was established in 2000. 
All referrals to Manchester Royal Eye Hospital (MREH) for patients who are 
registered with a GP in central Manchester Primary Care Trust are reviewed by 
one of 12 optometrists with specialist interest in glaucoma (OSIs). The current 
criteria necessitating referral to MREH after referral refinement are a 
modification of the original criteria to reflect the JCG. This includes single 
referral criteria consisting of IOP ≥30mmHg confirmed at a second visit, 
unequivocal pathological cupping of the optic disc noted after pupil dilation or 
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visual field loss consistent with a diagnosis of glaucoma confirmed at a second 
visit. Combined referral criteria include IOP ≥22 mmHg plus a suspicious optic 
disc appearance or optic disc asymmetry. An abnormal optic disc and 
corresponding visual field defect irrespective of the IOP necessitates a referral. 
Additional referral criteria include anterior segment signs of secondary glaucoma 
with IOP >22 mmHg on two occasions, or suspected angle closure (symptoms 
of sub-acute attacks or occludable angle and IOP >22 mmHg). 
 
Nottingham 
The glaucoma referral refinement scheme based at Queens Medical Centre was 
established in 2009. All new referrals for suspected glaucoma are assessed by 
one of 3 hospital-based optometrists. Patients found to have a normal ocular 
examination by these optometrists are discharged. Those patients that are found 
to have glaucoma and who require urgent treatment or who are identified as 
having occludable anterior chamber angles are discussed with a consultant on 
the same day with a treatment plan established and an appropriate prescription 
issued if necessary. Patients diagnosed as ocular hypertensive or in whom 
glaucoma is suspected are offered a review in an ophthalmology clinic.  
 
Gloucestershire 
The Gloucestershire glaucoma referral refinement scheme was established in 
2008, after a successful 5-year pilot from 2003 to 2008. Patients who are 
registered with a Gloucestershire GP practice and are seen by one of 77 local 
OSIs may have their referral refined by this same optometrist. The pilot was 
conducted in the Forest of Dean. In 2008, all community optometrists with no 
specialist interest in glaucoma (non-OSIs) were offered the opportunity to 
participate and become accredited to the scheme. Patients who are registered 
with a Gloucestershire GP practice are seen by one of 103 (85%) accredited 
community optometrists and have their referral refined by the same accredited 
optometrist (for consistency in nomenclature accredited community optometrists 
will subsequently also be referred to as OSI). The optometrist is only reimbursed 
for referral of those patients who meet the following NICE compliant, referral 
criteria: patients younger than 65 years with IOP in either eye of ≥ 22mmHg, 
patients aged 65 years or older with an IOP ≥ 25mmHg, measured twice on 
each of 2 separate patient visits with a Goldmann or Perkins tonometer. If initial 
measurement is ≥ 30mm Hg and/or angle closure is suspected, repeated IOP 
measurements on one occasion are sufficient for referral. Regardless of IOP, 
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patients are referred if the optic disc appearance is glaucomatous and/or a 
reproducible visual field defect (evident on two separate occasions) is noted with 
automated perimetry. When a patient attends a non-accredited optometrist, a 
referral is made in the usual way, without refinement, via the patient’s GP to the 
hospital glaucoma clinic.  
 
Huntingdon 
The Community and Hospital Allied Network Glaucoma Evaluation Scheme 
(CHANGES) was established in 2006 and involves an initial triage of the referral 
letter by a hospital based optometrist into either low or high-risk according to a 
protocol. A referral is deemed low-risk if only one/none of the following risk 
factors were noted for either eye: abnormal optic disc, abnormal visual field, 
abnormal IOP (22-28mmHg or IOP asymmetry). All other referrals were deemed 
high-risk (including any reference to a shallow anterior chamber). Low-risk 
patients are seen by one of 8 community based OSIs and high-risk patients are 
seen directly in the hospital’s specialist glaucoma clinic. Only those low-risk 
patients with a normal ocular examination (IOP less than 22mmHg, normal optic 
disc and visual fields) are discharged. 
 
 
Each of these schemes requires participating optometrists to gain accreditation 
through a hospital approved training scheme. A diploma in glaucoma is not a 
prerequisite. All patients seen by an OSI in these schemes have IOP measured 
using Goldmann or Perkins tonometry, optic disc assessment with slit-lamp 
binocular indirect ophthalmoscopy recommended and visual field assessment 
using a perimeter with a supra-threshold algorithm. Patients who fulfill 
predetermined criteria are subsequently referred to the hospital, and the others 
are discharged with feedback to the original referring optometrist.  
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Schematic diagram of each scheme 
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Data Collection: 
 
The outcomes of GRRS in Huntingdon, Manchester, Gloucestershire and 
Nottingham were retrospectively analysed. A two month time period based on 
date of a patient’s hospital appointment was used for both pre NICE (March and 
April 2009) and post JCG (March and April 2011) time frames. A total of 4 
months were collected for the post NICE data; a two-month time period soon 
after the implementation of the NICE guidance (November and December 2009) 
and a 2 month period later following implementation (August and September 
2010). These time frames were chosen to allow an analysis of temporal changes 
in scheme activity in a timeframe of significant alteration in national policy.  
 
In Huntingdon and Nottingham the data from the non-OSI who initiated the 
referral as well the subsequent findings from the next eye health professional in 
the pathway were collected. In Manchester and Gloucestershire the data from 
the findings of the OSI and that of the subsequent hospital visit were analysed. 
The pathway of a patient through each of these schemes differed with respect to 
the eyecare professional involved therefore the activity of OSI and non-OSI 
could be compared with respect to reason for referral as well as the 
unnecessary referral rate of these referrals during a period of changing national 
policy. 
 
In addition the outcomes of all low and high-risk referrals to Hinchingbrooke 
Hospital in Huntingdon since the CHANGES scheme was implemented in 2006 
was collected and analysed as an additional component to the HIEC work. The 
primary outcome measures from this work were to establish the number of 
unnecessary referrals generated by OSI and non-OSI for each reason for 
referral as well as assessing the accuracy of the examination findings of these 
optometrists with respect to a consultant ophthalmologist in glaucoma which is 
deemed as the gold standard. 
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Summary of the Main Findings from the multi-site review: 
 
Data relating to 1086 patients were analysed: 434 from Huntingdon, 179 from 
Manchester, 204 from Gloucestershire and 269 from Nottingham. 
By time period, 190 (17.5%) attended their hospital appointment in the pre NICE 
time period, 338 (35.7%) early post NICE, 287 (26.4%) later post NICE and 271 
(25.0%) post JCG.  
 
Of the 1086 patients, 521 were male. 56.1% of patients referred from an OSI 
were male as compared to 43.7% of non-OSI referrals.  Mean age of patients 
seen by the OSIs was 63.2 years compared to 62.0 years by non-OSIs. 
 
Reason for Referral for non-OSI and OSI 
 
The reason for referral can be based on an elevated IOP, abnormal optic disc or 
visual field (VF) appearance, or any combination of these. The most common 
reason for a non-OSI referral was an elevated IOP only (accounting for 36.1% of 
non-OSI referrals). In the pre NICE timeframe IOP only referrals accounted for 
19.0% of referrals, increasing to 45.1% in the early post NICE period. This 
reduced in the post NICE period to 32.0% and rose again post JCG to 41.3%. 
This general rise over time was coupled with a decrease in many other reasons 
for referral by the non-OSI, particularly for referrals not involving IOP. This is 
exemplified by disc only referrals which dropped from 15.9% pre NICE to 6.1% 
early post NICE. A more detailed breakdown of the temporal trend for reason for 
referral by non-OSIs (Huntingdon and Nottingham schemes) is found in the table 
below.  
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Reason for non-OSI referral by time period: Huntingdon and Nottingham 
 
Guideline period 
Pre NICE Early post 
NICE 
Later post 
NICE 
Post JCG 
Total  
 
Reason for 
referral Count % Count % Count % Count % Count % 
IOP only 24 19.0 96 45.1 58 32.0 76 41.3 254 36.1 
Disc only 20 15.9 13 6.1 34 18.8 22 12.0 89 12.6 
VF only 8 6.3 6 2.8 10 5.5 13 7.1 37 5.2 
IOP+Disc 20 15.9 33 15.5 19 10.5 18 9.8 90 12.8 
IOP+VF 5 4.0 9 4.2 8 4.4 6 3.3 28 4.0 
Disc+VF 14 11.1 13 6.1 21 11.6 22 12.0 70 9.9 
IOP+Disc+VF 9 7.1 28 13.1 7 3.9 5 2.7 49 7.0 
Other 26 20.6 15 7.0 24 13.3 22 12.0 87 12.4 
Total 126 100.0 213 100.0 181 100.0 184 100.0 704 100.0 
 
 
 
 
 
 
 
 
 
The most common reason for referral by the OSIs was for raised IOP and it 
accounted for 28.8% of OSI referrals. IOP only referrals by the OSI demonstrated 
a less marked increase post NICE than the non-OSI, 10.9% to 28.0%. The 
proportion of referrals not involving a raised IOP demonstrated an increase in the 
early post NICE period again mainly on account of disc only referrals which 
accounted for 18.8% of referrals pre NICE to 20.0% post NICE. A more detailed 
breakdown of the temporal trend for reason for referral by OSIs (Manchester and 
Gloucestershire schemes) is found in the table below.  
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Reason for OSI referral by time period: Gloucestershire and Manchester  
 
Guideline period 
Pre NICE Early post NICE Later post NICE Post JCG 
Total  
 
Main reason for 
referral 
Count % Count % Count % Count % Count % 
IOP only 7 10.9 35 28.0 44 41.5 24 27.6 110 28.8 
Disc only 12 18.8 25 20.0 16 15.1 16 18.4 69 18.1 
VF only 3 4.7 3 2.4 6 5.7 5 5.7 17 4.5 
IOP+Disc 13 20.3 27 21.6 17 16.0 18 20.7 75 19.6 
IOP+VF 4 6.2 8 6.4 4 3.8 2 2.3 18 4.7 
Disc+VF 8 12.5 19 15.2 12 11.3 14 16.1 53 13.9 
IOP+Disc+VF 17 26.6 8 6.4 4 3.8 6 6.9 35 9.2 
Other 0 0.0 0 0.0 3 2.8 2 2.3 5 1.3 
Total 64 100.0 125 100.0 106 100.0 87 100.0 382 100.0 
  
 
Unnecessary referral rate 
 
The overall unnecessary referral rate (URR) for non-OSI referrals was 36.1%, 
with a pre NICE URR of 29.2%, early post NICE of 35.0%, later post NICE of 
34.7% and post JCG of 43.9%. The overall URR for OSI referrals was 14.1%, 
with pre NICE URR of 15.2%, early post NICE of 15.0%, later post NICE of 
17.2% and post JCG of 14.1%.  
 
The URR for each site for each time period is given in the table and figure 
below. When interpreting this graph it is important to note that for Nottingham 
and Huntingdon the graph represents the URR for the non-OSI and for 
Manchester and Gloucestershire the URR is representative of the OSI. 
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Unnecessary Referral Rate by site and by time period  
 
Period  
Site (professional 
initiating referral) 
Pre NICE Early post 
NICE 
Later post 
NICE 
Post JCG 
 
Overall 
Nottingham (non-OSI) 19.5 32.8 25.3 53.7 33.5 
Huntingdon (non-OSI) 33.3 37.6 42.1 38.3 38.0 
Manchester (OSI) 4.9 6.5 16.9 3.0 8.9 
Gloucestershire (OSI) 8.7 20.3 12.5 25.9 18.6 
Non-OSI overall 29.2 35.0 34.7 43.9 36.1 
OSI overall 6.3 15.2 15.0 17.2 14.1 
Overall 21.9 27.8 27.6 35.4 28.6 
 
 
Temporal trends in Unnecessary Referral Rate by site 
 
 
 
Observed Percentage unnecessary
referral by Period for each Study site
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 183 
 
 
 
Summary of Main Findings from Huntingdon data: 
 
The analysis of the Huntingdon database included 2912 patients (average age, 
63.6 years; 1623 men) referred by primary care. Of these referrals, 2154 (74%) 
were categorised as at high-risk (average age, 63.6 years; 941 men) and 758 
(26%) were deemed low-risk (average age, 59.5 years; 348 men).  
 
The number of patients seen in both low and high-risk had increased since 
2006. The total number of low-risk referrals involving IOP was 467 (61.6%) with 
a sharp rise in these numbers since 2009. The numbers of high-risk referrals 
involving IOP was 1558 (72.3%) with a steady increase in numbers since 2006. 
The highest unnecessary referral rates were for referrals due to an IOP between 
22 and 27mmHg (45.4%), IOP asymmetry (52.8%), VF defect (46.3%) and IOP 
and VF (54.0). Modelling of the JCG may have resulted in 65 less referrals and 
the NICE commissioning guidance 28 less referrals. 
 
The agreement between an OSI and a non-OSI to a consultant ophthalmologist 
in determining whether the IOP in either eye was normal (<22mmHg) or 
abnormal (>21mmHg), expressed as a percent positive predictive value (PPPV), 
was 61.2% for the OSI and 49.4% for the non-OSI. For high-risk IOP referrals 
(IOP > 28mmHg) the PPPV between a non-OSI and consultant was 75.0%. OSI 
in the Huntingdon scheme do not review patients with high-risk referral letters 
and thus this corresponding value for an OSI is not known. 
The PPPV for the identification of an abnormal optic disc for an OSI and non-
OSI was 51.3% and 43.3% respectively. 
 
OSIs and to a lesser extent non-OSIs were substantially better at identifying 
normal IOPs and normal optic discs. 
 
 
 
 
 184 
Summary of Main Conclusions and Recommendations: 
 
This report of activity from four established referral refinement schemes of 
differing design has demonstrated that OSIs can successfully refine the referrals 
from non-OSIs for suspected glaucoma leading to a reduction in the 
unnecessary referral rate of patients being reviewed in secondary care. This 
work has also highlighted the key role the secondary care provider, particularly 
the consultant ophthalmologist, plays to ensure patients with glaucoma are 
correctly diagnosed and also in preventing missed cases of glaucoma from 
inappropriate discharge. It is therefore recommended that patients with a high-
risk of being diagnosed with glaucoma based on the examination findings of the 
non-OSI should be referred directly to secondary care and those at lower risk 
could effectively and safely be reviewed by an OSI, ideally in the community 
setting. The results of this analysis lead us to recommend that it would be 
effective and safe to define the low-risk category as referrals based on IOP only, 
optic disc only, VF only and IOP and VF, with all other referrals including any 
reference to a shallow anterior chamber angle better suited to a direct referral to 
secondary care.   
 
Advantages of referral refinement that utilises OSIs may include better access 
for patients and less anxiety experienced by patients awaiting a referral to the 
hospital service. The additional numbers of clinicians specialising in glaucoma 
care as a result of training OSIs, added to feedback to non-OSIs about the result 
of their referral has been demonstrated to result in a general improvement in 
quality of referrals by the non-OSI community. Higher quality referrals to the 
hospital service result in a more efficient utilisation of a consultant 
ophthalmologist’s time in a service which is usually pressured by the demand for 
follow-up appointments for this chronic disease. The numbers of OSIs involved 
in a glaucoma referral refinement scheme will be governed by local factors, but it 
is important that close communication and a collective work ethic is created and 
maintained by the OSI, secondary care provider and commissioner for a scheme 
to be successful. Education and training of all optometrists, not only OSIs, 
should be encouraged to further reduce the unnecessary referral rate, 
particularly as high-risk referrals from a non-OSI would bypass the refinement 
stage and be referred directly to secondary care. 
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The referral criteria in the Manchester scheme resulted in the lowest 
unnecessary referral rate. It is advised to implement referral criteria that are 
based on national policy and College guidance if a national framework for 
glaucoma referral refinement is to be established. It is therefore the 
recommendation from the authors that OSIs utilise the referral criteria of the 
JCG which crucially allows the OSI to operate with professional and legal 
support. In addition, further modifications to the original NICE guidance to allow 
optometrists to use more discretion for borderline IOP levels in younger patients, 
especially if the IOP was measured using non-contact tonometry is required. 
This has been successfully piloted in Gloucestershire.  
 
It is the recommendation of the authors that a full comprehensive eye 
examination should be carried out by all OSIs in a glaucoma referral refinement 
scheme. This should involve Goldmann/Perkins tonometry as the sole method 
for measuring IOP, anterior chamber depth evaluation using Van Herick or 
gonioscopy, detailed (ideally dilated) indirect slit-lamp based ophthalmoscopy for 
disc assessment, and visual field testing using a suprathreshold visual field 
machine (ideally the same as that use by the local secondary care provider). 
The results have highlighted the potential for missed pathology if IOP is 
measured alone. 
 
 
Glaucoma Referral Refinement Activity in North London 
and Essex 
 
There is a relative paucity of GRRS in operation in north London and Essex 
when the HIEC Glaucoma Pathways project began in April 2011. 
 
Multiple meetings with Local Optical Committees (LOC), Consultant 
Ophthalmologists, Cluster and GP commissioning leads in these regions has 
resulted in a general increase in the awareness GRRS, and how implementation 
of these schemes can successfully result in many more patients being reviewed 
in a community setting in keeping with the Care Closer to Home initiative, as 
well as reducing the considerable burden new glaucoma out-patients 
appointments are placing on Ophthalmology departments nationwide. It is 
anticipated that these meeting will serve as a platform for continued 
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communication between all stakeholders and hopefully result in the 
implementation of GRRS for which the HIEC multi-site research project will 
provide a framework and evidence base. 
 
In the 12 months from April 2011 – April 2012 a new glaucoma referral 
refinement scheme has been agreed upon in Islington. The majority of glaucoma 
referrals to Moorfields Eye Hospital are generated by optometrists working 
within Islington and this scheme should successfully reduce the number of 
referrals for suspected glaucoma to Moorfields Eye Hospital by 25% in keeping 
with the recent NICE commissioning guidance on glaucoma [REF 5]. 
 
Through close collaboration with the HIEC, the GRRS in Barnet has been 
successfully updated to reflect national and College guidance. Education and 
training has been provided to both participating specialist optometrists as well as 
non-participating optometrists in an endeavour to raise the awareness and skills 
of optometrists in this region. 
 
GRRS serves as an efficient and safe alternative to the traditional referral 
pathway for patients with suspected glaucoma. There is a need for a national 
framework and guidance on glaucoma referral refinement to ensure equity of 
care and safety is afforded to all patients. It is hoped the work from the HIEC 
can serve as evidence base on which this guidance can be developed. 
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